Regulation of Rab8 in Toll-Like Receptor Signalling Pathways by Tong, Samuel Jia Ming
 i 
 
 
 
 
 
 
 
Regulation of Rab8 in Toll-Like Receptor Signalling Pathways 
by 
Samuel Tong Jia Ming 
Bachelor of Biomedical Science (Hons) 
 
 
 
 
 
 
 
 
 
A thesis submitted for the degree of Doctor of Philosophy at 
The University of Queensland in 2020 
Institute for Molecular Biosciences 
 ii 
Abstract 
 
Small GTPases of the Rab family have wide ranging and essential roles in recruiting 
effectors to mediate membrane trafficking and receptor signalling events in mammalian 
cells. Nucleotide loading and activation/deactivation of the Rabs themselves are regulated 
by guanine nucleotide exchange factors (GEFs), GTPase activating proteins (GAPs) and 
other accessory proteins. While Rabs have important roles in innate immune cells, for host-
pathogen interactions, receptor signalling and membrane trafficking, in many cases their 
GEFs and other accessory proteins have not been elucidated.  
 
Pathogen-activated, Toll-like receptors (TLRs) initiate and modulate transcription of 
inflammatory cytokines and other innate immune responses which are important for immune 
defence but can also contribute to chronic disease. Macrophages are key cells of the innate 
immune system and previous work from our laboratory established a role for promiscuous 
Rab family member, Rab8a, in TLR signalling. Rab8a is activated in TLR pathways to recruit 
phosphoinositide 3-kinase gamma (PI3K) as an effector which upregulates TLR-induced 
Akt/mTOR signalling to drive a biased program of anti-inflammatory cytokines. TLR-
associated PI3K has now emerged as a key mediator of macrophage programming (or 
polarisation) in inflammation and cancer and its cognate GTPase, Rab8a, has a prominent 
role in immunity and disease. Rab8a is itself recruited to macrophage ruffles and 
macropinosomes through its association with the TLR crosstalk-activated endocytic receptor 
LRP1. However, it is not yet known how Rab8a is activated in TLR pathways. This project 
set out to identify the essential Rab8a GEF(s) needed to activate Rab8a as part of the LRP1 
complex. 
 
Two well-known Rab8 GEFs, GRAB and Rabin8, which previously were uncharacterised in 
macrophages, were investigated in this project. GRAB was identified as part of the low 
density lipoprotein receptor-related protein 1 (LRP1) complex in pull-downs analysed by 
mass spectrometry. Co-immunoprecipitation and fluorescence microscopy showed that both 
GRAB and the structurally similar GEF, Rabin8, undergo LPS-inducible binding to Rab8a 
and are localised at sites of Rab8a enrichment. To carry out functional studies, stable 
knockouts (KOs) of Rabin8, GRAB, as well as a double KO were produced via CRISPR-
Cas9 gene editing in macrophage cell lines. Nucleotide activation assays were developed 
for this project and live-cell imaging with KO cell lines showed that both GEFs contribute 
additively to TLR4-induced Rab8a GTP-loading, but they are not needed for Rab8a 
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membrane recruitment. Analysis of TLR signalling after double KO of both GEFs suggested 
redundant roles for Rabin8 and GRAB in activating Rab8a for PI3K-dependent Akt/mTOR 
signalling. Live cell imaging utilising a fluorescent Akt1 reporter confirmed that LPS/TLR-
induced Akt signalling is generated on macropinosomes and requires GRAB and Rabin8 
GEF function.  
 
Next, to investigate possible regulators of the Rab8 GEFs, pull -downs and mass 
spectrometry were performed and identified a known multi-Rab effector, oculocerebrorenal 
syndrome of Lowe (OCRL) as a Rabin8 binding protein in LPS activated macrophages. 
Follow-up experiments provided initial characterisation  of a novel OCRL-Rabin8 interaction 
and indicate a possible recruitment mechanism for the Rab8 GEF during TLR signalling.  
 
In conclusion, these results identified both GRAB and Rabin8 as essential activators of Rab8 
downstream of TLR4 for inflammatory signalling in mouse macrophages. The results 
contribute these GEFs and other possible Rab recruiters to an expanding molecular complex 
that drives PI3K/Akt/mTOR signalling for control of inflammation and innate immune 
responses.  
 iv 
Declaration by Author 
 
This thesis is composed of my original work, and contains no material previously published 
or written by another person except where due reference has been made in the text. I have 
clearly stated the contribution by others to jointly-authored works that I have included in my 
thesis. 
 
I have clearly stated the contribution of others to my thesis as a whole, including statistical 
assistance, survey design, data analysis, significant technical procedures, professional 
editorial advice, financial support and any other original research work used or reported in 
my thesis. The content of my thesis is the result of work I have carried out since the 
commencement of my higher degree by research candidature and does not include a 
substantial part of work that has been submitted to qualify for the award of any other degree 
or diploma in any university or other tertiary institution. I have clearly stated wh ich parts of 
my thesis, if any, have been submitted to qualify for another award. 
 
I acknowledge that an electronic copy of my thesis must be lodged with the University Library 
and, subject to the policy and procedures of The University of Queensland, the thesis be 
made available for research and study in accordance with the Copyright Act 1968 unless a 
period of embargo has been approved by the Dean of the Graduate School.  
 
I acknowledge that copyright of all material contained in my thesis resides with the copyright 
holder(s) of that material. Where appropriate I have obtained copyright permission from the 
copyright holder to reproduce material in this thesis and have sought permission from co-
authors for any jointly authored works included in the thesis. 
 
 v 
Publications included in this thesis 
 
Chapter 4 
1. Wall AA, Luo L, Hung Y, Tong SJ, Condon ND, Blumenthal A, Sweet MJ and Stow 
JL (2017). Small GTPase Rab8a-recruited Phosphatidylinositol 3-Kinase γ Regulates 
Signaling and Cytokine Outputs from Endosomal Toll-like Receptors. Journal of 
Biological Chemistry. 2017;292(11): 4411-4422. 
 
2. Luo L, Wall AA, Tong SJ, Hung Y, Xiao Z, Tarique AA, Sly PD, Fantino E, Marzolo 
MP and Stow JL. TLR Crosstalk Activates LRP1 to Recruit Rab8a and PI3Kγ for 
Suppression of Inflammatory Responses. Cell reports. 2018;24(11):3033-3044. 
 
Chapters 4 – 6 
1. Tong SJ, Wall AA, Hung Y, Luo L, Stow JL. (2019) Guanine nucleotide exchange 
factors activate Rab8a for Toll-like receptor signalling. Small GTPases. 1-17; doi: 
10.1080/21541248.2019.1587278 – The published manuscript utilised results from 
Chapters 4 – 6 in this thesis. 
 vi 
Submitted manuscripts included in this thesis 
 
No manuscripts submitted for publication  
 
Publications during candidature 
 
These are the publications that include experimental data I produced and analysed during 
my candidature. 
1. Luo L, Bokil NJ, Wall AA, Kapetanovic R, Lansdaal NM, Marceline F, Burgess BJ, 
Tong SJ, Guo Z and Alexandrov K. (2017) SCIMP is a transmembrane non-TIR TLR 
adaptor that promotes proinflammatory cytokine production from macrophages. 
Nature communications. 8: 14133; doi: 10.1038/ncomms14133. 
 
2. Luo L, Tong SJ, Wall AA, Khromykh T, Sweet MJ and Stow JL. Development of SH2 
probes and pull-down assays to detect pathogen-induced, site-specific tyrosine 
phosphorylation of the TLR adaptor SCIMP. (2017) Immunology and cell biology. 
95(6): 564; doi:10.1038/icb.2017.10. 
 
3. Wall AA, Luo L, Hung Y, Tong SJ, Condon ND, Blumenthal A, Sweet MJ and Stow 
JL (2017). Small GTPase Rab8a-recruited Phosphatidylinositol 3-Kinase γ Regulates 
Signaling and Cytokine Outputs from Endosomal Toll-like Receptors. Journal of 
Biological Chemistry. 292(11): 4411-4422; doi:10.1074/jbc.M116.766337. 
 
4. Luo L, Wall AA, Tong SJ, Hung Y, Xiao Z, Tarique AA, Sly PD, Fantino E, Marzolo 
MP and Stow JL. (2018) TLR Crosstalk Activates LRP1 to Recruit Rab8a and PI3Kγ 
for Suppression of Inflammatory Responses. Cell reports. 24(11):3033-3044; 
doi:10.1016/j.celrep.2018.08.028 
 
5. Tong SJ, Wall AA, Hung Y, Luo L, Stow JL. (2019) Guanine nucleotide exchange 
factors activate Rab8a for Toll-like receptor signalling. Small GTPases. 1-17; doi: 
10.1080/21541248.2019.1587278 
 
 
 
 vii 
Contributions by others to the thesis  
 
Professor Jennifer Stow 
Contributed towards the conceptual design of the project, provided experimental 
advice and supported the editing of this thesis. 
 
Dr Lin Luo 
Contributed towards the conceptual design of the project, developed the GST probes 
used in this project, provided technical advice and assisted with the editing of this 
thesis.  
 
Dr Adam Wall 
Provided technical and experiment expertise and advice for all l ive- and fixed-cell 
microscopy imaging used in this project. 
 
Tatiana Khromykh 
Provided technical support with molecular cloning and tissue culture throughout the 
project. 
 viii 
Statement of parts of the thesis submitted to qualify for the award of another 
degree 
 
No works submitted towards another degree have been included in this thesis. 
 
Research Involving Human or Animal Subjects  
 
UQ Animal ethics number: IMB/535/17 (12-Mar-2018 to 12-Mar-2021) 
 ix 
Acknowledgements 
I would like to take the opportunity to express my gratitude and thank the individuals who 
have helped me during my candidature. Every member of the Stow lab (and others at the 
institute) has made my time here at the IMB an enjoyable and rewarding experience, so if 
not mentioned by name below (you know who you are), please know that I am truly grateful. 
 
First and foremost, I would like to express my sincerest gratitude to my supervisor, Professor 
Jennifer Stow. You have been an ever-present source of guidance, support and 
encouragement throughout my PhD, and I will be forever thankful for the time you spent 
discussing and troubleshooting my work, helping me design experiments and proof-reading 
my writing (so sorry about that). You always drove me to be better and have helped shaped 
me to become the scientist I am today. As you always say, onwards and upwards! 
 
I would also like to thank my other supervisor Dr Lin Luo, who was at the forefront of my 
training during my PhD. You have not only taught me essential scientific techniques and 
skills, but also gave excellent advice and guidance throughout my time here at the IMB. Your 
mentorship and supervision taught me what it meant to be a proper scientist and I deeply 
appreciate being your student.  
 
Additionally, I wish to thank my mentor and colleague Dr Adam Wall. My studies would have 
never been as successful without your support, assistance and guidance. The microscopy 
and molecular biology (CRISPR) techniques I learnt from you were critical components in 
this project, and for that I am indebted to you.  
 
I next want to express my appreciation to my fellow Stow lab PhD students who have all in 
one way or another contributed to the completion of this thesis. To Yu Hung, Xiao ZhiJian 
(James), Neeraj Tuladhar, Dominique McConnachie and Liu Li Ping, I wish to thank you all 
for the advice, technical assistance and friendship throughout my studies. I wish you all the 
absolute best for your individual PhDs and future careers.  
 
Next, I would like to thank the other Stow lab members, Tatiana Khromykh and Darren 
Brown for their technical assistance and advice. To Tatiana especially, I would like to 
express my gratitude for your help with tissue culture, molecular cloning and sequencing, 
along with your delicious home-made goodies. To the other post-docs in the lab, Dr Richard 
 x 
Lucas and Dr Yvette Koh, thank you for providing advice and assistance with the proof -
reading of this thesis. 
 
I would also like to extend my gratitude towards a previous member of the lab, Dr Nicholas 
Condon. I felt truly fortunate to have such an experienced and ‘battle hardened’ PhD student 
to learn from at the start of my candidature. You were a role model for me, and your advice 
and guidance became the pillar of support I relied on throughout the first year of my PhD. 
 
This project could not have been possible without the generous funding and support 
provided by the University of Queensland’s International Scholarship (UQI) programme and 
the Institute for Molecular Bioscience’s (IMB) Postgraduate Award and Travel Awards which 
provided living expenses and travel to the FASEB Small GTPases meeting. 
 
Finally, I would like to thank my friends and family for their continued support throughout my 
program. Living the past 4 years apart from most of you has not been easy, and I do regret 
not being around you all for such an extended period. I want to take this opportunity to 
express my sincerest gratitude to everyone for being so understanding. I especially like to 
thank my partner Hiok Joo for your patience, encouragement and willingness to put up with 
everyone asking when I was coming back. You have helped me through some tough times 
during my studies and this thesis would not be here without you. To my sister Sandy, thank 
you for always being there and ready to drop some truth bombs/advice. You are an amazing 
older sister and now that I’m heading back, you have another pair of hands to help carry 
your two lovely sons (within reason). To my mum and dad, thank you for all the help, advice 
and support you have given me throughout my life, you have been the greatest parents 
anyone could have asked for and hopefully, you will be relieved to know that I will now go 
on to earn some real money.  
  
 xi 
Financial support 
This research was supported by the University of Queensland International Scholarship 
(UQI) and the Institute for Molecular Bioscience (IMB) Postgraduate Award. 
 
Travel to attend the Federation of American Societies for Experimental Biology (FASEB): 
Small GTPases in Membrane Processing international conference was in part supported via 
an IMB postgraduate travel award 
 
Keywords 
macrophages, rab gtpases, rab8, guanine nucleotide exchange factors, grab, rabin8, toll-
like receptors, pi3k, lrp1, inflammation. 
 xii 
Australian and New Zealand Standard Research Classifications (ANZSRC) 
 
ANZSRC code: 060108 Protein Trafficking 40% 
ANZSRC code: 060110 Receptors and Membrane Biology 30% 
ANZSRC code: 110707 Innate Immunity 30% 
 
Fields of Research (FoR) Classification 
 
FoR code: 0601, Biochemistry and Cell Biology, 70% 
FoR code: 1107, Immunology, 30% 
  
 xiii 
Table of Contents 
Abstract................................................................................................................................................ ii 
Declaration by Author ........................................................................................................................ iv 
Publications included in this thesis ..................................................................................................... v 
Submitted manuscripts included in this thesis .................................................................................. vi 
Publications during candidature........................................................................................................ vi 
Contributions by others to the thesis................................................................................................ vii 
Statement of parts of the thesis submitted to qualify for the award of another degree ............. viii 
Research Involving Human or Animal Subjects............................................................................... viii 
Acknowledgements ............................................................................................................................ ix 
Financial support ................................................................................................................................ xi 
Keywords ............................................................................................................................................ xi 
Australian and New Zealand Standard Research Classifications (ANZSRC)  ................................... xii 
Fields of Research (FoR) Classification.............................................................................................. xii 
Table of Contents.............................................................................................................................. xiii 
List of Figures .................................................................................................................................... xvi 
List of Tables .................................................................................................................................... xvii 
List of Abbreviations..........................................................................................................................xix 
1. Introduction ..................................................................................................................................... 2 
Macrophages ................................................................................................................................... 2 
Toll-Like Receptors (TLRs) ............................................................................................................... 2 
Macrophage polarisation and inflammation.................................................................................. 5 
Rab GTPases..................................................................................................................................... 7 
Rabs in innate immune cells .................................................................................................................................................... 11 
Rab8 ............................................................................................................................................... 13 
Rab8 functions............................................................................................................................................................................ 14 
Rab8 effectors ............................................................................................................................................................................ 18 
Guanine nucleotide exchange factors (GEFs) ............................................................................... 21 
Rab8 GEFs.......................................................................................................................................................................................1 
2. Aims and Significance ..................................................................................................................... 7 
Project Hypothesis........................................................................................................................... 9 
AIM 1.................................................................................................................................................. 10 
Identify the candidate GEF(s) for Rab8a activation in TLR-activated macrophages................... 10 
AIM 2.................................................................................................................................................. 10 
Examine the functional role of GEF(s) in Rab8-mediated TLR-signalling .................................... 10 
AIM 3.................................................................................................................................................. 11 
 xiv 
Investigate upstream regulators of Rab8a GEFs in TLR signalling ............................................... 11 
3. Materials and Methods................................................................................................................. 13 
Plasmids ......................................................................................................................................... 13 
Microscopy.................................................................................................................................................................................. 13 
Rab8 activation assay  ................................................................................................................................................................ 13 
Protein-protein interaction ...................................................................................................................................................... 14 
CRISPR-Cas9  ................................................................................................................................................................................ 14 
Protein Expression ......................................................................................................................... 16 
Cell culture and transfection ......................................................................................................... 17 
Rab8 activation assay and immunoprecipitation......................................................................... 17 
Mass spectrometry ........................................................................................................................ 18 
Immunoblotting ............................................................................................................................. 19 
CRISPR/Cas9-knockout (KO) of GRAB and Rabin8 ....................................................................... 19 
Fluorescence microscopy .............................................................................................................. 23 
Membrane fractionation ............................................................................................................... 23 
Image analysis software ................................................................................................................ 24 
Statistics ......................................................................................................................................... 24 
Key resource table ......................................................................................................................... 25 
4. Results 1 ......................................................................................................................................... 29 
Introduction ................................................................................................................................... 29 
Results ............................................................................................................................................ 31 
Characterisation of Rab8a in mouse macrophages ............................................................................................................. 31 
An unbiased screen of Rab8 interacting partners in TLR4-activated macrophages ...................................................... 35 
Rab8 GEFs Rabin8 and GRAB both interact with Rab8a in an LPS-inducible manner ................................................... 36 
Localisation of Rabin8 and GRAB in mouse macrophages  ................................................................................................. 39 
Measuring Rab8 ac tivation  ...................................................................................................................................................... 41 
Discussion ...................................................................................................................................... 52 
5. Results 2 ......................................................................................................................................... 59 
Introduction ................................................................................................................................... 59 
Results ............................................................................................................................................ 61 
Generation of GRAB and Rabin8 CRISPR KO cell-lines ........................................................................................................ 61 
Both GRAB and Rabin8 contribute to LPS-induced Rab8 activation in mouse macrophages ...................................... 69 
Rab8a localisation is unaffected in the absence of either GRAB or Rabin8  .................................................................... 70 
Discussion ...................................................................................................................................... 73 
6. Results 3 ......................................................................................................................................... 77 
Introduction ................................................................................................................................... 77 
Results ............................................................................................................................................ 79 
Deletion or overexpression of either GRAB or Rabin8 does not affect Rab8-associated TLR-signalling ................... 79 
Double knockouts reveal additive functions for GRAB and Rabin8 in LPS-associated activation  ............................... 81 
Analysis of Rab8a me mbrane localisation and retention in the GRAB and Rabin8 double knockout cells ............... 83 
GRAB and Rabin8 both contribute to GTP-Rab8a-mediated Akt signalling. ................................................................... 84 
Visualising signalling through Akt enrichment on macropinosome membranes ........................................................... 86 
 xv 
Rab8 GEFs are involved in Akt signalling on macropinosomes.......................................................................................... 87 
Discussion ...................................................................................................................................... 90 
7. Results 4 ......................................................................................................................................... 95 
Introduction ................................................................................................................................... 95 
Results ............................................................................................................................................ 97 
Investigating kinase mediated activation of Rabin8 in macrophages  .............................................................................. 97 
Identification of a new Rabin8 binding partner in mouse macrophages....................................................................... 100 
OCRL localisation in LPS-ac tivated macrophages............................................................................................................... 102 
OCRL interacts directly with Rabin8 independently of Rab8  ........................................................................................... 103 
Discussion .................................................................................................................................... 108 
8. Final Discussion and Future Directions ....................................................................................... 113 
Significance and overview ........................................................................................................... 113 
Rab8 activation ............................................................................................................................ 115 
GEFs in TLR signalling................................................................................................................... 116 
Rab8 and its GEFs and membrane recruitment in macrophages .............................................. 119 
The macropinosome is a hub for immune receptor signalling .................................................. 121 
Identification of a novel Rab effector-GEF interaction between OCRL and Rabin8 ................. 122 
Conclusions .................................................................................................................................. 124 
9. REFERENCES ................................................................................................................................. 127 
Appendix 1. University of Queensland Animal Ethics Letter ......................................................... 148 
 
 
  
 xvi 
List of Figures 
Figure 1.1 M1 vs M2 macrophage polarisation 
Figure 1.2 The Rab GTPase cycle 
Figure 1.3 TLR4-Rab8a-PI3K signalling pathway in macrophages 
Figure 1.4 Functional domains of OCRL 
Figure 1.5 The Rab8 Sec2 GEFs Rabin8 and GRAB 
Figure 1.6 Interaction between Rab8a and Rabin8 
Figure 1.7 ERK1/2 kinase regulation of Rabin8 GEF function 
Figure 1.8 Kinase regulation of Rabin8 and GRAB 
 
Figure 4.1 Rab8a localises to ruffles and is enriched on macropinosomes in LPS 
stimulated mouse macrophages 
Figure 4.2 Rab8a with its effector PI3K functions to elicit Akt signalling downstream of 
TLRs 
Figure 4.3 The lipoprotein receptor LRP1 is involved in TLR-induced Akt activation 
Figure 4.4 GRAB identified as a Rab8a binding partner in LPS activated macrophage 
lysate 
Figure 4.5 Both Rab GEFs GRAB and Rabin8 are expressed in RAW 264.7 macrophage 
cells and have an LPS inducible interaction with Rab8a 
Figure 4.6 The Rab8 regulatory GEFs Rabin8 and GRAB co-localises with Rab8a on 
membrane ruffles in LPS-activated macrophages 
Figure 4.7 Generation of Rab activation probes using the Rab binding domains of known 
multi-GTPase effectors 
Figure 4.8 Removal of GST contamination through protease cleavage elution. 
Figure 4.9 Testing of active Rab8 capture constructs with GDP/Gpp(NH)p loaded RAW 
264.7 cell lysates. 
Figure 4.10 OCRL-RBD and PI3Kγ-RasBD constructs are able to detect Rab8 activation 
in macrophages responding to various stimuli 
Figure 4.11 Calibration and validation of the OCRL-RBD Rab8 activation probe 
 
Figure 5.1 Design and production of the Cas9-gRNA complex for generating GRAB and 
Rabin8 KO RAW 264.7 macrophage cell lines 
Figure 5.2 Illustration of resistance selection vectors for CRISPR-Cas9 mutant selection 
Figure 5.3 Transfection and screening for generating CRISPR-Cas9 KO RAW 264.7 
macrophage cell lines 
 xvii 
Figure 5.4 Screening CRISPR-Cas9 mutant cell lines for protein expression of target 
gene knockouts 
Figure 5.5 Loss of either GRAB or Rabin8 significantly reduces LPS induced Rab8 GTP-
loading in activated macrophages 
Figure 5.6 Absence of either GEF, GRAB or Rabin8 does not affect Rab8a localisation 
and enrichment on macrophage macropinosomes 
 
Figure 6.1 Absence or overexpression of either Rabin8 or GRAB does not affect Rab8a-
associated TLR signalling 
Figure 6.2 Both GRAB and Rabin8 contribute additively to LPS-induced Rab8 activation 
Figure 6.3 Neither Rabin8 nor GRAB controls Rab8 membrane recruitment, localisation 
or enrichment in macrophages 
Figure 6.4 Loss of both GRAB and Rabin8 perturbs Rab8a-associated TLR signalling 
Figure 6.5 Reintroduction of both Rabin8 and GRAB recovers LPS-induced Akt 
phosphorylation in double KO macrophages 
Figure 6.6 Optimisation of imaging protocols for demonstrating live cell Akt enrichment 
on macropinosome membrane domains 
Figure 6.7 The Rab8 GEFs GRAB and Rabin8 jointly controls TLR-associated Akt 
immune signalling on macrophage macropinosome membranes 
Figure 6.8 TLR4-associated Rab8a activation and signalling is jointly regulated by the 
GEFS GRAB and Rabin8 
 
Figure 7.1 The MAP kinase ERK1/2 does not regulate Rabin8-Rab8a associated TLR-
signalling 
Figure 7.2 The Rab effector OCRL is a novel Rabin8 binding protein 
Figure 7.3 OCRL is recruited to Rab8a positive macropinosomes 
Figure 7.4 OCRL has an enhanced interaction with constitutively active Rabin8 
Figure 7.5 Rabs 13, 8a and 5 are sequentially recruited during macropinocytosis in 
mouse macrophages 
Figure 7.6 Proposed models for a Rabin8-OCRL interaction in macrophages 
 
Figure 10.1 Uncropped blots for Figures 4.5B and C 
List of Tables 
Table 1.1 List of Toll-like receptors with their main ligands 
 xviii 
Table 1.2 Examples of known Rabs associated with immune functions 
Table 1.3 Examples of known Rab8 effectors and their functions 
Table 1.4 List of known OCRL interacting partners 
Table 1.5 List of Rab GEF family members and examples of their known functions 
 
Table 3.1 List of primers for the generation of various constructs used in this project 
Table 3.2 List of plasmids used in this project 
Table 3.3 List of primers used for generating CRISPR constructs 
 
Table 10.1 Off and on target scores for CRISPR guideRNAs 
Key Resource Table 
 
  
 xix 
List of Abbreviations  
 
Abbreviation Meaning 
ATCC American type culture collection 
Cas9 CRISPR associated protein 9 
CRISPR Clustered regularly interspaced short palindromic 
repeats 
DAMP Danger associated molecular patterns 
DMSO Dimethyl sulfoxide 
EDTA Ethylenediaminetetraacetic acid 
EGF Epidermal growth factor  
EGTA Egtazic acid 
ERK1/2 Extracellular signal-regulated kinase 1/2 
FBS Foetal Bovine Serum 
GAP GTPase activating protein 
GDI Guanosine nucleotide dissociation inhibitor 
GDP Guanosine diphosphate 
GEF Guanine nucleotide exchange factor 
GFP Green fluorescent protein 
GPI Glycosylphosphatidylinositol 
Gpp(NH)p 5'-Guanylyl imidodiphosphate 
GST Glutathione S transferase 
GTP Guanosine triphosphate 
GTP Guanosine triphosphate analogue 
GTTase Geranylgeranyltransferase 
HDR Homology-directed repair  
iBMMs Immortalised bone-marrow derived macrophages 
IFN- Interferon-  
IgG Immunoglobulin G 
IL-4/6/12/13 Interleukin-4/6/12/13 
Indels Insertions and deletions 
KO Knockout 
LPS Lipopolysaccharide  
LRP1 Low density lipoprotein receptor-related protein 1 
MAL MyD88 adaptor-like 
MAPK Mitogen-activated protein kinase 
MyD88 Myeloid differentiation primary response 88 
NF-B Nuclear factor B 
NHEJ Nonhomologous end joining  
OCRL Oculocerebrorenal syndrome of Lowe protein 1 
PAMPs Pathogen associated molecular patterns 
PCE Protease cleavage elution 
PI3K Phosphoinositide 3-kinase gamma 
PPRs Pattern recognition receptors 
RBD Rab binding domain 
RasBD Ras binding domain 
ROS Reactive oxygen species 
RPMI Roswell park memorial institute 
TIR Toll-interleukin receptor 
TLR Toll-like Receptor 
TNF Tumour necrosis factor  
 xx 
TRAM TRIF-related adaptor molecule 
TRIF TIR-domain-containing adapter-inducing interferon-β 
 
  
Chapter 1: Introduction 
 1 
 
 
 
Chapter 1 
Introduction 
  
Chapter 1: Introduction 
 2 
1. Introduction 
Macrophages 
Macrophages are important innate immune cells that play key roles in coordinating 
host responses against pathogens and other sources of danger (Gordon and Taylor 
2005, Xia and Triffitt 2006, Lacy and Stow 2011). These cells are differentiated from 
the bone marrow and are found either patrolling the circulatory system or residing in 
tissues throughout the body. As immune sentinels, macrophages express an array of 
cell surface receptors that allow for the detection of molecules associated with a wide 
range of pathogens (Gordon 2002). Along with pathogen clearance and initiating 
immune responses, macrophages are also important for maintaining tissue 
homeostasis, clearing cellular debris and promoting tissue repair (Mosser and 
Edwards 2008). 
 
As long-lived cells of the innate immune system, macrophages not only stimulate and 
trigger pro-inflammatory responses upon pathogen detection, but also secrete signals 
to resolve inflammation. This dual role of promoting and constraining inflammation has 
been attributed to a gradient of polarising transcriptional programs between M1 or 
classically activated (pro-inflammatory) and M2 or alternately activated (anti-
inflammatory) phenotypes (Mosser and Edwards 2008). These states determine both 
macrophage function and the cytokine signals they secrete, to communicate and 
coordinate with other immune cells for driving or dampening inflammation. Uncovering 
how these highly pleomorphic immune cells direct and regulate inflammation is 
essential for understanding innate immunity and inflammatory diseases.  
 
Toll-Like Receptors (TLRs) 
As primary immune surveillance cells, macrophages have distinct characteristics that 
make them ideally suited for detecting and destroying pathogens (Rosenberger and 
Finlay 2003). One such feature is the presentation of a large contingent of 
evolutionarily conserved pattern recognition receptors (PRRs), that recognise a wide 
range of specific pathogen-associated molecular patterns (PAMPs) (Akira and 
Uematsu et al. 2006). These PAMPs are common, highly conserved molecules or 
peptides that are essential for the survival of certain pathogen groups, making them 
ideal targets for immune recognition (Gordon 2002). PRRs are also able to recognise 
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another category of molecules called danger associated molecular patterns (DAMPs), 
normally consisting of altered endogenous, host proteins or lipids, activation by 
DAMPs allows macrophages to respond to tissue damage, facilitate the clearing of 
cellular debris and initiate wound healing (Koh and DiPietro 2011, Braza and Brouard 
et al. 2016). 
 
Toll-like receptors (TLRs) are a prominent subset of PRRs, named after the Toll gene 
in Drosophila which was discovered by Nobelists Nusslein-Volhard and Wieschaus 
(Anderson and Jürgens et al. 1985). Initially described as a dominant factor for 
controlling Drosophila embryo development, comparisons between the Toll and IL-1 
receptors introduced a link between the Toll genes and antifungal immunity (Lemaitre 
and Nicolas et al. 1996). Able to recognise different PAMPs and DAMPs associated 
with a wide range of pathogens, the TLR family, consisting of 10 known members in 
humans, constitutes an array of type I transmembrane proteins expressed in innate 
immune cells, epithelial cells and other cell types (O'Neill 2004, Trinchieri and Sher 
2007) (Table 1.1). Individually, most TLRs are activated by one or a few PAMPs and 
DAMPs as agonists, and collectively they provide wide-ranging anti-pathogen and 
infection surveillance. The members of the TLR family are localised to different 
subcellular locations which in part helps to tailor immune responses to particular 
pathogens/immune stimulants (Table 1.1). Macrophages utilise these receptors to 
facilitate the screening of their extracellular environment, endosomal/phagosomal 
compartments and cytoplasm for pathogen signatures.  
 
TLR4 is the prototypical TLR and is activated by lipopolysaccharide (LPS), a PAMP 
and coat component of Gram-negative bacteria (Hoshino and Takeuchi et al. 1999). 
LPS is presented to TLR4 on the macrophage cell surface in combination with the 
glycosylphosphatidylinositol (GPI)-anchored receptor CD14 and the co-receptor MD-
2 (Park and Song et al. 2009, Gay and Symmons et al. 2014), triggering TLR4 
dimerization and recruitment of the cytoplasmic signalling adaptors, Mal and MyD88 
(Gay and Symmons et al. 2014). These adaptors then recruit sequential arrays of 
signalling kinases that drive the transcription of pro-inflammatory cytokines (TNF, IL-
6, IL-12) and other anti-infective response outputs (Akira and Takeda 2004). TLR4 can 
also signal from a second set of adaptors, attracted by the different phospholipid 
environment of the endosomal, macropinosomal or phagosomal membranes after 
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receptor internalisation. The adaptors TIR-domain-containing adapter-inducing 
interferon-β (TRIF) and TRIF-related adaptor molecule (TRAM) are recruited to TLR4 
in the endosomal/phagosomal system for signalling pathways that activate the 
transcription of anti-inflammatory or regulator mediators such as interferon and IL-10 
(Kagan and Su et al. 2008). Thus, TLR4 output is spatially and temporally regulated 
by the location specific recruitment of distinct signalling adaptors, as opposed to other 
TLRs which mainly signal from one site; for TLR5 this is the plasma membrane and 
TLR9 is only known to signal from endosomal compartments (O'Neill 2004, Gay and 
Symmons et al. 2014, Rosadini and Kagan 2017). 
 
Upon activation, TLRs trigger an array of complex signalling and phenotypic changes 
in macrophages, through the activation of signal transducers such as mitogen 
activated protein kinases (MAPK) and the potent transcription factor nuclear factor B 
(NF-B) (Kawasaki and Kawai 2014). Depending on the resulting signalling cascade, 
macrophages can be activated to produce reactive oxygen species (ROS), pro- or 
anti-inflammatory cytokines, enhance phagocytosis/macropinocytosis or secrete 
chemokines for immune cell recruitment (Varin and Gordon 2009, West and Brodsky 
et al. 2011). The main roles of TLR-activated macrophages are to provide local innate 
immune defences and, via chemokines and cytokines, activate and recruit 
lymphocytes for adaptive immune responses. TLRs are one of the main groups of 
receptors contributing to inflammation as a protective, anti-infective response, but can 
also act in a pathognomonic context by triggering and maintaining inflammation in 
many chronic and inflammatory diseases.  
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Table 1.1. List of Toll-like receptors with their main ligands. 
Receptor Location Ligand References 
TLR 1-2 
(Heterodimer) 
TLR 1-6 
(Heterodimer) 
Plasma 
membrane 
Bacterial Lipopeptides (Takeuchi and 
Sato et al. 2002) 
TLR 3  Endosomal dsRNA (Alexopoulou and 
Holt et al. 2001) 
TLR 4  Plasma 
membrane 
Bacterial LPS (Hoshino and 
Takeuchi et al. 
1999, Takeuchi 
and Hoshino et al. 
1999) 
TLR 5  Plasma 
membrane 
Flagellin (Gewirtz and 
Navas et al. 2001, 
Hayashi and 
Smith et al. 2001) 
TLR 7/TLR 8 Endosomal Viral ssRNA (Diebold and 
Kaisho et al. 
2004, Heil and 
Hemmi et al. 
2004) 
TLR 9  Endosomal CpG DNA (Bacterial) (Hemmi and 
Takeuchi et al. 
2000) 
TLR 10 Plasma 
membrane 
No known ligand 
(Inflammatory modulator 
of TLR2) 
(Oosting and 
Cheng et al. 
2014) 
 
Macrophage polarisation and inflammation 
Upon activation, macrophages respond with diverse changes in gene and protein 
expression that are dictated by the microenvironment and immune stimuli they 
encounter. Broadly speaking, macrophages respond to immunological challenges by 
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transition ing into one of two polarised phenotypic states known colloquially as ‘M1 and 
M2’ (Mills and Kincaid et al. 2000). This classification is used for convenience to 
distinguish the different programs elicited by pro-inflammatory (M1) and anti-
inflammatory or inflammation resolving M2 cells (Figure 1.1). However, it is also widely 
acknowledged that the M1 and M2 classification is an oversimplification that does not 
reflect the dynamic and continuously varied states macrophages take on during 
different immunological circumstances. A key reason for interest in macrophage 
polarisation is that inflammation (including TLR-induced inflammation) has emerged 
as an underlying or overt component of many chronic diseases, ranging from diabetes 
to neurodegenerative diseases (Serhan and Savill 2005, Crusz and Balkwill 2015, 
Zolezzi and Inestrosa 2017). This is in addition to the causative role played by TLRs 
and inflammation in chronic inflammatory diseases such as rheumatoid arthritis and 
inflammatory bowel diseases (Ospelt and Gay 2010). In many of these pathologies, 
uncontrolled inflammatory signalling contributes to disease progression and 
complicates therapeutic interventions, and it often does so through dysregulation of 
M1 and M2 macrophage programming (Wang and Liang et al. 2014).  
 
As depicted in Figure 1.1, M1 macrophages are traditionally stimulated by pathogens 
through TLRs and/or pro-inflammatory cytokines from other immune cells such as 
interferon- (IFN-) and tumour necrosis factor (TNF) (Mosser and Edwards 2008). 
Characterised by an increased production of ROS and the inflammatory cytokines 
TNF, IL-12 and -6, M1 macrophages have enhanced antigen presentation and 
microbicidal capabilities for enhanced pathogen killing and clearance (Lawrence and 
Natoli 2011). In contrast, M2 macrophages are typically induced by immune regulatory 
cytokines such as IL-4 and IL-13 (Wang and Liang et al. 2014). These immune 
suppressive and wound-healing associated macrophages propagate an anti-
inflammatory environment, and have an increased expression of arginase-1 that 
promotes the production of important tissue healing compounds such as polyamines 
and ornithine (Galván-Peña and O’Neill 2014). In mouse macrophages, work by 
Christoph Hölscher and colleagues have also shown IL-10 associated alternative 
macrophage activation that resulted in increased Arg1 gene expression using a 
tuberculosis infection model (Schreiber and Ehlers et al. 2009). Macrophages retain a 
high level of plasticity and are capable of switching between these M1 and M2 states 
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in response to signalling changes in the extracellular milieu (Wang and Liang et al. 
2014). This flexibility allows for long-term participation during an inflammatory 
response, promoting or constraining inflammation when necessary to enhance 
pathogen clearing while minimising collateral tissue damage. Identifying the molecules 
and pathways associated with these phenotypic transitions is important for 
understanding the underlying machinery of how macrophages control and direct 
inflammation. As described below, a key focus of this project is to define the 
components of a Rab8/PI3K complex that drives macrophages towards an M2-like 
state to constrain inflammation. 
 
 
Figure 1.1. M1 vs M2 macrophage polarisation. Macrophage activation by different immune stimuli elicits 
polarising immune phenotypes (M1 or M2) and cytokine outputs for promoting or resolving inflammation (adapted 
from Mosser & Edwards. Nat Reviews 2008.)  
 
Rab GTPases 
Within the Ras superfamily of small (20-30 kDa) GTPases, Rabs are a family of 
molecular switches that function as master regulators for membrane/vesicle trafficking 
in eukaryotic cells (Zerial and McBride 2001, Stenmark 2009). Since they were first 
described in 1987 by Touchot and colleagues, and termed Ras genes from rat brain 
(Rab) (Touchot and Chardin  et al. 1987), more than 60 different Rabs have been 
identified in mammalian cells and implicated in the facilitation of important cellular 
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functions such as motility, ciliogenesis, proliferation and cell signalling (Peränen 2011, 
Kelly and Horgan et al. 2012).  
 
As molecular switches, Rab GTPases function by binding alternately to the 
nucleotides, guanosine triphosphate (GTP) and guanosine diphosphate (GDP) 
signifying the active and inactive states of the Rab protein respectively. In each state, 
Rabs interact with often discrete sets of proteins that dictate their recruitment and 
activation on specific cellular compartments. Figure 1.2 depicts the general pathway 
and highlights the key proteins that modulate Rab recruitment, activation and function. 
Briefly, newly synthesised Rabs are escorted to a protein prenyl transferase such as 
geranylgeranyltransferase (GGTase) for C-terminal prenylation (Pereira-Leal and 
Hume et al. 2001). The Rab is then recruited by various escort proteins and embeds 
into the target membrane through its prenylated tail (Pereira-Leal and Hume et al. 
2001, Goody and Rak et al. 2005) and once at the membrane, it is activated by a 
guanine nucleotide-exchange factor (GEF) which catalyses the release of GDP from 
the nucleotide binding pocket (Kelly and Horgan  et al. 2012). Due to the concentration 
of GTP being 10-fold higher than GDP in the cellular environment, this nucleotide 
release facilitates the binding of GTP onto the Rab resulting in activation (Müller and 
Goody 2018). Upon activation, the GTP-bound Rab recruits and interacts with specific 
effector proteins that bring about the desired function (Stenmark 2009). Common 
types of Rab effectors include membrane motors, membrane fusion proteins, 
signalling scaffolds and membrane tethers and while some Rabs are known to 
associate with a single effector, others are highly promiscuous with many possible 
effectors as binding partners at different cellular locations (Stenmark 2009).  
 
The reverse and equally important part of the switch cycle for Rabs is turnin g off their 
function through GTP hydrolysis; a process that is facilitated by GTPase activating 
proteins (GAPs) (Zerial and McBride 2001). GAPs work in opposition to Rab GEFs, 
by promoting the hydrolysis of GTP into GDP and switching ‘off’ the Rab GTPase. This 
is often accompanied by the Rab being extracted from the membrane through a Rab 
GDP dissociation inhibitor (GDI), which specifically recognises GDP-bound ‘off’ Rabs, 
sequestering them in the cytoplasm for potential recycling (Müller and Goody 2018).  
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Figure 1.2. The Rab GTPase cycle. Shown here are the general stages in a Rab cycle. (A) Through escort 
proteins, newly synthesised Rabs are sent for prenylation and sequestered in the cytoplasm by a Rab GDP 
dissociation inhibitor (GDI). (B) The Rab is recruited to its specific target membrane domains through various 
upstream adaptor proteins and is inserted via its prenylated tail. (C) Upon recruitment, the specific Rab GEF 
switches on the Rab by catalysing GDP-release, resulting in subsequent GTP-loading, allowing for Rab effector 
recruitment and function. (D) Once its function is completed the active Rab is switched off via GAP-mediated 
hydrolysis and the inactive GDP-bound Rab is recognised and extracted from the membrane by the GDI and 
sequestered back into the cytoplasm for recycling (Müller and Goody 2018). 
 
Earlier studies in yeast cells demonstrated that, in some pathways, a series of Rabs 
work in sequence to bring about a particu lar cell function. In such cases, some Rab 
effectors also act as GEFs to activate a subsequent Rab downstream, forming a ‘Rab 
cascade’ as first described by Novick and colleagues in 2002 (Ortiz and Medkova et 
al. 2002, Grosshans and Ortiz et al. 2006, Markgraf and Peplowska et al. 2007). This 
results in waves of different Rabs being sequentially recru ited and activated on specific 
cellular organelles/compartments, each eliciting a distinct set of effectors to facili tate 
cellular events (Pfeffer 2013). This coordination is key for the Rab-dependent 
management and control of multi-step, multi-effector processes such as trafficking 
steps, which require directed vesicular transport (motor proteins), membrane lipid 
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modification (lipid kinases or phosphatases) and vesicle fusion (SNAREs). 
Collectively, the sequential recruitment and activation of Rabs and their downstream 
effectors provide directionality in these pathways.  
 
In mammalian cells, there have been several well-defined pathways that are regulated 
by series of Rabs, although their overall coordination in these processes is less clear. 
An example is the complex networks of GTPases, including Rabs, that control the 
retrograde and anterograde trafficking and maturation of vesicles moving to and from 
the Golgi (Barr 2009). While an exact Rab cascade has not yet been determined for 
these processes, small glimpses of crosstalk events between Rabs linked to different 
stages of Golgi vesicle transport have been demonstrated. For instance, the medial 
Golgi-localised Rab33B has been shown to recruit the GEF complex Ric1-Rgp1 for 
Rab6 activation, which in turn mediates retrograde transport of mannose 6-phosphate 
receptors for processing, indicating a Rab handover event between different Golgi 
compartments (Pusapati and Luchetti et al. 2012). With roughly a third of mammalian 
Rabs associated with the Golgi network, it is reasonable to presume that more 
extensive Rab cascades contribute substantially to maintaining and coordinating the 
overall organisation and function of the Golgi complex (Goud and Liu et al. 2018). 
Endocytic and phagocytic processes are also governed by putative Rab cascades. 
For instance, work from our laboratory has demonstrated that during phagocytosis, a 
series of Rabs including Rabs 13 and 35, are recruited to facilitate the closure and 
maturation of the phagosome in macrophages (Yeo and Wall et al. 2016). Additionally, 
the well-known Rab endosomal markers, Rab5 on the early endosome, Rab11 on 
sorting/recycling endosome and Rab7 on late endosome/lysosome, are functionally 
linked by effector roles and by intervening by GEFs and GAPs to shepherd cargo 
through endocytic pathways (Markgraf and Peplowska et al. 2007).  
 
The many roles Rabs play in essential cellular processes and pathways means that 
loss of Rab expression or function can have widespread biological consequences. 
There is a growing list of genetic and acquired diseases associated with altered Rab 
function or expression (Banworth and Li 2018). For instance, the autosomal recessive 
disorder ‘Carpenter syndrome’, which presents with severe birth defects including 
craniosynostosis and polysyndactyly, has been linked to nonsense mutations in the 
Hedgehog signalling regulator Rab23 (Jenkins and Seelow et al. 2007). Another 
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example is the neurodegenerative disorder, Parkinson’s disease (PD). A hallmark of 
PD is the impaired intracellular transport and sorting of cargo-containing vesicles in 
dopamine neurons, which eventually causes the loss of axon projections and cell 
death (Abeliovich and Gitler 2016). Unsurprisingly, as master regulators of trafficking 
pathways, mounting evidence has linked a sub-set of Rabs in PD pathogenesis. 
Specifically, the leucine-rich repeat kinase 2 (LRRK2) phosphorylates several Rab 
family members, including Rabs 7, 8, 10 and 29, and PD-associated mutations of 
LRRK2 impair the function of these Rabs, contributing to the pathogenesis of this 
disease (MacLeod and Rhinn et al. 2013, Steger and Tonelli et al. 2016, Lis and Burel 
et al. 2018, Bonet-Ponce and Cookson 2019). Interestingly, Rab29 while a substrate 
of LRRK2 has also been shown to recruit and activate the kinase in turn, possibly 
exacerbating LRRK2 driven PD pathogenesis (Purlyte and Dhekne et al. 2018). Such 
findings indicate the potential for targeting Rab–mediated pathways as a therapeutic 
option for several diseases. However, the gross structural similarities between the 
members of this GTPase family and, with some Rabs being indispensable in other 
cell-types/functions, makes it challenging to target specific Rabs for drug treatment. 
As a result, alternative and indirect regulators that modulate Rab specific fun ctions 
have been seen as promising new targets for clinical studies (Qin and Wang et al. 
2017). 
 
Rabs in innate immune cells 
Immune cell function is dependent on highly organised and tightly controlled 
intracellular signalling and trafficking events (Gutierrez 2013, Luo and Wall et al. 2014, 
Yeo and Wall et al. 2016). From receptor expression, internalisation and degradation, 
to the secretion of inflammatory cytokines and chemokines, Rabs have been tightly 
associated with many vital immune cell processes (examples listed in Table 1.2) 
(Prashar and Schnettger et al. 2017). The complex vesicle trafficking pathways 
accompanying the formation and maturation of phagosomes during phagocytosis, for 
the destruction of pathogens and particles in innate cells, has been shown to involve 
many Rab GTPases (Yeo and Wall et al. 2016). These include Rabs 5, 8, 13, 31 and 
35, which engage in the closure of phagocytic cups, the maturation of the phagosomes 
and the fusion with lysosomes for pathogen killing (Botelho and Grinstein 2011, 
Gutierrez 2013, Yeo and Wall et al. 2016). Furthermore, Rab11 in macrophages, also 
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mediates inflammatory cytokine secretion from Golgi to cell surface pathways that 
intersect with phagocytic cups (Murray and Kay et al. 2005) and with recycling 
endosomes (Stanley and Lacy 2010). Rabs are also engaged on phagosome 
membranes for receptor trafficking and signalling, with studies demonstrating the role 
of Rab11 in TLR4 signalling from the phagosome (Husebye and Aune et al. 2010). 
Other Rabs are also engaged for the trafficking of TLR4, with the recycling, cell surface 
expression and lysosomal degradation of the receptor being regulated by Rabs 11, 10 
and 7 (Wang and Chen  et al. 2007, Husebye and Aune et al. 2010, Wang and Lou  et 
al. 2010). Aside from these trafficking roles, this project will extend the remit of Rab 
regulation in macrophages to a receptor signalling role focused on Rab8.  
 
Table 1.2. Examples of known Rabs associated with immune functions 
Rab Function References 
Rab5  Early endosome fusion and phagosome 
maturation 
(Vieira and Bucci et al. 
2003) 
Rab7 Enhanced pathogen clearance by 
promoting lysosomal targeting and fusion  
(Bhattacharya and Ojha 
et al. 2006) 
Rab8a Mediates anti-inflammatory cytokine 
biasing downstream of TLR activation  
(Luo and Wall et al. 
2014) 
Rab10 Regulates the delivery of TLR4 to the 
plasma membrane 
(Wang and Lou et al. 
2010) 
Rab11 Regulates transport of TLR4 to 
phagosomes from early recycling 
compartments 
(Husebye and Aune et 
al. 2010) 
Rab12  Negatively regulates secretory granule 
trafficking in mast cells 
(Efergan and Azouz et 
al. 2016) 
Rab13 Regulates formation of LPS-induced 
macropinocytosis in macrophages 
(Condon and 
Heddleston et al. 2018) 
Rab27a Neutrophil degranulation and exocytic 
secretion of TNF 
(Johnson and Hong et 
al. 2011) 
Rab32  Delivery of antimicrobial cargo to bacteria 
containing vesicles 
(Spanò and Galán 2012, 
Solano-Collado and 
Rofe et al. 2018) 
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Rab8 
Identified as the mammalian homolog to the yeast GTP binding proteins Sec4p and 
Ytp2p, Rab8 heads a subset of Rab GTPases along with Rab10 and Rab13, which 
differ from other Rabs through having a CAAX box on their C-terminus in contrast to 
a CC or CXC motif (Peränen 2011). The cystine residues on these domains undergo 
prenylation, which is essential for allowing the recruitment and binding of these Rabs 
to membranes (Zerial and McBride 2001). Rab8 has 2 isoforms, Rab8a and Rab8b 
which share 83% identity in humans. These two isoforms of Rab8 have both separate 
and redundant functions, sharing interactions with some but not all accessory proteins 
and regulators (Peränen 2011). Rab8a, and to a lesser extent Rab8b, are highly 
promiscuous Rab family members with multiple known effectors and roles in many 
cellular pathways. Therefore, it is unsurprising that genetic ablation of Rab8a in mice 
is lethal, with newborns only surviving a matter of days (Sato and Mushiake et al. 
2007). Nevertheless, these newborn mice have been used to demonstrate the need 
for Rab8a for apical trafficking in epithelial cells (Sato and Mushiake et al. 2007). A 
more extensive analysis of Rab8 knockouts subsequently showed that the deletion of 
Rab8b alone has no overt phenotype, but the double deletion of Rab8a and Rab8b 
produced a much more dramatic loss of apical integrity (loss of microvilli) in 
gastrointestinal tract epithelial compared with the Rab8a knockout alone (Sato and 
Iwano et al. 2014). The intestinal microvillus atrophy in the double knockouts indicate 
a synergistic and partially overlapping function of the two Rab8 isoforms. Ultimately, 
the functional differences between these two isoforms has still not been stringently 
defined, with some studies still linking them together under a single ‘Rab8’ banner. 
Rab8 is one of the most ubiquitous and multi-functional members of the Rab family 
with a relatively large list of effectors (examples listed in Table 1.3). The functions of 
Rab8 are mostly associated with vesicle trafficking and polarised trafficking for either 
endocytic, recycling or exocytic processes (Hattula and Furuhjelm et al. 2006, 
Peränen 2011). Rab8 is also prominently associated with cell surface protrusions on 
different cell types, including ruffles, filopodia, lamellipodia, phagocytic cups and 
primary cilia (Peränen 2011). Below describe several well-studied examples of Rab8 
regulated pathways. 
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Table 1.3. Examples of known Rab8 effectors and their functions. 
Effector Function Reference 
JRAB/MICAL L2 
Trafficking of tight-junction and 
adherent junction proteins 
(Polarisation) 
(Yamamura and 
Nishimura et al. 
2008) 
OCRL (inositol 
polyphosphate 5-
phosphatase) 
Facilitate plasma membrane 
signalling  
(Pirruccello and 
De Camilli 2012) 
Sec15 Exocytosis and Ciliogenesis 
(Wu and Mehta et 
al. 2005, Feng and 
Knödler et al. 
2012) 
Rab8IP (GC 
Kinase) 
Trafficking of secretory vesicles in 
response to cellular stress 
(Ren and Zeng et 
al. 1996) 
Linker for 
activation of X 
cells (LAX) 
Transport of CTLA-4 T-cell regulating 
receptor to the cell surface 
(Banton and Inder 
et al. 2014) 
Optineurin (FIP-2) 
Myosin VI 
Vesicle Trafficking from TGN to 
Plasma Membrane 
(Chibalina and 
Roberts et al. 
2008) 
PI3K  
LPS-induced mTOR and AKT 
signalling in macrophages 
(Luo and Wall et 
al. 2014, Wall and 
Luo et al. 2017) 
Rabaptin 5 Ciliogenesis 
(Omori and Zhao 
et al. 2008) 
 
Rab8 functions 
Trafficking to and from the plasma membrane 
The plasma membrane is a highly dynamic and compartmentalised cell structure that 
acts as a medium for many essential functions such as cell signalling, vesicular 
trafficking and cell adhesion (Laude and Prior 2004). Therefore, maintaining the 
plasma membrane is crucial for cell survival, requiring tightly controlled processes to 
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internalise, recycle and replenish membrane components (Cho and Stahelin 2005). 
Characterisation of Rab8 in multiple cell types has identified this Rab as a master 
regulator of trafficking to the plasma membrane, localising to dynamic ruffling cell 
surface structures, tubules and trafficking vesicles (Peränen 2011). Live-cell imaging 
of fluorescently tagged Rab8 in live cells demonstrated that this particular Rab is 
primarily on membranes that are rapidly tubulated and internalised from 
macropinosomes or endosomal vesicles from the plasma membrane and sorted back 
into recycling compartments (Hattula and Furuhjelm et al. 2006). This is followed by 
the recruitment of Rab11 to these recycling endosomes, which in turn recruits the 
Rab8 GEF Rabin8, facilitating the re-export of membrane vesicles back to the plasma 
membrane (Rowe and Suszko et al. 2008, Vetter and Stehle et al. 2015). Below are 
several specific examples of known cellular processes controlled by Rab8 membrane 
trafficking functions. 
 
Apical Polarity 
Approximately 60% of mammalian cells are epithelial-derived and form the building 
blocks of many organs and tissues, with their function intimately tied to cell polarity 
(Bryant and Mostov 2008). Multiple studies have identified Rab8 as a major contributor 
to the establishment and maintenance of epithelial cell polarisation by promoting 
directional transport of various apical and basolateral cargo proteins. One example 
was the use of a yeast two-hybrid screen with a GTP-Rab8 mutant construct against 
a mouse small intestine cDNA library and follow-up pull-down assays, Nakajo and 
colleagues demonstrated that the protein complex EH domain–binding protein 1–like 
1 (EHBP1L1)-Bin1-dynamin is able to interact with active Rab8 (Nakajo and 
Yoshimura et al. 2016). The authors later used immunofluorescence and knockouts of 
EHBP1L1 and Bin1 to demonstrate the role this Rab8-binding complex plays in the 
sorting and delivery of apical protein cargo (the glycoprotein DPP4) in mouse and 
human epithelial cells. Another study by Henry and Sheff utilised the overexpression 
of mutant Rab8 constructs in MDCK cells and visually demonstrated disruptions to the 
polarised trafficking of basolateral proteins, such as VSV-G (Henry and Sheff 2008). 
Additionally, knockdown studies performed on MDCK cysts revealed that both Rab11a 
and Rab8a are critical components of the molecular machinery for regulating the 
polarised architecture of lumen generation via promoting polarised transport and 
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targeting of Cdc42 and apical membrane initiation site (AMIS) formation (Bryant and 
Datta et al. 2010, Datta and Bryant et al. 2011).  
 
Ciliogenesis 
One of the best characterised Rab8 functions is regulating ciliogenesis. Cilia are 
antenna-like protrusions from the cell surface and function as important signalling and 
sensory organelles (Satir and Christensen 2007). Experiments on mouse and human 
intestinal epithelial cells showed that Rab8 is the predominant Rab associated with 
cilia formation, and depletion of either isoform of Rab8 led to the inhibition or disruption 
of cilia formation (Nachury and Loktev et al. 2007, Sato and Mushiake et al. 2007, 
Feng and Knödler et al. 2012). Specifically, Sato and colleagues demonstrated that 
depletion of Rab8 in mouse intestinal epithelial cells showed an accumulation of apical 
proteins (Sato and Mushiake et al. 2007), while Nachury and colleagues showed that 
mutants of Rab8 alters the number and length of cilia in RPE cells (Nachury and 
Loktev et al. 2007). Other studies expanded this pathway to include Rab11, a known 
regulator and marker for recycling endosomes, and its interaction the Rab8 GEF 
Rabin8 to redirect Rab8 positive endosomes towards the primary cilia (Vetter and 
Stehle et al. 2015, Wang and Deretic 2015).  
 
Neurite outgrowth 
Neuronal cell development and morphology is essential for the function of the nervous 
system. One key aspect is the extension of neurites between neurons to connect and 
form neural networks. This process of neurite outgrowth requires a continuous supply 
of plasma membrane to generate these cell protrusions (Read and Gorman 2009, 
Villarroel‐Campos and Gastaldi et al. 2014). Therefore, membrane trafficking is 
paramount to neuron maturation and function (Huber and Dupree et al. 1995, 
Villarroel‐Campos and Gastaldi et al. 2014). Indeed, experiments conducted have 
shown that either knockdown or knockout of both Rab8 and its respective GEFs, 
GRAB and Rabin8, in mouse cortical neurons have resulted in significant reductions 
to neurite outgrowth, presumably through disruptions to the Rab8-Rab11 dependent 
transport of membrane vesicles for axon outgrowth (Furusawa and Asada et al. 2016, 
Homma and Fukuda 2016).  
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TLR signalling in macrophages 
In macrophages, both Rab8a and 8b are distributed on membranes throughout the 
cell and exhibit prominent associations with cell surface ruffles and protrusions, as in 
other cell types. Earlier work in our laboratory showed that Rab8a is enriched on ruffles 
and on the macropinosomes that internalise from ruffles where it coincides with TLRs 
and their signalling adaptors (Luo and Wall et al. 2014, Wall and Luo et al. 2017). Live 
imaging shows Rab8a remaining on ruffle membranes as they form into 
macropinosomes before it is then rapidly shunted onto tubules emerging from the early 
macropinosomes as they mature and shrink (Wall and Luo et al. 2017). The Rab8a 
tubules are likely sorting membrane and cargo back to recycling endosomes for return 
to the cell surface. Rab8a is activated on the macropinosomes to recruit an atypical 
effector, namely PI3K (Wall and Luo et al. 2017), through which Rab8a contributes 
to Akt/mTOR signalling and inflammatory outputs downstream of several TLRs. 
Neither Rab8a nor PI3K are recruited directly to TLR complexes and in seeking other 
co-receptors, our group showed that the endocytic receptor, low density lipoprotein 
receptor-related protein 1 (LRP1) is activated by TLRs through a receptor crosstalk 
event, and that Rab8a is actually bound to LRP1 to enlist it for TLR signalling (Luo and 
Wall et al. 2018). LRP1 has also been shown in a number of studies, to help constrain 
inflammation in TLR pathways and in other contexts (Yancey and Blakemore et al. 
2010). How Rab8a is recruited to LRP1 and how it is activated for its signalling roles 
are yet to be determined and will be the topic of this thesis (Figure 1.3).  
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Figure 1.3. TLR4-Rab8a-PI3K  signalling pathway in macrophages. Upon binding the ligand bacterial LPS, 
TLR4 is activated through an unknown kinase X it crosstalk phosphorylates and activates LRP1, which scaffolds 
and recruits Rab8a. Rab8a is then activated by an unknown GEF to recruit its effector PI3Kγ and elicits downstream 
Akt/mTOR signalling, biasing of cytokine outputs towards and anti-inflammatory state to constrain inflammation 
(Luo and Wall et al. 2014, Wall and Luo et al. 2017, Luo and Wall et al. 2018, Wall and Condon et al. 2018 ). 
 
Rab8 effectors  
Rab8a has many known effectors in its disparate cellular roles (see Table 1.3). Here, 
I describe two of particular relevance to this project, that are Rab8 effectors in 
macrophages.  
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Phosphoinositide 3-kinase gamma (PI3K) 
PI3K is a class 1B PI3K that is enriched in macrophages. It has the role of converting 
the phosphoinositide, phosphoiniositol (4, 5)-biphosphate [PI(4,5)P2], to 
phosphoiniositol (3, 4, 5)-triphosphate [PI(3,4,5)P3], which is an signalling 
phosphoinositide that attracts the signalling kinase Akt. PI3K is traditionally recruited 
to G protein coupled receptors by the small GTPase Ras for signalling, however more 
recently it has been shown to act in receptor tyrosine kinase pathways and in TLR 
pathways (Luo and Wall et al. 2014, Kaneda and Messer et al. 2016). We showed that 
the Ras binding domain of the p110 catalytic subunit binds to GTP-Rab8a in 
macrophages, and that LRP1 and Rab8a enable the recruitment of this effector on 
early macropinosome membranes where it triggers Akt/mTOR signalling. Knockout of 
Rab8a in macrophage cell lines, or genetic ablation of PI3K in mice, confirm the roles 
of this Rab-effector pair in inflammatory signalling (Luo and Wall et al. 2014, Wall and 
Luo et al. 2017). This signalling then drives transcriptional programs enhancing the 
synthesis and secretion of anti-inflammatory cytokines and curtailing pro-inflammatory 
cytokines. Overall, this helps to constrain inflammatory responses.  
 
This immune suppressive function of PI3K in macrophages has been further 
supported by findings from other studies in mice (Kaneda and Messer et al. 2016) and 
in humans (Stark and Sriskantharajah  et al. 2015), where PI3K deficiency is 
associated with immunodeficiency and hyper inflammation. Hence, PI3K has 
emerged as a key determinant of an M2 polarised macrophage phenotype.  
 
Oculocerebrorenal syndrome of Lowe protein 1 (OCRL)  
Phosphoinositides are membrane bound molecules that shape important sign alling 
domains for many important cellular functions. These phospholipids contain an inositol 
ring which, upon phosphorylation on its three different residues at positions 3, 4 or 5, 
forms signalling platforms on specific membrane locations for the recruitment of 
various effector proteins (Ooms and Horan  et al. 2009). The phosphorylation states of 
these phosphoinositides are regulated by a range of phosphoinositide kinases, such 
as the PI3Ks described above and by inositol phosphatases. Oculocerebrorenal 
syndrome of Lowe protein 1 (OCRL) is one of 10 known mammalian inositol 5-
phosphatases (Figure 1.4), named after it was revealed to be a key protein in an X-
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linked genetic disease called oculocerebrorenal syndrome of Lowe, where mutations 
in the 5-phosphatase domain of OCRL result in neurological/renal/ocular defects due 
to disruptions in endolysosomal pathways (De Matteis and Staiano et al. 2017).  
 
Found to preferentially hydrolyse phosphoiniositol (4, 5)-biphosphate [PI(4,5)P2] into 
phosphoiniositol (4)-biphosphate [PI(4)P], OCRL regulates a wide range of important 
cellular processes. The main function of OCRL is to control the levels of available 
PI(4,5)P2, which alters the lipid membrane environment and affects the recruitment 
and interactions of a number of metabolic, trafficking and signalling molecules to 
mediate a variety of important cellular functions (examples listed in Table 1.4). One 
key example is OCRL’s role in regulating cytoskeletal reorganisation , by affecting the 
recruitment of actin-binding proteins such as talin and vinculin (Janmey and Lindberg 
2004). In macrophages, OCRL-dependent PI(4,5)P2 depletion on particular 
phagosome membranes have been shown as an important driver of phagosome 
maturation and attenuating downstream Akt signalling (Bohdanowicz and Balkin et al. 
2012). With recent work from our laboratory demonstrating that OCRL is likewise on 
macrophage macropinosome membranes suggesting that this important regulator of 
phosphoinositide signalling might play a similar role during macropinocytosis (Wall 
and Condon et al. 2018). 
 
OCRL is a promiscuous Rab interacting protein, known to bind to at least 17 Rab 
GTPases (Fukuda and Kanno et al. 2008) but notably including Rab8. Experiments in 
zebrafish (Danio Rerio) have identified Rab8 as an essential recruiter of OCRL to 
facilitate maintenance of primary cilia (Luo and West et al. 2012). Crystal structure 
analysis have revealed the nature of GTP-loaded Rab8 binding to OCRL via an 
interaction with its Rab binding domain (RBD) (depicted in Figure 1.4, residues 540–
678) (Hagemann and Hou  et al. 2012). Exploiting this active-Rab/effector interaction 
provides a means for utilising the RBD of OCRL, and other effectors, to capture GTP-
Rab8 for activation assays as described in this thesis. Furthermore, OCRL is of 
interest in macrophages due to its potential for linking several members of the Rab8 
subfamily through shared or sequential interactions. 
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Figure 1.4. Functional domains of OCRL. Depicted here are the known functional domains and Rab binding 
domain of OCRL. (Hagemann and Hou et al. 2012, De Matteis and Staiano et al. 2017) 
 
Table 1.4. List of known OCRL interacting proteins 
Effector Function Reference 
Clathrin Facilitate clathrin vesicle uncoating after 
budding 
(Nández and Balkin  et al. 
2014) 
Rab5 Facilitates early endosome trafficking by 
inhibiting Rac-dependent actin polarisation 
(Vicinanza and Di 
Campli et al. 2011) 
Rab8 Exocytosis and ciliogenesis (Hagemann and Hou  et 
al. 2012, Luo and West 
et al. 2012) 
Rab35 Promotes cytokinesis abscission (Dambournet and 
Machicoane et al. 2011) 
Arf6 Clathrin recruitment for pit assembly and 
budding 
(Krauss and Kinuta et al. 
2003) 
APPL1 Receptor endocytosis and signalling 
through modulating Akt binding 
(Pirruccello and De 
Camilli 2012) 
Rac Regulates Rac dependent polarisation and 
vesicular trafficking  
(Faucherre and Desbois 
et al. 2003) 
 
Guanine nucleotide exchange factors (GEFs) 
As molecular switches, the functions of small GTPases are dependent on their ability 
to recruit specific effectors on targeted organelles at the appropriate time. This precise 
effector recruitment is dependent on structural changes undertaken by the GTPase, 
as it alternates between an ‘on’ GTP-bound state and an ‘off’ GDP-bound state, a 
process catalysed by specific GEFs and GAPs. As such, GEFs and GAPs have 
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become attractive alternative targets for altering GTPase activity through either 
enhancing/inhibiting their catalytic activity, or by modulating their recruitment to 
relevant membranes (Bos and Rehmann et al. 2007, Cherfils and Zeghouf 2013, 
Müller and Goody 2018). As effector binding and function only occurs when the 
GTPase is switched on, identifying the GEF(s) responsible for activating the GTPase 
is essential for understanding the regulatory machinery for any small GTPase-
associated pathway. With over 150 members of the Ras-related superfamily of small 
GTPases, the GEFs responsible for regulating these proteins are categorised in 
equally diverse groups and subfamilies. Specifically, each subfamily of the Ras-like 
GTPases (Rho, Ras, Rab, Ran and Arf) have affiliated groups of GEFs that mostly 
share conserved catalytic domains for facilitating GEF-GTPase specific nucleotide 
exchange (Bos and Rehmann et al. 2007). Examples are the Rho GEFs which share 
a common Dbl homology (RhoGEF) domain (Cook and Rossman et al. 2014), and the 
Ras GEFs which possess a catalytic CDC25 homology GEF domain (Popovic and 
Rensen-de Leeuw et al. 2013). In this thesis, I will be focusing on the GEFs of the Rab 
family of Ras-related GTPases. 
 
As with the other members of the Ras GTPase family, Rabs in general possess a slow 
intrinsic dissociation rate of nucleotides, as a consequence of having a high affinity for 
both GDP and GTP nucleotides (Bos and Rehmann  et al. 2007). Therefore, to 
increase the response rate, GEFs act as catalysts to accelerate this process by 
several hundred-fold (Vetter and Wittinghofer 2001). Structural information for various 
Rab GEFs revealed that this occurs through an interaction between the switch I and II 
regions of a GDP-bound GTPase molecule and the catalytic GEF domains of the 
specific GEF, driving a conformational change of the Rab nucleotide binding site and 
releasing the bound GDP (Ishida and Oguchi et al. 2016). While this GEF-Rab 
interaction does not favour either GDP or GTP from reinserting into the empty 
nucleotide binding site, activation of the Rab occurs due to the 10-fold higher 
concentration of GTP to GDP in the cellular environment (Kelly and Horgan  et al. 
2012). Upon activation, the Rab is now available to recruit and bind its specif ic effector 
to facilitate downstream functions. There are currently several known families of Rab 
GEFs, classified by their catalytic GEF domain structures (Müller and Goody 2018). 
The two largest classes of Rab GEFs are the differentially expressed in normal and 
neoplastic cells (DENN) domain containing GEFs (18 members in humans) and the 
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vacuolar protein sorting 9 (VSP9) domain containing GEFs (9 members in humans), 
along with other smaller groups such as transport protein particle (TRAPP) complexes, 
which are multi-subunit GEFs, and the focus of this report, the Sec2-domain containing 
GEFs (Ishida and Oguchi et al. 2016). Despite the distinct separation and homology 
between these GEF families, there is interestingly no correlation between the GEF 
family members and Rab sub-families with the exception of the VPS9 proteins 
targeting the Rab5 family members (Carney and Davies et al. 2006). Several 
examples of each of these GEF family members and their target Rab is listed in Table 
1.5. 
 
In addition to targeting Rab GEFs directly, there is now a growing interest in  identifying 
the molecular mechanisms that govern GEF activity as an alternative approach for 
modulating specific Rab functions. There are several known mechanisms for 
controlling GEF function, which revolves around either altering the recruitment and 
location of the GEF to a targeted cellular compartment, or modulating its catalytic 
activity through occluding/exposing its GEF domain to prevent/enhance Rab binding 
(Müller and Goody 2018). A well-known example is the recruitment of the GEF Sec2p 
(yeast homolog to the mammalian Rabin8) to secretory vesicles by the upstream 
GTPase Ypt32 in yeast cells (Mizuno-Yamasaki and Medkova et al. 2010). The 
authors demonstrated that preventing the recruitment, but not activity, of the GEF 
Sec2p to secretory vesicles prevented the activation of its GTPase Sec4p (yeast 
homolog to the mammalian Rab8) on the target membranes, inhibiting vesicle 
transport and maturation. Therefore, to elucidate additional components of the 
regulatory machinery that modulates Rab activation and function, the upstream 
proteins that dictate the recruitment and activation of its respective GEF must also be 
identified.  
 
This project focuses on identifying the respective Rab8a GEF(s) that is/are 
responsible for activating Rab8a in the TLR4-Rab8a-PI3K inflammatory signalling 
complex in macrophages. 
 
Chapter 1: Introduction 
 1 
 
Table 1.5. List of Rab GEF family members and examples of their known functions 
GEF Target Rab Function Reference 
DENN-domain GEFs 
DENND1A Rab35 Endosome membrane trafficking (Allaire and Marat et al. 2010) 
DENND1B Rab35 Regulation of T-cell receptor signalling  (Yang and Hojer et al. 2016) 
DENND2B Rab13 Actin remodelling (cell trafficking and growth) (Ioannou and Bell et al. 2015) 
DENND3 Rab12 Autophagosome Trafficking (Xu and Fotouhi et al. 2015) 
DENND5A Rab39 Exocytic trafficking and secretion of IL-1 in 
response to caspase-1  
(Becker and Creagh et al. 2009, 
Yoshimura and Gerondopoulos et al. 
2010) 
DENND6 
(FAM116) 
Rab14 Regulation of cell-cell adhesion by trafficking 
proteases  
(Linford and Yoshimura et al. 2012) 
VPS9-Domain GEFs 
Rabex5 Rab5 Endosome maturation and membrane fusion (Zhu and Liang et al. 2009) 
Varp Rab21 Dendrite formation in melanocytes (Ohbayashi and Yatsu  et al. 2012) 
RIN1 Rab5 Epidermal growth factor receptor internalisation 
and degradation 
(Balaji and Mooser et al. 2012) 
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RIN3 Rab31 Trafficking of receptor containing vesicles between 
the TGN and early endosomes 
(Kajiho and Sakurai et al. 2011) 
ALS2 Rab5 Endosome trafficking (Otomo and Hadano et al. 2003) 
TRAPP complex 
mammalian 
Trs130 (mTrs130) 
Rab1 Early Golgi trafficking of COPI-coated vesicles (Yamasaki and Menon  et al. 2009) 
Sec2p 
Rabin8 Rab8 Ciliogenesis  (Nachury and Loktev et al. 2007) 
GRAB Rab8 Neurite outgrowth  (Furusawa and Asada et al. 2016) 
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Rab8 GEFs 
To date there are two main GEFs that specifically regulate Rab8 activity, the proteins 
Rabin8 and GRAB (Figure 1.5). Described below is a short literature review on these 
known Rab8 GEFs summarising what is currently known about these proteins. 
 
 
Figure 1.5. The Rab8 Sec2 GEFs Rabin8 and GRAB. Depicted here are the known locations of the highly 
conserved functional GEF coiled-coil domains and Rab11-binding domains of Rabin8 and GRAB (Guo and Hou et 
al. 2013, Horgan and Hanscom et al. 2013, Vetter and Stehle et al. 2015). 
 
Rabin8 (Rab3IP) 
The first identified and most well characterised GEF of Rab8, Rabin8, also known as 
Rab3-like interacting protein (Rab3IP), is best known for the pivotal role it plays in 
ciliogenesis, where it facilitates Rab8-mediated vesicle transport and fusion of Golgi-
derived vesicles to the pericentrosomal area surrounding the centrosome (Chiba and 
Amagai et al. 2013, Patrussi and Baldari 2016). Belonging to the Sec2-GEF family of 
proteins, Rabin8 has a highly conserved Sec2p coiled-coil GEF domain where it 
predominately interacts with Rab8, however some studies hint at a possible GEF 
interaction with Rab10 and Rab3 (Sato and Fukai et al. 2007, Homma and Fukuda 
2016, Patrussi and Baldari 2016). Crystal structures of these proteins revealed that 
Rabin8 preferentially forms a homodimer and interacts with Rab8 via the overlapping 
of two GEF coiled-coil domains (Figure 1.6). This interaction disrupts a magnesium 
binding site adjacent to the nucleotide binding pocket, resulting in a decreased affinity 
for the nucleotide (GDP) and the subsequent release of GDP, leaving the pocket open 
for GTP binding and Rab activation (Guo and Hou et al. 2013). 
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Figure 1.6. Interaction between Rab8a and Rabin8. Structural studies have demonstrated that Rab8a and 
Rabin8 interaction occurs between the switch I and II regions of Rab8a and the homod imerised coiled-coil Sec2P 
GEF domains of two Rabin8 molecules. This binding interface causes a conformational change within the 
nucleotide binding pocket, resulting in the release of GDP and nucleotide exchange with GTP (Guo and Hou et al. 
2013) 
 
As mentioned previously, the function and recruitment of Rabin8 has been  well 
characterised during ciliogenesis. Identified as an effector of Rab11, Rabin8 forms a 
Rab11-FIP3-Rabin8 complex on recycling endosomes, which in turn recruits and 
activates Rab8 for docking and delivery of the vesicle to the ciliary base (Vetter and 
Stehle et al. 2015). This association between Rabin8 and Rab11 was further 
investigated in other studies, identifying a 69-residue sequence that is essential for 
Rab11a interaction (Knödler and Feng et al. 2010). This upstream recruitment of 
Rabin8 has been tightly associated with facilitating Rab8 localisation to the ciliary 
base, indicating that, at least in this context, Rabin8 contributes to both the activation 
and targeted recruitment of Rab8. 
 
Rabin8 exists in a naturally auto inhibitory state and its GEF activity is tied to kinase 
driven phosphorylation to relieve this state (Wang and Ren et al. 2015). This study by 
Wang and colleagues demonstrated that Rabin8 GEF activation in response to 
epidermal growth factor (EGF) is regulated by the mitogen-activated protein kinase 1 
(MAPK1) extracellular signal-regulated kinase 1 and 2 (ERK1/2). ERK1/2 is a central 
regulatory kinase for many cellular processes from cell proliferation to metabolism 
mostly through the MAPK cascade of Ras-Raf-MEK-ERK (Wortzel and Seger 2011). 
The authors identified four serine residues namely, 16, 19, 247 and 250 of Rabin8 that 
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are phosphorylated by ERK1/2 in HEK293 cells stimulated with EGF (Figure 1.7). This 
phosphorylation leads to an ‘unfolding’ of the GEF, releasing its inhibited state and 
exposing its GEF domain (Wang and Ren et al. 2015). This change in structural 
configuration allowed the binding and subsequent activation of Rab8, facilitating the 
recruitment of effectors for exocytic signalling and receptor trafficking functions. In 
another study, the serine/threonine kinase nuclear Dbf2-related protein 2 (NDR2) was 
also shown to phosphorylate Rabin8, but at serine-272 during ciliogenesis in RPE1 
cells (Figure 1.8) (Chiba and Amagai et al. 2013). Interestingly, the authors 
demonstrated that the effects of this kinase did not alter Rabin8’s GEF activity, but 
rather Rabin8 recruitment and localisation was altered by promoting its binding to 
Sec15, an essential component of the exocyst complex. This redirection of Rabin8 
localisation eventually drove Rab8 activity towards the forming cilia (Chiba and 
Amagai et al. 2013). Taken together, these findings highlight the various effects of 
kinases that are used to differentially regulate Rabin8-Rab8 function. 
 
 
Figure 1.7. ERK1/2 kinase regulation of Rabin8 GEF function. The ERK1/2 phosphorylation sites 
(ser16/19/247/250) identified on Rabin8 that when phosphorylated, drives a conformational change which ‘unfolds’ 
Rabin8 and relieves its autoinhibited state, exposing the Sec2p GEF domain for Rab8 binding and nucleotide 
exchange (Wang and Ren et al. 2015). 
 
GRAB (Rab3IL1) 
Though not as well characterised as Rabin8, GRAB, also known as Rab3a interacting 
protein like 1 (Rab3IL1), is structurally very similar in its GEF interaction with Rab8 as 
Rabin8 (Guo and Hou et al. 2013). Sharing a 55% homology with Rabin8, structural 
analysis has shown that GRAB, likewise, has the Sec2p homologous coiled-coil GEF 
domain (See Figure 1.5), and interacts with Rab8 in a biochemically identical manner 
to Rabin8 (Guo and Hou  et al. 2013).  
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Initially identified as a GEF for the neuron and endocrine specific Rab GTPase Rab3a, 
GRAB was first shown to regulate Rab3’s role in the secretion of neurotransmitters 
and hormones (Luo and Saiardi et al. 2001, Matsumoto and Miki et al. 2004). Further 
insights into GRAB function have since demonstrated that this protein has a greater 
GEF specificity and activity for Rab8 compared to Rab3 (Yoshimura and 
Gerondopoulos et al. 2010). Additionally, like Rabin8, studies have identified GRAB 
as an effector for Rab11, suggesting a similar recruitment mechanism to Rabin8 
(Horgan and Hanscom et al. 2013). This interaction is further elaborated with 
mediating axonal outgrowth, demonstrating a Rab11-GRAB-Rab8 pathway that was 
similar to the Rab11-Rabin8-Rab8a complex described earlier (Furusawa and Asada 
et al. 2016). 
 
Interestingly, like Rabin8, GRAB’s GEF function is shown to be regulated through 
phosphorylation by specific serine kinases. Multiple studies have implicated different 
kinases that regulate GRAB GEF function in various systems (Figure 1.8). For 
instance, the serine kinase c-Jun N-terminal kinase (JNK) has been identified to 
phosphorylate Ser169 of GRAB in myocytes, promoting the secretion of the important 
muscle repair cytokine IL-6, however, in this study GRAB GEF function has not yet 
been tested (Lee and Min  et al. 2017). Interestingly in another publication, GRAB 
phosphorylation at Ser169/180 by the neuron specific proline-directed serine/threonine 
membrane bound kinase Cdk5 is shown to actually decrease its GEF binding affinity 
to GDP-bound Rab8, modulating axon outgrowth (Furusawa and Asada et al. 2016). 
While it is unknown if GRAB also exists in an autoinhibitory state like Rabin8, it is clear 
that kinases are important regulators for both of these Rab8 GEFs.  
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Figure 1.8. Kinase Regulation of Rabin8 and GRAB. Several studies have identified kinase-mediated regulation 
of either Rabin8 or GRAB in various pathways. Shown here are examples of known kinases, along with their 
phosphorylation sites that regulate Rabin8 – or GRAB – associated pathways (Chiba and Amagai et al. 2013, 
Wang and Ren et al. 2015, Furusawa and Asada et al. 2016, Lee and Min et al. 2017).  
 
The similarities between Rabin8 and GRAB prevent the exclusion of either, in terms 
of Rab8 regulation in macrophage TLR signalling, making both of these proteins viable 
candidates for further investigation. This project will address and identify the regulatory 
GEFs, along with potential upstream modulators that activate the small GTPase 
Rab8a for its role in TLR-associated inflammatory signalling. 
 
Chapter 2: Aims and Significance 
 6 
 
 
 
Chapter 2 
Aims and Significance  
Chapter 2: Aims and Significance 
 7 
2. Aims and Significance 
Key roles of macrophages are to mount innate immune responses to kill pathogens 
and to recruit cells of the adaptive immune system for more extensive anti -microbial 
programs in order to ward off infection. Macrophages are engaged for these roles by 
pathogen-mediated activation of Toll-like receptors (TLRs), which generate signalling 
and transcriptional pathways leading to the secretion of inflammatory cytokines, 
chemokines and other effectors. TLR–mediated pathways are essential for effective 
immune defence but must also be tightly constrained to avoid excessive inflammation 
and tissue damage. In fact, poorly controlled inflammation, including from TLR 
responses, contributes to a heavy burden of chronic inflammatory and autoimmune 
diseases and, acutely to high morbidity and mortality in sepsis. Therefore, generating 
a greater understanding of TLR-mediated signalling pathways is a significant goal for 
biomedical research and the pharmaceutical industry in seeking new drug targets and 
approaches for managing inflammation and infection.   
 
Rab GTPases and their attendant regulators are critical for enabling and controlling a 
wide range of cell functions. In innate immunity, Rab GTPases control key processes 
such as receptor trafficking, cytokine secretion, macropinocytosis, phagocytosis and 
receptor mediated signalling to promote and drive immune cell functions. In a detailed 
series of studies, our research group has identified and characterised an important 
role for Rab8 as a signalling regulator downstream of multiple TLRs (Luo and Wall et 
al. 2014, Wall and Luo et al. 2017, Wall and Condon  et al. 2018). TLRs activated by a 
range of pathogen-associated agonists, induce the crosstalk phosphorylation and 
activation of the endocytic receptor LRP1 (Luo and Wall et al. 2018). LRP1-bound 
Rab8a is activated to recruit the class 1B PI3K, PI3K, as an effector which generates 
PI(3,4,5)P3 enriched domains on surface ruffles and macropinosomes for the 
recruitment of the signalling kinase Akt. The LRP1/Rab8a/PI3K complex enhances 
TLR-mediated Akt/mTOR signalling which biases the output of inflammatory cytokines 
towards anti-inflammatory responses. Accordingly, and in a series of subsequent 
papers in the literature, PI3K has emerged as an important regulator for promoting 
M2 macrophage polarisation for the resolution of inflammation in animal models and 
humans (Stark and Sriskantharajah et al. 2015, De Henau and Rausch  et al. 2016, 
Kaneda and Messer et al. 2016). In this context, there are several novel aspects of 
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Rab function, for instance, i) Rab8a is a novel GTPase for recruiting a PI3K effector, 
a role normally ascribed to Ras in other receptor pathways, ii) LRP1 is a novel scaffold 
for Rab8a and how Rab8a is activated as part of this receptor complex is not known, 
and finally, iii) in this novel signalling function for Rab8, the contributions of Rab8 GEFs 
and GAPs are unknown.  
 
Inflammation in clinical settings is a widespread and rapidly growing problem. The 
recent decades have seen an increased burden of chronic diseases such as arthritis 
and diabetes where inflammation contributes almost universally to the underlying 
pathology and debilitating symptoms. The availability of specific PI3K inhibitors for 
clinical intervention highlights the potential for drugging TLR pathways to control 
inflammation and macrophage polarisation in a number of diseases. Notably, PI3K 
inhibitors are now being tested in clinical trials as a means to retain tumour associated 
macrophages in M1 states to enhance tumour cell killing (Kaneda and Messer et al. 
2016). Identifying additional regulators of PI3K inflammatory signalling function will 
therefore be beneficial to the development of new therapeutics for modulating 
inflammation in various diseases. As a direct activator of PI3K immune signalling, 
targeting this particular function of Rab8a could be an alternative therapeutic for 
modulating this inflammatory pathway.  
 
With a growing list of disease-causing mutations within the small GTPase family of 
proteins (for example the Ras oncogenes), clinical research into identifying therapeutic 
inhibitors for this important group of regulatory proteins is becoming increasingly 
important (Cook and Rossman  et al. 2014, Simanshu and Nissley et al. 2017, 
Banworth and Li 2018). Unfortunately, biochemical and structural studies have 
revealed that small GTPases make challenging drug targets due to their small size, 
globular structure, and lack of well-defined binding pockets (Hong and Guo et al. 
2015). In saying this, several small GTPase inhibitors have been proven to be able to 
compete and interfere with their activity, either through interfering with the nucleotide 
binding pocket (preventing GTP or GDP loading) or inhibiting protein -protein 
interactions with effectors or regulatory proteins such as GEFs and GAPs (Gao and 
Dickerson et al. 2004, Agola and Hong et al. 2012). In particular, in-vitro work by 
Waldmann and colleagues generated a stapled helical peptide, stRIP3, that could 
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compete and interfere with the interactions between Rab8 effector OCRL for binding 
to active-Rab8a (Spiegel and Cromm et al. 2014). While these molecular inhibitors 
have been demonstrated to be important molecular tools for interrogating the functions 
and characteristics of individual GTPase pathways, a majority of these studies have 
been limited to in-vitro experiments and the therapeutic efficacy has not yet been 
tested. Furthermore, being one of the more ubiquitous and multi -functional of the 
Rabs, direct inhibition of Rab8 itself might have wide ranging implications that could 
lead to unwanted side-effects.  
 
As an alternative, the regulatory GEFs and GAPs of GTPases are often viewed as 
more attractive drug targets for manipulating the activity and function of a specific 
small GTPase for several reasons. From a structural standpoint, GEFs and GAPs are 
much larger and often have multiple functional domains with deeper, more defined 
binding pockets, making them easier targets for drug design (Cherfils and Chardin 
1999). Indeed, preliminary data from our lab implicating AS160 as a GAP for Rab8 in 
the TLR pathway, is one example (A. Wall unpublished data). Targeting GEFs, 
kinases, expanding and identifying more components of this immune signalling 
pathway is warranted to allow greater insights into other potential targets for 
modulating inflammation.  
 
Therefore, the key question I set out to address in this project is to find out how Rab8a 
is activated and regulated on the dorsal ruffles and macropinosome membranes, 
downstream of TLRs, where it functions in signalling pathways. Answering this 
question compels us to identify and characterise the upstream GEF(s) responsible for 
activating Rab8a and nucleotide exchange in macrophages. As the project evolved, it 
came to focus on two known Rab8a regulators, the GEFs Rabin8 and GRAB, exploring 
their roles in TLG signalling and examining upstream kinases and regulators for these 
GEFs.  
 
Project Hypothesis  
Preceding studies demonstrate that LPS and other TLR agonists activate Rab8a for 
the recruitment of PI3K as an effector to modulate Akt/mTOR signalling and selective 
cytokine transcription (Luo and Wall et al. 2014). I propose that Rab8 guanine 
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nucleotide exchange factors (GEFs) will be required to facilitate GDP-GTP exchange 
on Rab8a to activate the GTPase for this role. Based on the typical roles of GEFs in 
other pathways, a Rab8a GEF in this instance could facilitate GDP exchange, direct 
membrane recruitment of Rab8a and control the selective recruitment of the effector 
PI3K. Furthermore, a GEF would require additional in teracting proteins to participate 
in either scaffolding or recruiting to the relevant membrane domains on ruffles and/or 
macropinosomes. It is therefore likely that one or more regulatory proteins are involved 
in recruiting the GEF(s) to TLR signalling membrane domains. Studies on Rab 
cascades also lead us to hypothesise that these accessory proteins could be effectors 
of an upstream Rab.  
 
To elucidate answers to these questions, this project will be spilt into three distinct 
aims that are described below. 
 
AIM 1 
Identify the candidate GEF(s) for Rab8a activation in TLR-activated 
macrophages.  
The first aim of this project will be to develop and utilise biochemical assays (protein 
pull-down, immunoprecipitation and Rab activation assays), novel knockout 
macrophage cell lines (CRISPR-Cas9) and live cell imaging to identify potential Rab8a 
GEFs in LPS-activated mouse macrophages. 
 
AIM 2 
Examine the functional role of GEF(s) in Rab8-mediated TLR-signalling 
Utilising a combination of biochemical assays, fluorescence microscopy and gene 
manipulation, I will assess the phenotypic changes in Rab8 activation and Rab8a-
associated TLR signalling in the absence of candidate GEFs, eg Rabin8 and/or GRAB, 
in LPS-treated macrophages, to determine which GEF is involved in regulating Rab8a-
associated TLR inflammatory signalling pathways. 
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AIM 3  
Investigate upstream regulators of Rab8a GEFs in TLR signalling 
Using pull-downs and mass spectrometry, I seek to identify possible binding partners 
and regulators for the Rab8 GEF responsible for activating Rab8a (identified in Aim 2) 
in TLR-signalling pathways. Additionally, both candidate Rab8 GEFs, GRAB and 
Rabin8 have several regulatory kinases tied to their GEF activity. Using known 
inhibitors of these kinases and measuring the effects on Rab8 activation through the 
activation assay established in the previous aims, I can possibly identify novel kinases 
that modulate either Rabin8 or GRAB in TLR-activated macrophages. 
 
Chapter 3: Materials and Methods 
 12 
 
 
 
Chapter 3 
Materials and Methods 
  
Chapter 3: Materials and Methods 
 13 
3. Materials and Methods 
Plasmids 
Microscopy 
For generating the GFP-Rabin8 and GFP-GRAB plasmid, full-length mouse GRAB 
and Rabin8 were PCR amplified from mouse RAW 264.7 cell cDNA with the primers 
listed in Table 3.1. The respective genes were later inserted into a pEF6-GFP-C1 
backbone using BamHI/NotI and SpeI/NotI respectively. pEGFP-C1 vector 
(Clonetech) with full-length mouse Rab5, Rab8a and Rab13 were generously provided 
by Prof M. Fukuda (Tohoku University). The Rab8a construct was later su b-cloned 
into ptd-Tomato-C1 as described in previous work (Luo and Wall et al. 2014, Wall and 
Luo et al. 2017). Full-length TRAM was cloned from RAW 264.7 cDNA into the 
Clontech vector pEGFP-N1 using BamHI/HindIII (Wall and Luo et al. 2017). The 
TagRFP-T-Akt1 construct was generously provided by James Burchfield (University 
of Sydney) (Norris and Yang et al. 2017).  
 
Rab8 activation assay 
For the Rab8 activation assays, the GST-OCRL-RBD construct was generated by sub-
cloning a codon-optimised human OCRL-RBD (residues 539-901) into pGEX-6p-1 
and expressed in E. coli BL21(DE3) bound to GSH-Sepharose beads and was used 
in previous studies (Wall and Luo et al. 2017). The original truncated codon-optimised 
OCRL-RBD construct (His6-TEV-OCRL, 539-901) was generously provided by Itzen 
and colleagues and used as the template for the activation probe (Hagemann and Hou  
et al. 2012). The GST-PI3K-RBD (residues 1-356) was subcloned into pGEX-6P-1 
from mouse cDNA obtained from the Facility for Life Science Automation at the 
Institute for Molecular Bioscience. Both these GST constructs (OCRL-RBD and PI3K-
RBD) used in this study was generated by my supervisor Lin Luo. For the GST-MICAL-
L2-RBD probe, I PCR amplified the MICAL-L2-RBD from a FRET Rab13 biosensor 
developed by the McPherson laboratory (Montreal Neurological Institute) using the 
primers listed in table 3.1 (Ioannou and Bell et al. 2015). The amplified MICAL-L2-
RBD was inserted into a pGEX-6P-1 vector via restriction enzyme digestion by 
BamHI/EcoRI.  
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Protein-protein interaction 
For determining the direct protein-protein interactions between Rabin8 and OCRL, I 
generated a His-OCRL plasmid by subcloning the OCRL-RBD from the GST-OCRL-
RBD construct (see Rab8 activation assay construct above) into a pOpine-His vector 
(addgene plasmid #26043). Using the primers listed in table 3.1, I PCR amplified the 
OCRL-RBD (residues 539-901) and inserted it into a pOpine-His vector with 
KpnI/HindIII. This construct was used in conjunction with GST-Rabin8 constructs 
(human Rabin8 WT, phospho-mimic [serine to aspartic acid] and phospho-deficient 
[serine to alanine] mutants in a pGEX-6P-1 vector), generously provided by Wei Guo 
and colleagues (Wang and Ren et al. 2015). The mutations were performed on serine 
residues 16/19/247/250. 
 
CRISPR-Cas9 
Several constructs were made for performing CRISPR knockout of GRAB and Rabin8. 
The first was cloning Rabin8 and GRAB guideRNA sequences into the Cas9 
mammalian expression plasmid px458 [Addgene plasmid #48138, by (Ran and Hsu 
et al. 2013)] using primers ordered from IDT (Table 3.3). Sequences used were based 
on mouse gDNA information on the NCBI database and primer oligos targeting PAM 
CRISPR was designed as described by Ran et al 2013 with the help of an online 
CRISPR design tool by the Zhang laboratory (crispr.mit.edu , Broad Institute, MIT, 
USA). 
 
Donor selection plasmids were made by PCR amplifying homologous regions (primers 
in Table 3.3) from RAW 264.7 genomic DNA that flank the target mutation site. The 
PCR products were then run on 1% agarose with 0.5 µg/ml ethidium bromide and gel 
purified using QIAqu ick Gel Extraction Kit (Qiagen, Germany). The purified ‘arms’ 
were digested with restriction enzymes per NEB digestion protocol (10X Cutsmart 
buffer for 1 hr at 37ºC). For GRAB, the enzymes HindIII/MluI was used for the left 
homologous ‘arm’ and SalI/NheI for the right homologous ‘arm’, as for Rabin8, MluI 
and BamHI was used for the left ‘arm’ and NheI/SalI was used for the right ‘arm’. The 
purified ‘arms’ are then cloned into the selection vector pFloxNeoFlox (designed by 
Adam Wall) via the Gibson Assembly Reaction (NEB, United States), the donor 
vectors were then digested via the same restriction enzymes to check for the correct 
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insertion of the homologous ‘arms’. CRISPR selection resistance plasmid pFloxNeo-
DTA was designed by Adam Wall (IMB, University of Queensland) (Wall and Luo et 
al. 2017). 
 
Table 3.1. List of primers for the generation of various constructs used in this project 
Primer Name Sequence (5’ – 3’)  Construct 
mRabin8 F AATTACTAGTATGGCTAACGACCCCTTG pEF6-
EGFP-
Rabin8 
mRabin8 R 
AATTGCGGCCGCCGAGTTCCTCTTTGAAA
TA 
mGRAB F AATTGGATCCATGGAGATCCGAGAGAAG pEF6-
EGFP-
GRAB 
mGRAB R 
AATTGCGGCCGCCGGCCTCCTGGGGGAA
GAA 
hMICAL-L2-RBD F AATTGGATCCGAGGAGCAGCAGCTGGAC pGEX-6P-
1-MICAL-
L2-RBD 
hMICAL-L2-RBD R AATTGAATTCCTACTGGGAGGGGCTGCT 
His-OCRL-RBD F AATTGGTACCATGGCTAATGATCCCTTG pOpine-
mod-His-
OCRL 
His-OCRL-RBD F AATTAAGCTTTCAATCTTCTTCTGAACC 
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Table 3.2. List of plasmids used in this project 
Plasmid Name Use Source 
td-Tomato-Rab8a Live-cell/Fixed-cell Imaging Adam Wall 
EGFP-Rab8a Live-cell/Fixed-cell Imaging Mitsunori Fukuda 
pEGFP-N1-TRAM Live-cell Imaging Adam Wall 
pGEX-6P-1-Rab8a 
Pull-down and mass 
spectrometry 
Lin Luo 
pEF6-GFP-C1-Rabin8 Live-cell/Fixed-cell Imaging Generated in this project 
pEF6-GFP-C1-GRAB Live-cell/Fixed-cell Imaging Generated in this project 
pGEX-6P-1-OCRL-RBD Pull-down/Rab8 activation Lin Luo 
pGEX-6P-1-PI3K-RBD Pull-down/Rab8 activation Lin Luo 
pGEX-6P-1-MICAL-L2-
RBD 
Pull-down/Rab8 activation Generated in this project 
pOpine-mod-His-OCRL-
RBD 
Pull-down Generated in this project 
 
Protein Expression 
Recombinant GST-tagged proteins were produced by cloning genes of interest into a 
bacterial expression plasmid pGEX-6P-1 and expressed in E. coli BL21(DE3) via 
induction using 0.5 mM IPTG for 18 hr at 18ºC with constant agitation. The bacteria 
cells are then pelleted via centrifugation at 5, 000g and resuspended in ice-cold STE 
buffer (10 mM Tris pH 8, 150 mM NaCl, 1 mM EDTA, 1 mM DTT and 1 mM PMSF). 
The cells were later lysed using a Constant Systems cell disruptor according to the 
manufacturer’s instructions (Thermo Scientific, Australia). Bacterial lysates were 
centrifuged at 20, 000 rpm and the proteins were then applied to Glutathione 
Sepharose beads (GE Healthcare Life Science, Australia) for affinity purification. The 
beads were washed with buffer (1 M NaCl, 20 mM Tris pH 7.4) and stored in 20mM 
Tris pH 7.4 with 20% glycerol. His-tagged OCRL proteins were expressed similarly 
with different expression vectors (pET19-OCRL).  
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Cell culture and transfection 
The mouse macrophage cell line RAW 264.7 (obtained from ATCC) was the primary 
cell-line used in this study. Cells were maintained in complete RPMI medium (Lonza, 
Australia) supplemented with 10% heat-inactivated Fetal calf serum (Thermo Trace, 
Australia) and 2 mM L-glutamine (Invitrogen) at 37ºC in humidified 5% CO2. Primary 
mouse bone marrow-derived macrophages (BMMs) were differentiated from femur 
bone marrow cells for 7 days in RPMI medium supplemented with 10% heat-
inactivated Fetal calf serum (Thermo Trace, Australia), 2 mM L-glutamine (Invitrogen), 
20 unit/ml penicillin, 20 µg/ml streptomycin 100 ng/ml macrophage colony-stimulating 
factor-1 (CSF-1). For experimental procedures, all cells were treated with 10 ng/ml 
LPS unless stated otherwise. BMMs from TLR4-/- mice were kindly provided by Matt 
Sweet (IMB, The University of Queensland) (Hoshino and Takeuchi et al. 1999). 
 
RAW 264.7 macrophages were transfected using Lipofectamine 2000TM 
(ThermoFisher Scientific, San Diego, CA) as per manufacturer’s instruction. Cells 
were seeded either on 25mm coverslips or Mattek 35mm glass bottom dishes (Mattek 
Cooporation) at a density of 0.1x106 cells/ml and incubated with transfection 
complexes for 2-4 hr before changing the medium, finally, cells were incubated 
overnight and then used for experiments.  
 
Rab8 activation assay and immunoprecipitation 
The Rab8 activation assay, based on capture and pull-down of GTP-Rab8a with GST-
OCRL-RBD bound GSH-Sepharose resin, has been described previously (Wall and 
Luo et al. 2017). Briefly, cells +/- LPS (100 ng/ml, 15 min) were lysed in ice-cold lysis 
buffer A [25 mM TRIS pH 7.4, 150 mM NaCl, 5mM MgCl2, 1% NP-40, PhosSTOPTM 
(Roche Applied Science, Switzerland), EDTA-free cOmplete Mini protease inhibitor 
(Sigma-Aldrich, Australia) and 5% glycerol], and centrifuged at 14,000 × g for 15 min. 
Lysates were applied to 30µl of 50% GSH-Sepharose bead slurry with bound with 
either GST-OCRL-RBD or GST-PI3K-RasBD to capture active, GTP-loaded Rab8. 
Binding was performed in microspin columns (GE Healthcare) for 1 hr at 4ºC with 
constant agitation. For the loading calibration assay, cell lysates were applied to GSH-
Sepharose resin and treated with lysis buffer containing either Gpp(NH)p (Sigma-
Aldrich) at the described concentrations or 1 mM GDP (Sigma-Aldrich) for 15 min at 
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room temperature with constant agitation. The nucleotide exchange reaction was 
terminated by placing the sample on ice and adding 32 mL of 1 M MgCl2 (for a final 
concentration of 60 mM). The resin was later washed multiple times with ice-cold lysis 
buffer and bound proteins eluted by boiling at 95ºC for 5 min in 2X SDS-PAGE sample 
buffer (1M Tris pH7.4, 20% glycerol, 6mM EGTA, 2.5% SDS, 6% -Mercaptoethanol). 
Eluted samples were analysed by immunoblotting. For quantification, experiments 
were performed independently in triplicates and due to the variations in basal GTP-
Rab8 captured between separate control cell replicates (see for example control time 
0 in Figure 5.5 for both representative blots), band intensities for individual repeat 
experiments were set relative to the amount of GTP-Rab8 captured in untreated 
control cell extracts (control time 0 or basal resting levels of GTP-Rab8 is set at 1) to 
correct for this variation. Therefore, the amount of GTP-Rab8 measured in each 
sample is set relative to the basal levels of GTP-Rab8 in control cells, and these 
relative changes were later used for statistical analysis. 
 
For immunoprecipitations, LPS treated cells were lysed by passaging through a 27-
gauge needles in ice-cold lysis buffer B [25mM TRIS pH 7.4, 150mM NaCl, 5mM 
MgCl2, 1% NP-40, 1% Triton X-100 (Sigma-Aldrich), PhosSTOPTM (Roche Applied 
Science, Switzerland), EDTA-free cOmplete Mini protease inhibitor (Sigma-Aldrich, 
Australia) and 5% glycerol], and centrifuged at 14,000 × g for 15 min. A small sample 
of cleared cell lysate was saved as input while the rest was mixed with antibody bound 
PierceTM Protein G beads (ThermoFisher, Australia) for 1 hr at 4◦C with constant 
agitation. The bound proteins were eluted from beads as described above, separated 
on 10% SDS-PAGE gels and analysed by immunoblotting. Pierce BCA Protein Assay 
Kits (#23225) were used to quantify total protein in cell lysates, according to the 
manufacturer’s instructions.  
 
Mass spectrometry 
LPS treated immortalised bone marrow-derived mouse macrophages were lysed as 
above (Immunoprecipitation, lysis buffer B) and the lysates applied to GSH-Sepharose 
resin with bound GST-Rab8a or GST-Rabin8 (WT, phosphomimic and 
phosphodeficient mutants). The bound proteins were eluted using a single-step 
protease cleavage protocol using a commercially available PreScission protease 
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purification samples were analysed by mass spectrometry using a LC MS/MS with a 
Shimadzu Prominence Nano HPLC (Japan) coupled to a Triple TOF 5600 mass 
spectrometer (ABSCIEX, Canada) equipped with a nano electrospray ion source at 
IMB, The University of Queensland as described previously (Luo and Bokil et al. 2017). 
Protein identification was performed via database searching using ProteinPilot v4.5 
(ABSCIEX, Canada) against the UniProt_Sprot_20130205 database (B106,000 
entries of all species searched, FDR of 1%). 
Immunoblotting  
Cell lysates were fractionated using 10% SDS-PAGE gels and transferred onto to 
polyvinylidene difluoride (PVDF) membranes (Merck Immobilon -P) using wet 
transfer apparatus (Bio-Rad). All protein gels were ran using a 1 X running buffer 
(25mM Tris, 192mM glycine and 1% Sodium Dodecyl Sulfate [SDS]) for ~1 hr at 120 
volts. Western transfers were performed using a 1 X transfer buffer (25mM Tris, 
192mM glycine and 20% methanol) at 30 volts overnight at 4C (current maintained 
at 30mA). 
 
The membranes were blocked in 5% skim milk in 1 X TBST buffer (20mM Tris, 150mM 
NaCl and 0.1% TWEEN [Sigma Aldrich, #P1379], pH 7.4) for ~1 hr at room 
temperature and blotted with the appropriate antibodies overnight at 4C with constant 
agitation. The membranes were wash three times with TBST and blocked with 
appropriate secondary antibody (in 5% skim milk in TBST) for ~1hr at room 
temperature. The membranes were washed three times in TBST, and results were 
visualized with an ECL kit (SuperSignal West Pico) and X-ray films (FujiFilm Super 
RX). Antibodies used are listed in the key resource table below. The specificity of 
commercial antibodies for Rabin8 and GRAB was verified for Western blotting and 
microscopy by testing on multiple samples with CRISPR KO controls. 
 
CRISPR/Cas9-knockout (KO) of GRAB and Rabin8 
CRISPR targeting guideRNAs were generated using published genome sequences 
(NCBI). The third exon of Rabin8 and the second exon of GRAB, which contained the 
start site and downstream coding regions were chosen to create a specific double-
stranded break which would result in non-homologous end joining leading to a 
frameshift mutation, effectively creating a KO. The following primer pairs were ordered 
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from IDT: GRAB Forward TAATACGACTCACTATAGGCAGGCGTGACACATCCAG; 
GRAB Reverse TTCTAGCTCTAAAACCTGGATGTGTCACGCCTGC; Rabin8 
Forward TAATACGACTCACTATAGAGAGAGAAGGGCTACGAA; Rabin8 Reverse 
TTCTAGCTCTAAAACTTCGTAGCCCTTCTCTCT. These primers were used to 
generate guideRNA sequences as per manufacturer’s instructions (GeneArt™ 
Precision gRNA Synthesis Kit, ThermoFisher Scientific) and combined with puri fied 
S.pyogenes Cas9 nuclease protein (IDT) to form the genome targeting complex. The 
complex was co-transfected with a pFloxNeo resistance plasmid into RAW 264.7 cells 
using the LipofectamineTM CRISPRMAXTM transfection reagent (ThermoFisher 
Scientific) and transfected cells were selected in RPMI medium with 1 mg/ml G418 
(Geneticin, Invitrogen) and clonal lines were screened for loss of GRAB or Rabin8 
protein expression by immunoblotting (see Figures 5.4 and 6.2). 
Chapter 3: Materials and Methods 
 21 
Table 3.3. List of primers used for generating CRISPR constructs 
Primer Name Sequence (5 - 3) 
px458 Rabin8 CRISPR I F CACCGGGGCTTCGTAAACGCGAC 
px458 Rabin8 CRISPR I R AAACGTCGCGTTTACGAAGCCCC 
px458 Rabin8 CRISPR II F CACCGTACGAAGCCCATCTGTTC 
px458 Rabin8 CRISPR II R AAACGAACAGATGGGCTTCGTAC 
px458 Rabin8 CRISPR III F CACCGAGAGAGAAGGGCTACGAA 
px458 Rabin8 CRISPR III R AAACTTCGTAGCCCTTCTCTCTC 
px458 GRAB CRISPR I F CACCGCAGGCGTGACACATCCAG 
px458 GRAB CRISPR I R AAACCTGGATGTGTCACGCCTGC 
px458 GRAB CRISPR II F CACCGTCCATGGAGGAACTGCGC 
px458 GRAB CRISPR II R AAACGCGCAGTTCCTCCATGGAC 
px458 GRAB CRISPR III F CACCGCCATGGAGATCCGAGAGA 
px458 GRAB CRISPR III R AAACTCTCTCGGATCTCCATGGC 
GRAB Left arm F GAATAGGAACTTCGGTAAAGCTTATCCGATCTCCTCCCAGGAAGTGGAGG 
GRAB Left arm R CGGTATATATATATATATGTCGACATGGTTAGAAGGGCTCCGAGTTCCTA 
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GRAB Right arm F  CGGTATATATATATATATGTCGACATGGTTAGAAGGGCTCCGAGTTCCTA 
GRAB Right arm R AGATCTGCGATCGCAATCAATTGCTGGTTCCACAGGAGGGGTCAGGATA 
Rabin8 Left arm F TCGAGATTTAATTAAGATACGCGTGACGATCCCAGGCATTTCAACTGTGC 
Rabin8 Left arm R GAATAGGAACTTCGGTAAAGCTTATCCGATTCCGTGCTCAACCCAAAGAT 
Rabin8 Right arm F AGATCTGCGATCGCAATCAATTGCTGGTTGGTCAAAGTCTGCGGTGAGA 
Rabin8 Right arm R AGATCTGCGATCGCAATCAATTGCTGGTTGGTCAAAGTCTGCGGTGAGA 
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Fluorescence microscopy 
For fixed cell imaging, RAW 264.7 cells were seeded on 2 mm glass coverslips at 0.1 
X 106 cells/ml and left to adhere overnight. The cells were later transiently transfected 
with the appropriate constructs and left overnight to express. After which the cells were 
treated with/without LPS (30 min) and fixed in 4% PFA. After fixation the coverslips 
are then washed with PBS (3 times) and co-stained with Alexa-488 phalloidin (1:500 
for 30 min). The coverslips were mounted on glass microscope slides and imaged 
using an upright Zeiss Axiolmager equipped with Apotome2 and Axiocam 506 camera 
with a mercury light source. Images were captured using a 63X plan  apochromat 
objective oil immersion lens.  
 
For live cell imaging, RAW 264.7 macrophages were seeded onto 35 mm glass bottom 
MatTek dishes (MatTek Corporation, uncoated) at 0.1 X 106 cells/ml and left overnight 
to adhere. The cells were later transiently transfected with the appropriate constructs 
and left to express overnight. Prior to imaging, the media was changed from RPMI to 
Leibovitz L-15 medium (Invitrogen) supplemented with 10% heat-inactivated fetal calf 
serum (Thermo Trace, Australia) and 2 mM L-glutamine, which is a CO2 independent 
media. The cells were treated with LPS and imaged using a Zeiss Axiovert 200 
Inverted Microscope with CSU-X1 scanhead. For the two channels, GFP and RFP 
were sequentially imaged over 15-10 min at 5 sec intervals using a 63X LCI PlanN 
water immersion lens. Alternatively, single channel images were taken at 5 sec 
intervals for 20 min.  
 
Membrane fractionation 
RAW 264.7 cells treated with LPS (30 min) were lysed by passage through a 27-gauge 
needle in 500µl of fractionation buffer [20 mM HEPES pH 7.4, 10 mM KCl, 2mM MgCl2, 
1 mM EDTA, 1mM EGTA, 1mM DTT and EDTA-free cOmplete Mini protease inhibitor 
(Sigma-Aldrich, Australia)]. The extract was processed through centrifugation steps to 
clarify the suspension as follows: 720 x g for 5 min (nuclei pellet), 10, 000 x g for 5 min 
(mitochondria pellet), 100, 000 x g for 1 hr (membrane pellet) leaving a cytoplasmic 
supernatant. The supernatant (cytosolic fraction) was retained, while the membrane 
pellet was washed in 400µl of fractionation buffer by pipetting and recentrifuged at 
100, 000 x g for 1 hr. Finally, the membrane pellet is resuspended in 0.1% SDS in TBS 
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and both cytosolic and membrane fractions were boiled in SDS-PAGE sample buffer 
and the samples were used for immunoblot analysis. 
 
Image analysis software 
Analysis of immunoblots and fluorescence imaging was performed using ImageJ 
software (version 2.0.0; NIH, USA). Adobe Photoshop CS6 was also used to crop 
regions of interest on images.  
 
Statistics 
Data are shown as arithmetic means ± s.e.m., unless otherwise stated. Data sets with 
normal distribution (assessed by Shapiro-Wilk test) were analysed with Student’s t-
test to directly compare one experimental variation. For multiple comparisons, Sidak’s 
method was used for post-hoc analysis of Two-way ANOVA. All analysed experiments 
used biological and technical replicates (3 replicates each unless stated otherwise) to 
compute statistical significance. In all statistical analysis, a P value < 0.05 was 
considered statistically significant and calculated using GraphPad Prism version 7.0 
(GraphPad Software, San Diego, CA).  
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Key resource table  
Reagent Source 
Additional 
Information 
Antibodies  
Mouse anti-Rab8 BD Biosciences, USA WB 1:1000, #610845 
Mouse anti-Flotillin-1 BD Biosciences, USA WB 1:500, #610820 
Rabbit anti-Rabin8 
(Rab3IP) 
ProteinTech, USA 
WB 1:1000, #12321-
1-AP 
Rabbit anti-GRAB 
(Rab3IL1) 
ProteinTech, USA 
WB 1:1000, #17827-
1-AP 
Rabbit anti-OCRL1 ProteinTech, USA 
WB 1:1000, #17695-
1-AP 
Rabbit anti-GAPDH 
Cell Signalling Technology, 
USA 
WB 1:4000, #14C10 
Rabbit anti-pAkt (Ser473) 
Cell Signalling Technology, 
USA 
WB 1:1000, #9271 
Rabbit anti-Akt 
Cell Signalling Technology, 
USA 
WB 1:1000, #9272 
Rabbit anti-pERK1/2 
(Thr202/Tyr204) 
Cell Signalling Technology, 
USA 
WB 1:3000, #9102 
Rabbit anti-ERK1/2  
Cell Signalling Technology, 
USA 
WB 1:3000, #137F5 
Rabbit anti-phospho 
p70S6K (Thr389) 
Cell Signalling Technology, 
USA 
WB 1:1000, #9205 
Rabbit anti-phospho 
PRAS40 (Thr246) 
Cell Signalling Technology, 
USA 
WB 1:1000 #2997 
Mouse anti-His 
Cell Signalling Technology, 
USA 
WB 1:1000, #2365 
Mouse anti-Myc 
Cell Signalling Technology, 
USA 
WB 1:3000, IP 1:100, 
#9B11 
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Rabbit anti-GFP 
ThermoFisher Scientific, 
Australia 
WB 1:2000, #A6455 
HRP-conjugated goat anti-
rabbit IgG 
ThermoFisher Scientific, 
Australia 
WB 1:10 000, #G-
21234 
HRP-conjugated goat anti-
mouse IgG 
ThermoFisher Scientific, 
Australia 
WB 1:5 000, #G-
21040 
Mouse anti--actin Sigma Aldrich, Australia WB 1:1000, #A1978 
Tissue-culture 
RAW 264.7 mouse 
macrophage like cells 
derived from Abelson 
murine leukaemia virus-
induced tumour 
American Type Culture 
Collection 
ATCC TIB-71 
TLR4-/- and WT Bone 
Marrow-Derived 
Macrophages (BMMs) 
Matthew Sweet, IMB, 
University of Queensland 
Differentiated from 
TLR4-/- & paired WT 
mice femur bone 
marrow 
Immortalised Bone 
Marrow-Derived 
Macrophages (BMMs) 
Dr Ashley Mansell, Hudson 
Institute of Medical 
Research, Melbourne, 
Australia 
Cells were 
immortalised with a 
J2 recombinant 
retrovirus (v-myc and 
v-raf oncogenes) 
(Halle and Hornung et 
al. 2008) 
RPMI 1640 media 
ThermoFisher Scientific, 
Australia 
#21870 
DMEM  
ThermoFisher Scientific, 
Australia 
#11995 
Chemicals / Drugs 
U0126 (Erk1/2 Inhibitor) Sigma Aldrich, Australia #U120, used at 10M 
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Gpp(NH)p/ GTP-analog Sigma Aldrich, Australia #G0635 
GDP Sigma Aldrich, Australia #G7127 
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Results 1: Identifying regulators of Rab8 
activation in macrophages 
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4. Results 1 
Introduction  
In this project, I look to identify and characterise the regulatory proteins responsible 
for activating the small GTPase Rab8a to facilitate targeted TLR-associated immune 
signalling in macrophages. Previous work from the Stow laboratory has identified this 
GTPase to be a key modulator for controlling inflammatory responses (Luo and Wall 
et al. 2014, Wall and Luo et al. 2017). Functioning downstream of several TLRs, 
Rab8a was found to recruit the class IB PI3K, PI3K as an effector, to facilitate 
inflammatory signalling and cytokine biasing to constrain inflammation (Luo and Wall 
et al. 2014, Wall and Luo et al. 2017). As a GTPase, Rab8a has to first be activated 
via GTP-loading to facilitate effector recruitment and downstream function. Therefore, 
while the inflammatory outputs of this Rab8a-PI3K complex have been described, the 
regulatory proteins responsible for activating Rab8a in this pathway are yet to be 
identified. Hence, uncovering these modulators of Rab8a would expand the 
understanding of this important immune signalling cascade, and also reveal new 
targets for controlling specific PI3K function in inflammation and macrophage 
polarisation.  
 
Amongst the Rab family members, Rab8a is particularly multi-functional, with 
numerous, known effectors which act on different membranes in many cell types 
(Peränen 2011). Guanine nucleotide exchange factors (GEFs) (as described in the 
introduction chapter) typically activate Rabs by controlling the exchange of GDP for 
GTP in the nucleotide-binding site, which often promotes membrane association. 
Identifying the GEF(s) for Rab8a in macrophages is important for understanding how 
this GTPase is activated on specific membrane domains for TLR signalling. As 
mentioned earlier in the introduction, there are two well-known, structurally-similar and 
potent Rab8 specific GEFs: GRAB and Rabin8 (Yoshimura and Gerondopoulos et al. 
2010, Guo and Hou et al. 2013, Wang and Ren et al. 2015). Both these GEFs have 
been understood to function in multiple Rab8 controlled trafficking pathways such as 
ciliogenesis for Rabin8 and neurite axon outgrowth for GRAB (Feng and Knödler et al. 
2012, Furusawa and Asada et al. 2016). Interestingly, these Rab8 regulators might 
also have some functional overlap, with separate studies tying them to the same Rab8-
associated neurite outgrowth pathway (Furusawa and Asada et al. 2016, Homma and 
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Fukuda 2016). However, despite their similarities, the exact roles and level of 
redundancy between GRAB and Rabin8 in Rab8 pathways are still not entirely known. 
GRAB and Rabin8 are, to date, unstudied in macrophages, or in the context of 
macropinosomes or TLR signalling pathways. In addition to these well -established 
Rab8 regulators, it is possible that there are unidentified GEFs for Rab8a. Therefore, 
an unbiased screening approach will be used to identify any potential GEF of Rab8a 
in these immune cells.  
 
In this chapter, an investigation is launched to identify the regulatory GEF(s) for Rab8a 
in mouse macrophages. Using an unbiased protein affinity pull-down screen followed 
by mass spectrometry analysis, I identified several known Rab8a binding partners in 
TLR-activated macrophage lysates, that led to the detection of the Rab8 GEF GRAB. 
A combination of biochemical analysis with fluorescence microscopy was later used 
to confirm the interactions between Rab8a, GRAB and the closely related GEF Rabin8 
in these immune cells. The results presented here formed part of a publication 
identifying the regulatory proteins that activate Rab8 for biasing TLR-signalling in 
macrophages (Tong and Wall et al. 2019).  
 
Measuring Rab activation, namely the exchange of GDP for GTP, is fundamental to 
studies on GEFs. A principle readout for assessing GEF activity will be the quantity 
and rate of endogenous Rab8 GTP-loading. To date, there have been several 
methods used for measuring Rab GTPase activation, most were developed for 
measuring GTP loading and kinetics on purified proteins. Therefore, it is necessary for 
this project to develop a method for measuring the relative activation of Rab8a in cells, 
by comparing GTP-Rab8a levels under different conditions and in the presence or 
absence of putative GEFs. Therefore, part of this chapter describes the studies 
performed to establish a Rab8a activation assay. Thus, I set out to use the known 
Rab8 binding domains of three Rab8-binding effectors namely, MICAL-L2, PI3K and 
OCRL, as probes to capture GTP-Rab8 in cell extracts and the results of these assays 
are described here.  
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Results  
Characterisation of Rab8a in mouse macrophages  
Recombinant Rab8a localisation in mouse macrophages 
To establish the localisation and function of Rab8a as a subject of the current study, 
tdTomato-Rab8a was transiently transfected into RAW 264.7 macrophages, which 
were then activated by incubation with LPS prior to fixation. The cells were stained 
with fluorescent phalloidin to show actin-rich ruffles. In Figure 4.1A, tdTomato-Rab8a 
is found in a perinuclear location (consistent with its other roles in trafficking) and 
prominently on actin-rich ruffles at the cell surface. Some of these ruffles circularise 
consistent with ruffle closure to form macropinosomes (highlighted in insets). Rab8a 
is typically found on recycling membranes within cells in addition to its presence on 
the ruffles that are prominent on activated macrophages (Wall and Condon  et al. 
2018). Hence, despite the lack of antibodies available for staining endogenous Rab8a, 
but in many previous studies these recombinant Rab8a are believed to accurately 
reflect the subcellular distribution of this Rab in previous studies (Luo and Wall et al. 
2014, Wall and Luo et al. 2017, Eguchi and Kuwahara et al. 2018). 
 
Next, GFP-Rab8a was transfected into RAW 264.7 cells for live cell imaging after LPS 
activation. This imaging confirmed the recruitment and enrichment of GFP-Rab8a to 
macropinosomes that derive from Rab8a containing ruffles (Figure 4.1B). Rab8a is 
tied to TLR signalling pathways through colocalisation with components of this 
pathway on ruffles and macropinosomes (Luo and Wall et al. 2014). Localising the 
TLR4 receptor itself is very difficult, but here I co-transfected fluorescently tagged 
Rab8a with the TLR4 adaptor TRAM. Live cell confocal imaging of LPS-treated RAW 
264.7 cells co-expressing td-Tomato-Rab8a and the TLR adaptor GFP-TRAM showed 
that both proteins are enriched on the same macropinosome membranes, and 
therefore are available for joint immune signalling functions (Figure 4.1C).  
 
This imaging serves to demonstrate the location of Rab8a on ruffles and newly formed 
macropinosomes in TLR-activated macrophages. These results were consistent with 
previous findings from our laboratory which have gone on to show that Rab8a on these 
membranes is engaged for regulation of signalling downstream of TLRs (Luo and Wall 
et al. 2014, Wall and Luo et al. 2017).  
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Figure 4.1 Rab8a localises to ruffles and is enriched on macropinosomes in LPS stimulated mouse 
macrophages. (A) Fluorescence microscopy images of fixed, LPS-treated (30 mins) RAW 264.7 cells transiently 
overexpressing td-Tomato-Rab8a and stained with Alexa488-phalloidin. (B) Live cell confocal spinning disc images 
of LPS-treated RAW 264.7 cells transiently transfected with GFP-Rab8a showing enrichment of Rab8a on 
macropinosomes and subsequent internalisation via tubules. (C) Live ce ll confocal image of RAW 264.7 
macrophage cells transiently co-expressing GFP-TRAM and td-Tomato-Rab8a showing colocalization both 
constructs on a macropinosome. Movies were taken over 15 mins at 5 sec intervals. Scale bars, 10 µm. 
 
Rab8a with its effector PI3K functions to elicit Akt signalling downstream of TLRs 
The class 1B PI3K, PI3K, was earlier identified as a novel effector for Rab8a and as 
a modulator of Akt signalling downstream of TLR4 (Luo and Wall et al. 2014). This 
earlier study also demonstrated that knockdown of Rab8a or KO of PI3K only affected 
Akt phosphorylation and not total Akt protein levels (Luo and Wall et al. 2014). In 
collaborative studies with other members of the laboratory, my experiments 
contributed to characterise the recruitment and function of Rab8a in response to other 
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members of TLRs. This immune signalling function is demonstrated here in LPS 
stimulated RAW 264.7 macrophage cells after CRISPR deletion of Rab8a [Figure 4.2A 
and Figure 4A in (Wall and Luo et al. 2017)]. This representative gel shows the 
selective loss of Rab8a protein in the Rab8a KO cells which is accompanied by 
reduction of LPS-induced phospho-Akt and no reduction of phospho-ERK1/2. This 
result implies that Rab8a is required for robust Akt signalling downstream of TLR4.  
 
These experiments were then repeated in primary bone marrow derived macrophages 
(BMMs) from WT mice and PI3K-/-mice (Figure 4.2B). The loss of PI3K resulted in a 
marked reduction of LPS-induced phospho-Akt, a modest reduction in phospho-
mTOR and no reduction in phospho-ERK1/2. This result recapitulates the Akt 
signalling changes resulting from the loss of Rab8a, serving as one line of evidence 
that Rab8a and PI3K jointly modulate Akt signalling downstream of TLR4 [Figures 5A 
and B from (Wall and Luo et al. 2017)]. These experiments also highlight a TLR-
signalling role of Rab8a that can be used to assay for Rab8a activation and function 
in macrophages.  
 
 
Figure 4.2. Rab8a with its effector PI3K  functions to elicit Akt signalling downstream of TLRs. Immunoblots 
showing the levels of Akt and ERK1/2 phosphorylation using phospho Akt (Ser473) and phospho ERK1/2 
(Thr202/Tyr204) specific antibodies on the lysates of (A) control and Rab8a KO RAW 264.7 cells or (B) control and 
PI3Kγ-/- BMMs, treated with LPS over a 60 min time course. These results were published in an article in JBC 
during this project (Wall and Luo et al. 2017). Experiments for Figure A was performed by Dr Adam Wall (IMB, 
University of Queensland), while I conducted the experiments for Figure B. 
 
The lipoprotein receptor LRP1 is involved in TLR-induced Akt activation. 
After demonstrating that this Rab8a-PI3K complex controls Akt phosphorylation as a 
subset of the TLR-signalling response, we turned our attention to understanding how 
the Rab8a complex is recruited for signalling from these immune receptors. Since 
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neither Rab8a nor PI3K directly interact with TLRs, further studies were undertaken 
to identify how Rab8a is recruited for signalling on the ruffle-macropinosome 
membranes. The lipoprotein receptor LRP1 was subsequently identified as a crosstalk 
receptor that functions to scaffold and recruit Rab8a to TLRs upon activation, allowing 
the GTPase to be activated and in turn enlist its effector PI3K to elicit Akt signalling 
(Luo and Wall et al. 2018). During the process of identifying this crosstalk receptor, 
RAW 264.7 cells CRISPR deleted for LRP1 (generated by Dr Adam Wall, IMB, 
University of Queensland) were made available for signalling studies performed by me 
as a collaboration. A loss of LRP1 resulted in decreased LPS-induced Akt 
phosphorylation compared to control cells without affecting the levels of phospho-
ERK1/2 [Figure 4.3 and Figure 6A in (Luo and Wall et al. 2018)], recapitulating the 
effects of depleting Rab8a or PI3K shown above.  
 
 
Figure 4.3. The lipoprotein receptor LRP1 is involved in TLR-induced Akt activation. Immunoblot showing 
the levels of Akt (Ser473) and ERK1/2 (Thr202/Tyr204) phosphorylation using phospho-specific antibodies on the 
lysates of control and LRP1 CRISPR KO RAW 264.7 macrophage cells treated with LPS over a 60 min time course. 
Blots of total LRP1 (bottom-most blot) confirmed a loss of protein expression in the KO cell line, and total Akt, 
ERK1/2 and GAPDH were included as loading controls. This result was later used in a published art icle in Cell 
Reports (Luo and Wall et al. 2018). 
 
Taken together, these results demonstrate that Rab8a is on macrophage ruffles and 
macropinosomes where it is recruited by LRP1 and engages in Akt signalling 
downstream of TLR4. The unknown component of this complex is the GEF that 
activates Rab8a for this role; accordingly my project turned to the search for the 
activators and regulators of Rab8a. 
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An unbiased screen of Rab8 interacting partners in TLR4-activated macrophages 
Rab GTPases are molecular switches that flip between two states, an ‘on’ GTP-bound 
state and an ‘off’ GDP-bound state, which are facilitated by their specific GEFs and 
GAPs respectively. In seeking to identify a Rab8a GEF responsible for activating 
Rab8a downstream of TLRs, I followed the strategy that successfully identified PI3K 
and LRP1 as members of this Rab8a complex (Luo and Wall et al. 2014), namely to 
perform an unbiased screen for Rab8a binding partners in macrophage extracts using 
mass spectrometry. This approach has the potential to pull-down any known or novel 
Rab8a interacting GEF in these immune cells. 
 
Immortalised bone marrow-derived macrophages (iBMMs) were used for this 
approach, offering the chance to use cells more closely resembling primary cells and 
still acquire large cell volumes required. Cells were grown to confluence in 15cm tissue 
culture dishes, incubated with LPS (30mins) and cell lysates were prepared. The 
lysates were applied to columns containing either glutathione Sepharose beads bound 
with GST alone (GST control) or beads bound with bacterially expressed GST-tagged 
full-length mouse codon optimised Rab8a (codon optimisation tool, IDT). The samples 
were later eluted using a single-step protease cleavage elution (PCE) technique with 
PreScission proteases (GE healthcare). This technique, previously published by the 
laboratory, uses proteases to perform targeted retrieval of the bait protein and any 
genuine binding partners, reducing the presence of unspecific contaminant proteins in 
the resulting eluent (Luo and King et al. 2014). The final eluates were separated on a 
gradient gel (Figure 4.4A) and a number of excised bands were analysed by mass 
spectrometry (IMB core facility). Results from the mass spectrometry identified many 
proteins, including several known Rab8a binding partners indicating that successful 
pull-downs had occurred. Among these pull-down proteins, several known influencers 
of Rab8 activity were identified including the effector PI3K (Wall and Luo et al. 2017), 
the Rab GDP dissociation inhibitors (GDIs) alpha and beta (Ullrich and Stenmark et 
al. 1993, Shisheva and Chinni et al. 1999), the Rab stabilising chaperone MSS4 (Itzen 
and Pylypenko et al. 2006, Zhang and Zhang et al. 2015) and, in addition, the known 
Rab8 regulatory GEF, GRAB (Figures 4.4B and C) (Itzen and Pylypenko et al. 2006, 
Guo and Hou et al. 2013, Furusawa and Asada et al. 2016). Each of these proteins 
had at least one trypsin-digested peptide that were identified by the mass spectrometry 
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analysis with a confidence of 95% (Figure 4.4C), providing assurance that they are 
genuine binding partners. Importantly, the screen identified 2 peptides of the Rab8 
GEF GRAB (depicted in Figure 4.4B), leading to a ProteinPilot score of 4 which 
equates to a protein identification confidence of 99.99% (Figure 4.4C). The 
identification of GRAB as a putative Rab8a binding partner is a novel finding as this 
GEF has not been empirically or functionally studied before in this cell type. With a 
candidate GEF now identified, the next step was to confirm this interaction with Rab8a 
and investigate the possible roles of GRAB in Rab8a macrophage function.  
 
 
Figure 4.4. GRAB identified as a Rab8a binding partner in LPS activated macrophage lysate. GSH-
Sepharose beads with bound GST-Rab8a were used to pull-down proteins from LPS-treated (30 min) IBMM cell 
lysate and eluted with proteases. The elutes were separated on a 7-15% SDS-PAGE gradient gel. (A) A faint band 
between 150 kDa and 100 kDa indicating the presence of a previously identified effector PI3Kγ and another band 
above 37 kDa was identified as the Rab8a GEF GRAB (~43kDa), both of which were absent in the GST control 
sample. (B) Schematic of the two trypsin-digested peptides from GRAB identified from the mass spectrometry 
analysis mapped onto the peptide sequence of GRAB. (C) Sample list of known Rab8a interacting proteins 
identified in the mass-spectrometry analysis. The mass spectrometry ‘score’ is a measurement of peptide 
confidence from the ProteinPilot scoring algorithm: Score = -log(1-(PercentConfidence/100)). For example, a score 
of 2 = 99% confidence, whereas a score of 4 = 99.99% confidence. %Cov (coverage) refers to the percentage of 
all identified peptide(s) relative to total amino acid sequence, whereas %Cov (50%) and %Cov (95%) refer to 
peptide coverage with 50% and 95% confidence respectively. 
 
Rab8 GEFs Rabin8 and GRAB both interact with Rab8a in an LPS-inducible manner 
Although not previously studied in macrophages, there is gene expression evidence 
showing that GRAB is present in both RAW 264.7 macrophages and mouse BMMs 
(BioGPS, http://biogps.org) (Lattin and Schroder et al. 2008, Hammer and Yum et al. 
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2010). Interestingly, data from these genome wide expression experiments also 
showed that the other Rab8 GEF, Rabin8, is likewise expressed in these same mouse 
macrophage cells. While Rabin8 was not picked up in the pull-downs or identified by 
the mass spectrometry analysis above, given the structural and functional similarities 
reported between GRAB and Rabin8, it was decided that both proteins will be studied 
and characterised in parallel with regards to possible roles in regulating Rab8a 
immune function in macrophages.  
 
First, to affirm that both GRAB and Rabin8 are expressed in the RAW 264.7 
macrophage-like cell line (the main cell line used in the project), immunoblots using 
the extracts of untreated RAW 264.7 cells were performed with commercial ly available 
antibodies. Results showed bands that correspond to the molecular weights of the 
respective proteins in each of three RAW 264.7 clonal lines (Rabin8 at 56kDa and 
GRAB at 43kDa), with no signal seen in the empty lane control confirming the 
specificity of the antibodies for these proteins (Figure 4.5A). This indicates that both 
proteins are indeed expressed in these macrophages, agreeing with previous mRNA 
expression studies (Hammer and Yum et al. 2010).  
 
With both proteins present in these macrophages, co-immunoprecipitation studies 
were performed as an approach to both verify that GRAB binds to Rab8a and 
investigate if Rabin8 is likewise interacting with Rab8a in these macrophages. 
Attempts to use commercially available antibodies for either Rab8a or GRAB proved 
that neither was successful as a pull-down antibody, despite being able to detect these 
proteins. As an alternative approach, I stably expressed and reconstituted myc-Rab8a 
in a Rab8a KO cell line previously generated using CRISPR/Cas9 editing in RAW 
264.7 cells (Wall and Luo et al. 2017). This allowed the use of the myc antibody for 
Rab8a immunoprecipitations. These cells (RAW 264.7 macrophages expressing myc-
Rab8a) were treated with and without LPS (30 min), lysed and the resulting lysates 
applied to columns containing myc IgG coated PierceTM Protein G beads. The final 
eluents were separated on SDS-PAGE gels for immunoblotting (Figures 4.5B and C). 
The results on this representative gel, show that myc-Rab8a was enriched on the 
beads and that it successfully co-immunoprecipitated endogenous GRAB but, notably, 
only in LPS-activated cells. The same samples were used to screen for Rabin8 in myc-
Rab8a precipitations (Figure 4.5C) and Rabin8 was likewise co-immunoprecipitated 
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only in LPS-activated cells. Based on the immunoblotting of GRAB and Rabin8 in the 
‘input’ lanes in the gels in Figures 4.5B and C, it is evident that their protein expression 
levels in these mouse macrophages remain unchanged after acute LPS treatment; 
moreover, co-immunoprecipitation of either protein with myc-Rab8a indicated that 
both proteins have LPS-inducible interactions with Rab8a upon macrophage 
activation.  
 
Figure 4.5. Both Rab GEFs GRAB and Rabin8 are expressed in RAW 264.7 macrophage cells and have an 
LPS inducible interaction with Rab8a. (A) Immunoblots showing the endogenous expression of Rab8 GEFs 
Rabin8 and GRAB in RAW 264.7 macrophage cells. Blots were done using the lysates of three different untreated 
RAW 264.7 cell lines for assessing the relative expression of each protein. Levels of relative Rabin8 and GRAB 
protein expression were quantified by using the densitometric ratio between the band intensities of Rabin8 or GRAB 
and GAPDH. (B/C) Representative blots showing the immunoprecipitation of (B) GRAB or (C) Rabin8 using anti-
myc antibodies from cell lysates of Rab8a KO cells +/- LPS (30 min) reconstituted with myc-Rab8a. 
Taken together, these results highlight two key findings: i) GRAB as well as Rabin8 
are Rab8a binding partners in LPS-activated macrophages. ii) The LPS-inducible 
interaction of both proteins with Rab8a imply a possible TLR related function with 
Rab8a in these immune cells. This supports the data from the previous pull-down and 
mass spectrometry analysis which identified GRAB as a Rab8a binding partner in LPS 
treated cell extracts and additionally, shows that Rabin8 can also interact with Rab8a 
under similar conditions. Henceforth I investigated both GRAB and Rabin8 in 
experiments to determine if either of these proteins is responsible for activating Rab8a 
during TLR-activation in macrophages.  
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Localisation of Rabin8 and GRAB in mouse macrophages 
It has been previously shown that Rab8a is localised and enriched on macrophage 
dorsal ruffles and early macropinosomes in response to immune stimuli such as LPS 
(Wall and Condon  et al. 2018) (see Figure 4.1A and B). With both Rabin8 and GRAB 
now identified as candidate Rab8a partners, I next wanted to examine the localisation 
and distribution of these proteins in macrophages. Again, I found the relevant 
antibodies were not suitable for staining endogenous GRAB or Rabin 8. Therefore, I 
generated GFP-tagged constructs of both GRAB and Rabin8 for expression and 
localisation in cells. Full-length GRAB and Rabin8 were amplified from RAW 264.7 
macrophage cDNA and ligated into a pEF6-GFP-C1 plasmid (Figure 4.6A). Proper 
insertion of either GRAB or Rabin8 was screened and confirmed by PCR of purified 
plasmids (Figure 4.6B, primer sequences in Table 2.1 in Materials and Methods), and 
later also confirmed with sequencing. LPS treated or untreated (30 min) RAW 264.7 
macrophages transiently expressing either GFP-Rabin8 or GFP-GRAB were fixed and 
imaged to examine their cellular distribution. Both proteins demonstrated diffuse 
labelling in the cytoplasm with some localisation in the cell periphery on ruffle 
membranes, which became more pronounced upon LPS-treatment (Figures 4.6C and 
D). This reveals that GRAB and Rabin are likely widespread in their intracellular 
distributions and that they can be recruited to membranes, including ruffle membranes 
of interest in this project.  
 
To see if Rab8a is present on these same ruffle membranes, the GFP-GRAB and 
Rabin8 were transfected in tandem with td-Tomato-Rab8a (Luo and Wall et al. 2014, 
Wall and Luo et al. 2017). RAW 264.7 macrophages co-transfected with either GFP-
GRAB or GFP-Rabin8 with td-Tomato Rab8a, were treated with LPS (30 min), fixed 
and co-stained with phalloidin to visualise F-actin as a cell marker. The imaging 
demonstrated that both GFP-GRAB and GFP-Rabin8 have similar but non-identical 
staining patterns when compared individually to recombinant Rab8a (Figures 4.6E and 
F). td-Tomato Rab8a was on perinuclear and peripheral membranes overlaid with 
widespread distributions of the GFP-labelled proteins. Importantly, both GRAB and 
Rabin8 were observed together with Rab8a, colocalised on dorsal and peripheral ruffle 
membranes (as highlighted in the insets). Thus, these findings show that GRAB and 
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Rabin8 are widespread in macrophages, reflecting a similar distribution to that of 
Rab8a and in keeping with the fairly ubiquitous expression of all three proteins in 
multiple cell types and on multiple membrane domains. The colocalisation of GRAB 
or Rabin8 with Rab8a supports the findings from pull-downs and coprecipitation earlier 
in the chapter which show binding of these proteins. Moreover, the convergence of 
both GRAB or Rabin8 with Rab8a suggests the potential for binding and functional 
interactions throughout the cell, including on the ruffles where Rab8a functions in TLR 
signalling.  
 
 
Figure 4.6. The Rab8 regulatory GEFs Rabin8 and GRAB co-localises with Rab8a on membrane ruffles in 
LPS-activated macrophages. (A) Illustration of pEF6-GFP-C1 mammalian expression plasmid with either PCR 
amplified mouse Rabin8 or GRAB genes from RAW 264.7 macrophage cDNA. (B) Agarose gel showing the results 
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of a PCR screen for either the Rabin8 or GRAB inserts in the respective constructs (PCR was performed using the 
screening primers depicted in [A] and listed in Table 3.1 in the Materials and Methods chapter). (C/D) Fluorescence 
microscopy images of fixed +/- LPS (30 min) RAW 264.7 cells transiently overexpressing either (C) GFP-Rabin8 
or (D) GFP-GRAB. Magnified inserts highlight membranes and possible macropinosomes enriched with either 
GFP-Rabin8 or GFP-GRAB. (E/F) Fluorescence microscopy images of fixed LPS-treated RAW 264.7 cells 
transiently co-expressing either (E) GFP-GRAB or (F) GFP-Rabin8 with td-Tomato-Rab8a and co-stained with 
Alexa350-phalloidin. Magnified inserts highlight actin rich peripheral membranes displaying strong colocalisation 
of both td-Tomato-Rab8a and either GFP-GRAB or GFP-Rabin8 with the actin marker phalloidin. Scale bars, 10µm. 
 
With GRAB and Rabin8 established as Rab8a binding proteins in macrophages, the 
next steps involve investigating Rab activation in order to assay and establish GEF 
function. Thus, I turned my attention to establish a robust assay for quantifying 
endogenous Rab8 activation and GTP-loading. 
 
Measuring Rab8 activation 
Generation of active Rab8 capture constructs 
Establishing the activation of Rab GTPases on cell membranes for my experiments, 
requires tools and protocols that can reliably assess changes to the GTP-loading of 
endogenous Rabs. One approach for identifying Rabs in their GTP-bound states is to 
use probes or binding proteins that have unique interactions with Rabs only in their 
GTP-bound states. These probes (often effector binding protein domains) can be used 
for labelling or ‘capture’ of Rabs in pull-downs.  
 
For assessing Rab8 activation in macrophages, I set out to develop Rab-GTP probes 
based on known Rab8 effectors with the help of my co-supervisor Dr Lin Luo (Figure 
4.7A). The first probe involved the production of a GST-tagged construct using the 
Rab binding domain (RBD) of a known, multi-Rab effector, the inositol 5-phosphatase, 
oculocerebrorenal syndrome of Lowe protein 1 (OCRL) (Hagemann and Hou  et al. 
2012). The truncated OCRL539-901 construct containing the RBD was generously 
provided by Hou and colleagues (Max-Plank-Institute of Molecular Physiology, 
Germany) and it has been previously used in structural studies characterising the 
interaction between Rab8 and OCRL (Hou and Hagemann  et al. 2011). The second 
probe uses the RBD of another multi-Rab effector, the molecule interacting with CasL-
like 2 (MICAL-L2) (Fukuda and Kanno et al. 2008). The known RBD of hMICAL-L2 
(residues 806 – 903) was sub-cloned from a WT Rab13 biosensor generously 
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provided by Prof Peter McPherson (MNI, McGill University) (Ioannou and Bell et al. 
2015). The third probe is made up of the Ras binding domain (RasBD) of PI3K which 
we have previously identified as a Rab8a effector (Luo and Wall et al. 2014). The 
RasBD of mPI3K (residues 1 – 356) was PCR amplified from mouse cDNA obtained 
from the facility of life science automation (IMB, University of Queensland). As 
validated Rab8 effectors, all three of these proteins interact specifically with only GTP-
Rab8 (among other Rabs). The principle of this assay is to exploit these probes as 
GST-fusion proteins for pulling-down Rab8 (and other interacting, activated Rabs) in 
the ‘active’ GTP-bound conformation, allowing us to quantify the relative levels of 
activated endogenous Rab8 (by immunoblotting) in macrophage extracts (Figure 
4.7C).  
 
All three domains were GST-tagged through inserting them into a pGEX-6P1 vector, 
the fusion proteins were bacterially expressed and bound to glutathione Sepharose 
beads. Samples were taken from each construct, boiled, separated on SDS-PAGE 
gels and the relative expressions were analysed via Coomassie staining. While both  
the PI3K and OCRL constructs were able to express relatively efficiently and cleanly, 
the production of GST-MICAL-L2-RBD was always accompanied by a large 
contamination of GST (Figure 4.7B). This GST contamination was initially thought to 
be a result of an impure bacteria colony with a portion of the cells expressing the empty 
vector. However, this GST contamination persisted even after re-streaking and testing 
single pure colonies from the original bacteria culture, indicating perhaps inefficient 
translation or premature cleavage of the GST tag during expression (Figure 4.7B, left 
gel col 1 and 2). With GST having a similar molecular weight to Rab8 (~22kDa), the 
shear amount of GST present impaired Western blotting, I believe as a result of 
artificially trapping the antibodies or masking the epitopes of the target Rab. Therefore, 
I took additional approaches in an attempt to remove the excess free GST before 
proceeding.  
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Figure 4.7. Generation of Rab activation probes using the Rab binding domains of known multi-GTPase 
effectors. (A) Schematics depicting three different bacterially expressed GST-tagged constructs and domains 
used for each protein compared to the full-length (FL) protein. Namely, the Rab binding domains (RBD) of human 
OCRL (residues 539-901) and human MICAL-L2 (residues 806-903) and the Ras binding domain of mouse PI3Kγ 
(residues 1-356). Red boxes denote the published Rab binding domains for each of these effectors. (B) Coomassie 
stained gels showing the expression of the above-mentioned GST-constructs. While there were good expression 
efficiencies of all three fusion proteins, there was a substantial GST contamination observed in the GST-MICAL-
L2-RBD samples despite screening multiple pure bacterial colonies (col 1 and 2 samples in the left gel), 10µl of 
bound bead slurry was used per lane. (C) Illustration of the GST-Rab GTPase activation capture constructs using 
GSH Sepharose beads coated with GST-tagged RBD. 
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Removal of unbound GST with a single-step protease elution method 
I employed a single-step protease cleavage protocol previously utilised in this chapter 
for improving the specificity of protein pull-down elutes for mass spectrometry analysis 
(Figure 4.4) (Luo and King et al. 2014). This method employs a PreScission protease 
protocol marketed by GE Healthcare together with the commercially available pGEX-
6P1 bacterial expression vector that contains a cleavage site between  the GST affinity 
tag and the target fusion protein. This site is recognised by a modified human 
rhinovirus 3C protease, which binds and cleaves off the affinity tag for recovery and 
elution of the bait with any specifically bound protein (Walker and Leong et al. 1994). 
Compared to boiling (the conventional elution protocol), utilising this cleavage method 
to elute the MICAL-L2-RBD would leave all free GST bound to the glutathione 
Sepharose beads during sample recovery, effectively removing the contamin ation 
(Figure 4.8A). The gels in figure 4.8B compare the recovery of MICAL-L2-RBD bait 
protein off the GST-MICAL-L2-RBD resin using either the traditional boiling technique 
in sample buffer or protease cleavage. As anticipated, the samples that underwent 
protease cleavage have markedly lower levels of GST contamination compared to the 
boiled samples (Figure 4.8B). However, the resulting eluant is substantially diluted due 
to the addition of buffers required to perform this elution method (Figure 4.8B, right 
blot). After successful removal of the contaminant GST, all three constructs were ready 
for testing as probes for the Rab8 activation assay. 
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Figure 4.8. Removal of GST contamination through protease cleavage elution. (A) Schematic diagram 
illustrating the predicted outcomes when using different elution methods. Initial methods involving elution through 
boiling would cause all proteins bound to the resin (specifically or unspecifically bound) to be eluted out, resulting 
in a large amount of contaminant free-GST in the sample, whilst using a PreScission cleavage method (which 
targets the sites between the GST-tag and RBD) would only elute out the MICAL-RBD and bound proteins, leaving 
both the GST-Tag and contaminant GST in the sample columns resulting in a purer eluent for analysis. (B) Ponceau 
staining comparing the amount of free unwanted GST between the elution methods of boiling the beads (left blot) 
and using protease mediated elution (right blot). 30µl of GST-MICAL-L2-RBD bound bead slurry was eluted per 
sample and 4 replicates of each elution method were tested.  
 
Validation of Rab8 activation probes  
The first task was to establish that these probes exclusively bind to Rab8 in its GTP-
loaded form. RAW 264.7 cell macrophages lysates were incubated with either 1mM 
GDP or 500µM of the non-hydrolysable GTP-analog, Gpp(NH)p, and applied to 
columns containing each of the Rab8 activation probes. Promisingly, all three probes 
demonstrated the ability to pull-down and enrich GTP-loaded Rab8a/b with little or no 
pull-down of the GDP-incubated samples, as indicated on representative gels (Figure 
4.9). Both Rabs 8a and 8b (from here on, Rabs 8a and 8b will be referred together as 
Rab8 if not otherwise mentioned) are anticipated to bind to these probes as the Rab8 
antibody used binds to both homologs. The OCRL-RBD and mPI3K-RasBD produced 
robust capture of Rab8. The MICAL-L2-RBD probe still suffered from being less 
Chapter 4: Results 1 
 46 
abundant (more dilute) as a probe and capturing less Rab, also still in the presence of 
a low level of contaminant GST, probably visible due to unspecific antibody binding. 
Though diluted, the MICAL-L2-RBD still demonstrated a clear ability to discriminate 
between GDP-loaded and GTP-Rab8 from the macrophage lysates, preferentially 
pulling-down GTP-bound Rab8, making it a valid Rab activation probe. I did not 
attempt to blot with other Rab antibodies at this stage to determine whether other GTP-
Rabs in the macrophages extracts also bind, but this could be done in the future. Thus, 
I successfully produced three probes that can bind to and capture GTP-Rab8.  
 
 
Figure 4.9. Testing of active Rab8 capture constructs with GDP/Gpp(NH)p loaded RAW 264.7 cell lys ates. 
Immunoblots showing the levels of captured active GTP-Rab8 from the lysates of RAW 264.7 were loaded with 
either GDP (1mM) or the non-hydrolysable GTP analog, Gpp(NH)p (500µM) and applied to GSH-Sepharose beads 
using either GST-OCRL-RBD, GST-PI3Kγ-RasBD or GST-MICAL-L2-RBD bound beads for pull-downs.  
 
I next sought to test these probes for the capture of endogenous GTP-Rab8 after 
macrophage activation. We had established that LPS activates Rab8a-mediated 
signalling (Luo and Wall et al. 2014). Other macrophage processes likely to engage 
Rab8 are macropinocytosis and phagocytosis, which can be initiated through 
stimulation with macrophage colony stimulating factor (M-CSF) (Yoshida and Gaeta 
et al. 2015) and human Ig-G coated latex beads respectively (Yeo and Wall et al. 
2016). Therefore RAW 264.7 cells were treated with different activators under the 
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following conditions; LPS (100 ng/ml, 30 min), human-IgG conjugated latex beads (2µl 
of a 1/10 dilution, 30 min) and macrophage colony stimulating factor (M-CSF) 
(20ng/ml, 30 min). After treatment, the cells were lysed and the resulting lysates 
applied to the resin-bound probes for GTP-Rab capture, which was analysed using 
Western blotting. Phosopho-ERK1/2 and phospho-Akt was blotted in the respective 
samples to signify activation of the cells, GAPDH was blotted as a loading control and 
the base levels of the probes and Rab8 were examined on the gels. There was 
typically some level (varied) of Rab8 pulled-down from the lysates of non-activated 
cells, which could indicate constitutive or other means of Rab8 activation occurring in 
the cells but in general, the probes were able to recover increased amou nts of GTP-
Rab8 from cells activated by each different condition.  
 
The OCRL-RBD construct detected increased levels of GTP-Rab8 in response to each 
of these stimulants, most markedly in LPS treated cells (Figure 4.10A, left column). 
Interestingly, with the exception of the IgG-bead treated cells (Figure 4.10C, middle 
column), the PI3K-RasBD probe was also able to detect an induced activation of 
Rab8 in both M-CSF and LPS treated macrophages (Figures 4.10A and B). 
Unfortunately, with the MICAL-L2-RBD construct, I could not discern any differences 
in Rab8 GTP-loading from any of the conditions (Figure 4.10, entire right column). 
However, it is clear that the concentration of the probe itself was much lower than for 
the other 2 probes. I tried to overcome the dilution of this probe by loading more of the 
reaction mixture on the gels, however this still showed lower amounts of both probe 
and captured Rab.  
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Figure 4.10. OCRL-RBD and PI3Kγ-RasBD constructs are able to detect Rab8 activation in macrophages 
responding to various stimuli. Immunoblots showing the levels of active GTP-Rab8 that was pulled down from 
the extracts of stimulated RAW 264.7 macrophages using three di fferent Rab8 activation probes. RAW 264.7 cells 
were treated with either (A) LPS (100 ng/ml, 15 min), (B) M-CSF (20 ng/ml, 30min) or (C) IgG-coated beads (30min) 
and the resulting lysates applied to GSH-Sepharose beads bound with either GST-OCRL-RBD, GST-PI3Kγ-RasBD 
or GST-MICAL-L2-RBD probes. GAPDH was used as an input and protein loading control while phospho-ERK1/2 
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(Thr202/Tyr204) and -Akt (Ser473) were measured to observe for macrophage activation in response to the various 
stimuli. These experiments were performed multiple times and the blots shown here are representative. 
Further optimisation and characterisation will be needed to render all three probes as 
useful tools for detecting Rab8 activation in cell lysates. However, these preliminary 
results highlight three observations; i) all three of these Rab activation probes are able 
to selectively bind to GTP-loaded Rab8, ii) of the three constructs, both the OCRL-
RBD and PI3K-RasBD probes demonstrate the most promise as potential tools for 
assessing Rab or Ras activation in cells and iii) Rab8 is indeed activated in 
macrophages stimulated with either LPS, M-CSF or IgG opsonised beads, consistent 
with previous studies highlighting its multiple roles in immune signalling and endocytic 
pathways (Luo and Wall et al. 2014, Yeo and Wall et al. 2016, Condon and Heddleston 
et al. 2018). Of the three probes tested, the OCRL-RBD construct displayed the most 
sensitivity for detecting changes to Rab8 GTP-loading, and thus this probe was 
pursued for further studies in this project. 
 
Optimisation and validation of the OCRL-RBD Rab8 activation probe 
To further optimise this activation assay, its ability to detect quantitative activation was 
tested. RAW 264.7 mouse macrophage lysates were loaded with either GDP (1mM) 
or increasing amounts of a non-hydrolysable GTP-analogue (1, 10 or 100µM) and was 
then applied to the OCRL-RBD probes. As expected, Western blotting revealed the 
amount of active Rab8a captured correlates with higher concentrations of GTP, 
proving the validity of this assay as a quantitative readout for Rab8 GTP-loading 
(Figure 4.11A). Next, varying concentrations of lysate from RAW 264.7 cells treated 
with LPS (100ng/ml, 30mins) were applied to the probe. On a representative gel, the 
highest concentrations of lysate showed increased capture of LPS-activated Rab8a 
but at lower concentrations, the activated Rab8 was inconsistently captured or not 
detected on the gels (Figure 4.11B). Incubation times for lysates-probe binding were 
also tested. Results showed that incubating the lysates with the GST-RBD-OCRL 
beads at 1 hr captured more activated Rab8a compared to a short incubation time of 
10 min (Figure 4.11C). Taken together these conditions served to optimise the assay 
for detecting GTP-Rab8 in RAW 264.7 cell lysates and prepared the assay for 
investigating biological questions. 
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Rab8 is activated downstream of TLR4 in LPS-activated macrophages 
To measure physiological activation of Rab8 using the assay, an LPS time course was 
performed on RAW cells and Rab8 GTP-loading was assessed using the same 
optimised parameters from earlier. Interestingly, results shown in Figure 4.11D 
showed a ‘wave’ of increased GTP-loaded Rab8 in response to LPS-stimulation over 
a 15-30min period. This corresponds to the pattern of Akt phosphorylation (see Figure 
4.2A, control), and is consistent with the timing for the binding of the GTP-Rab8a 
effector PI3K and its activity.  
 
The Rab8 activation experiment was repeated using primary bone marrow derived 
macrophages (BMMs) from TLR4-/- and wild-type mice. This was done to demonstrate 
Rab8a activation in primary macrophages and to determine whether this is 
downstream of LPS/TLR4. In wild-type, control BMMs the assay detected LPS-
induced Rab8, despite a much higher baseline of Rab8 activation in non -LPS treated 
cells. In the absence of TLR4, there was less basal activated Rab8 and LPS did not 
induce an increase, in fact there was much less active Rab8a captured from these 
lysates (Figure 4.11E). This confirms that the RAW 264.7 macrophage cell line and 
primary macrophages have the same response in showing LPS-induced activation of 
Rab8, and this immune associated GTP-loading of Rab8 is indeed downstream of 
TLR4. These results prove the efficacy of this Rab8 activation assay as a reliable 
system for measuring changes in endogenous Rab8 activation within these cells, and 
the optimised version of this probe was utilised in a published article during my PhD 
of which I contributed as a co-author (Wall and Luo et al. 2017). With a Rab8 activation 
assay now established, I was ready to investigate the GEF activity for GRAB and 
Rabin8 in macrophage TLR-signalling. 
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Figure 4.11. Calibration and validation of the OCRL-RBD Rab8 activation probe. Immunoblots showing the 
levels of active GTP-Rab8 that was pulled down from RAW 264.7 macrophage lysates using GST-OCRL-RBD 
bound glutathione Sepharose beads. Results showing pull -downs of active Rab8 using the OCRL-RBD probes on; 
(A) GDP/GTP loaded cell lysates, (B) a calibration using different concentrations of lysate from +/- LPS (15 min) 
treated cells, (C) lysate from +/- LPS (15 min) treated cells incubated with probes for either 1 hr or 10 min, and (D) 
lysate from cells following a 60 min LPS time course. (E) +/- LPS (30 min) control and TLR4-/- mouse BMM lysate. 
The total volume used per pull-down was kept at a 400μl with 30μl of bead slurry, and pull-downs in C and D used 
400µg of protein as per the calibration in (B).100 ng/ml of LPS was used for all activation assay treatments shown 
here. 
 
 
 
Chapter 4: Results 1 
 52 
Discussion 
Having discovered an interesting and novel role for Rab8a in TLR signalling, a key 
pursuit for our research was to identify how Rab8a is activated for this role. In the 
context of our earlier work, Rab8a activation is relevant for its scaffolding by the 
crosstalk activated endocytic receptor LRP1, and for the recruitment of its effector, 
PI3K. In its other cellular roles, Rab8a is activated by one or both of  the two known 
Rab GEFs, GRAB and Rabin8 and these proteins became the focus for this chapter 
after emerging from studies on Rab8a binding partners. A second focus for this 
chapter then became the establishment of an activation assay to measure Rab8a 
nucleotide activity and subsequently, GEF activity. 
 
Initial results demonstrate relevant aspects of Rab8a in macrophages. Upon cell 
stimulation with bacterial LPS, Rab8a becomes enriched on cell surface ruffles and 
macropinosomes, where it is poised to participate in TLR4 signalling, as demonstrated 
by the colocalisation of Rab8a and the TLR4 adaptor, TRAM (Figure 4.1C). It is on 
these membrane domains where Rab8a plays an important role during TLR-signalling, 
driving anti-inflammatory cytokine secretion to constrain inflammation through its 
effector PI3K (Luo and Wall et al. 2014, Wall and Luo et al. 2017). Indeed, in signalling 
assays, deletion of either Rab8a, its effector PI3K or its associated recruiter LRP1, in 
RAW 264.7 macrophages reduced LPS triggered Akt phosphorylation, a key signalling 
kinase within this inflammatory pathway (Figure 4.2 and 4.3).  
 
Pull-down of GST-Rab8a was used to ‘fish’ for Rab binding partners in activated 
macrophage lysates. Interestingly, this revealed other potential proteins of interest, 
such as the GDIs (Ullrich and Stenmark et al. 1993, Shisheva and Chinni et al. 1999) 
and the Rab escort protein, MSS4 (Itzen and Pylypenko et al. 2006) as binding 
partners in macrophages. These proteins could be further pursued, and they may in 
the future flesh out the regulatory repertoire for Rab8a in TLR signalling. PI3K 
emerged from this screen and it is a known LPS-induced Rab8 effector (Luo and Wall 
et al. 2014), confirming that this pull-down captured proteins based around LPS-
activated Rab8a. GRAB was also captured as a binding partner for Rab8a and it is a 
known GEF for this Rab (Guo and Hou et al. 2013) and its expression in macrophages 
was confirmed, along with the expression of the other known Rab8 GEF, Rabin8. The 
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pull-down and mass spectrometry identification of only GRAB, in the first instance, 
suggest it might be the sole GEF for Rab8a in the context of interest. However, for 
comparison, both GRAB and Rabin8 were studied in parallel. Co-immunoprecipitation 
experiments using RAW cells expressing myc-Rab8a verified that GRAB bound to 
Rab8a in activated cell extracts, validating the results observed from the earlier pull-
down experiments and mass spectrometry analysis. Rabin8 was also found to bind to 
myc-Rab8a. Both GRAB and Rabin8 showed similar, LPS-induced binding to myc-
Rab8a. The reason for not picking up Rabin8 in the initial pull-downs is not clear.   
 
In LPS-activated macrophages, the production and expression of GFP-labelled GRAB 
and Rabin8 showed they are widespread in cells, as expected for these normally 
soluble proteins, but both are recruited to cell surface ruffles where they colocalised 
with tagged Rab8a. This is in accord with their binding to Rab8a in extracts and in 
intact cells, both GRAB and Rabin8 are on the membrane domains where they are 
seemingly both available to interact with and activate this GTPase to facilitate TLR 
signalling. Indeed, high-resolution crystal structures have shown that both GRAB and 
Rabin8 bind via the same domains to Rab8 (Sato and Shirakawa et al. 2007, Guo and 
Hou et al. 2013). Functional studies performed individually on GRAB and Rabin8 
showed that both operate in some of the same complexes. For instance, both GEFs 
are known to form a complex with GTP-loaded Rab11 to facilitate Rab8 recruitment 
for the subsequent targeting of exocytic membrane vesicles (Horgan and Hanscom et 
al. 2013, Wang and Deretic 2015). Both GEFs have also been found to function in the 
same pathways, such as regulating the transport of membrane vesicles for neurite 
outgrowth (Furusawa and Asada et al. 2016, Homma and Fukuda 2016). These known 
functional similarities between GRAB and Rabin8 provided a background for 
continuing to study both as potential Rab8a GEFs in TLR-activated macrophages. 
 
One key measurement for assessing GEF function is by quantifying endogenous Rab 
activation (GTP-binding). As mentioned previously, protocols for gauging endogenous 
Rab activity are limited. The first of these methods used radioactive phosphate 
isotopes (32Pi) to label the pools of GTP/GDP within cells. After which, the respective 
GTPase protein is immunoprecipitated and thin -layer chromatography was used to 
measure the ratios of bound radiolabelled GTP/GDP bound protein was measured 
(Gibbs and Schaber et al. 1987). However, extensive safety precautions was required 
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for this technique due to the use of millicurie levels of 32Pi, and the added need to 
culture the cells in phosphate-depleted media could alter cellular responses, made 
this technique obsolete as other assays were developed (Taylor and Resnick et al. 
2001). Another technique uses monoclonal antibodies, which only recognises the 
GTP-bound configurations of specific GTPases, however few of these antibodies have 
ever been proven to be effective with rare examples such antibodies reported for GTP-
Rab6 and GTP-Rho (Nizak and Monier et al. 2003, Goffinet and Chinestra et al. 2008). 
While it is not entirely known why there is a lack of these active-configuration specific 
antibodies for small GTPases, the small size, globular structure and relatively high 
similarities between the GTPase family members may prove to be challenging targets 
for developing these specific antibodies. The final and most common method for 
measuring GTPase activation in cells is through the use of effector binding domains 
to selectively bind and detect GTP-bound GTPases in lysates or protein solutions. 
Indeed, commercial GTPase activation kits, such as the G-LISA assays developed 
by Cytoskeleton Inc, utilised various effectors to generate activation probes for 
members of the Rho, Ras and Arf sub-family of GTPases. Interestingly, despite being 
the largest subfamily of GTPases to date there is no available commercial assay for 
measuring the activation of endogenous Rabs in cellular systems.  
 
In saying this, there have been instances of endogenous Rab activation being 
measured in specific studies, for example the use of a GST-tagged Rab8 effector 
called synaptotagmin-like protein 1 (Slp1) to pull-down and assess the role of Rab7 in 
apoptosis, indicating that it is possible to generate such assays for Rab family 
members (Romero Rosales and Peralta et al. 2009). For Rab8 in particular, work by 
Peränen and colleagues identified a Rab8/Rab27 effector called synaptotagmin-like 
protein 1 (Slp1) (Hattula and Furuhjelm et al. 2006), which was used in a later study 
by the Guo laboratory to demonstrate changes to endogenous Rab8 activity and 
Rabin8 GEF function in HeLa cells (Wang and Ren et al. 2015). While effective for 
assessing Rab8 activation, being a specific effector for Rabs 8 and 27 limited the use 
of this Slp1 construct for just these two Rabs.  
 
For this project, due to the absence of a commercially available GTP-Rab8 specific 
antibody, we set about generating three Rab8 activation probes using the RBDs of the 
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multi-Rab effectors, OCRL and MICAL-L2, and the RasBD of PI3K. In some of its 
other roles, Rab8a shares effectors with other Rabs. For instance, OCRL and MICAL-
L2, are effectors also for Rabs 1, 3, 5, 13 and 35 (Fukuda and Kanno et al. 2008) and 
probes based on their RBDs would potentially have the ability to pul l-down activated 
versions of Rab8a but also these other Rabs. In contrast, Rab8a binds to the RasBD 
of PI3K as an effector specifically identified in TLR signalling, which is directly relevant 
to the context of interest. However, it should be noted that the RasBD of PI3K has 
not been directly tested, in our hands, for binding to other Rabs. The assay we 
developed relied on these probes for strong and selective binding to GTP-loaded 
Rab8a, rather than for their specificity to Rab8a per se, since Rab8a will be detected 
in the eluate by immunoblotting.  
 
Initial experiments with GDP/GTP-analogue loaded GTPases in RAW 264.7 
macrophage lysates demonstrated that all three constructs are able to pull-down Rab8 
in the presence of GTP, indicating a binding preference for GTP-loaded Rab8 (Figure 
4.9). By this measure, the probes are successful in detecting activated Rab8 in cell 
extracts. OCRL-RBD and PI3K-RasBD constructs were then able to detect a robust 
increase in GTP-Rab8 after LPS activation of cells. This verified previous findings 
showing that Rab8 activity is indeed induced upon TLR4-stimulation (Wall and Condon 
et al. 2018) as a key precept for the current project. However, this LPS-associated 
increase in GTP-Rab8 levels was not observed using the MICAL-L2-RBD probe. This 
is likely due to the extra dilution of this probe during purification (evident from the 
difference in ‘bait’ intensity between the MICAL-L2-RBD and the OCRL-RBD or PI3K-
RasBD, Figure 4.10A ponceau stains). While preliminary testing using GDP/GTP-
analogue loaded macrophage lysates demonstrated that the MICAL-L2-RBD was still 
sensitive enough to detect a difference in GTP-Rab8 levels (Figure 4.9), this indicates 
that the current protocol for the MICAL-L2-RBD probe is not sensitive or concentrated 
enough to detect the subtler change in Rab8 GTP-loading during LPS-TLR4 
activation.  
 
I also tested the capabilities of these Rab8 activation probes to detect changes in 
GTP-Rab8 in lysates from macrophages activated with other stimuli, namely M-CSF 
(stimulates macropinocytosis) (Yoshida and Gaeta et al. 2015)] and IgG opsonised 
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beads (stimulates phagocytosis). While LPS induced the clearest (biggest) induction 
of Rab8 activation, M-CSF and IgG produced smaller increments in GTP-Rab8a 
capture after cell treatments. This is consistent with the prominent TLR-induced 
recruitment of Rab8a to macropinosomes, in keeping with this as one of the main roles 
of Rab8a in macrophages. Since we know that Rab8a is active downstream of multiple 
TLRs (Wall and Luo et al. 2017), it would be fruitful in the future to test other TLR 
ligands in the activation assay. The OCRL-RBD construct appeared to be more 
effective in capturing GTP-Rab8a than the PI3K-RasBD in treated cells. This might 
reflect the differential sensitivity of the binding domains. With these results, it was clear 
that the OCRL-RBD was the most sensitive and robust of the activation probes and 
was selected for further use in the project. 
 
In cells, the GTP-/GDP-loaded states of Rabs are often transient in nature, catalytically 
driven by the regulatory partners they interact with, such as GEFs and GAPS. 
However, by themselves GTP-bound Rabs also have an intrinsic, albeit slow, GTP 
hydrolytic activity that naturally switches off the Rab (Nottingham and Pfeffer 2015, 
Pylypenko and Hammich et al. 2018). This calls attention to the incubation times I 
used for the probes during capture of GTP-bound Rab8 from macrophage lysates. 
Given the slow nucleotide exchange on Rabs, unsurprisingly, the results showed that 
incubating the lysates with the GST-RBD-OCRL beads for 1 hr showed better capture 
of GTP-Rab8 than 10 min (Figure 4.11C) and the longer incubation time was employed 
throughout my studies. 
 
During the optimisation of the GST-tagged OCRL-RBD, I confirmed that Rab8 was 
indeed activated in macrophages treated with LPS and this occurred in a peak at 15-
30 mins, which coincides with the LPS induced AKT phosphorylation pattern in Figure 
4.3, which ties the Rab8a activation with its recruitment of the PI3K effector for 
signalling. Furthermore, this LPS-induced Rab8 activation was abolished in TLR4-/- 
BMMs, verifying that this Rab8 GTP-loading is directly tied to immune receptor 
activation. These results confirm that Rab8 is activated upon macrophage stimulation 
with LPS, resulting in downstream PI3K function to elicit TLR-associated signalling 
responses.  
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In conclusion, this chapter describes the identification of the candidate Rab8 specific 
binding partners GRAB and Rabin8 as potential activators of Rab8 in TLR-associated 
pathways. In developing and establishing a reliable Rab8 activation assay, I can now 
further investigate Rab8 activity in macrophages and test the roles of GRAB and 
Rabin8 in TLR-associated Rab8 activation. By creating a useful activation assay using 
two RBD probes, the assay can now be used much more widely to examine activation 
of Rab8 (and other Rabs) in vitro and in cell extracts.  
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Chapter 5 
Results 2: Deletion of GRAB and Rabin8 and 
its effects on Rab8 activation and localisation 
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5. Results 2 
Introduction 
In macrophages, Rab8a localises dynamically on cell surface ruffles and becomes 
enriched on early macropinosome membranes. This recruitment of Rab8a becomes 
enhanced when macrophages are activated by various TLR ligands (Wall and Luo et 
al. 2017). In the previous chapter, with help from my supervisor Dr Lin Luo, I developed 
a Rab8 activation probe for pull-downs of GTP-Rab8 in the extracts of LPS activated 
RAW 264.7 macrophages and we used the assay to show that LPS increases GTP-
Rab8 in macrophage extracts (see Figure 4.11D). However, the GEF responsible for 
nucleotide exchange to GTP-load Rab8a for this signalling function is yet to be 
characterised.  
 
In the previous chapter, using protein pull-down and immunoprecipitation experiments, 
I initially identified GRAB and subsequently demonstrated the presence of GRAB and 
Rabin8 as candidate Rab8 GEFs in LPS-activated macrophages. Cellular imaging in 
LPS-activated RAW 264.7 cells, using fluorescently tagged constructs, demonstrated 
that both GRAB and Rabin8 colocalise with Rab8a on macrophage surface ruffles 
from which macropinosomes arise. This indicates that both proteins are available to 
interact with Rab8a on relevant membranes tied to its TLR-signalling function. Now, 
further functional studies are needed to examine if either GRAB or Rabin 8 are indeed 
the GEFs responsible, specifically, for TLR-induced Rab8 activation. In order to assign 
GRAB or Rabin8 to the role of GEF activation for this specific function of Rab8a, I 
needed to deplete these proteins within our cells of interest.  
 
Gene knockouts (KO) in mice are traditionally problematic for Rabs and their 
accessory proteins. The Rab8a KO is embryonically lethal in mice and mouse KO 
models for GRAB and Rabin8 are not available (Sato and Mushiake et al. 2007). Most 
phenotypic studies on GRAB or Rabin8 have been performed using siRNAs (Fukuda 
2008, Wang and Ren  et al. 2015, Eguchi and Kuwahara et al. 2018). Given the 
difficulty of transfection in RAW 264.7 cells and other macrophage lines, siRNAs are 
not an ideal approach for assaying cell functions. More recently our laboratory has had 
success using the clustered regularly interspaced short palindromic repeats (CRISPR) 
and CRISPR-associated protein 9 (Cas9) gene editing system to generate the 
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complete deletion of Rabs8a and 13 and LRP1 in RAW 264.7 cell lines (Wall and Luo 
et al. 2017, Condon and Heddleston et al. 2018, Luo and Wall et al. 2018). Therefore, 
using these methods and improved CRISPR protocols developed by Ran and 
colleagues (Ran and Hsu et al. 2013), I set out to generate KO RAW 264.7 cell lines 
of both, GRAB and Rabin8, to investigate the functional roles of these proteins during 
TLR-Rab8a-signalling.  
 
This chapter describes the generation of GRAB and Rabin8 CRISPR-Cas9 KO RAW 
264.7 macrophage cell-lines for investigating the roles these proteins play in TLR-
associated Rab8 activation and function. Using the optimised Rab8 activation probe 
from the previous chapter and live-cell confocal imaging of Rab8a, I will assess 
changes to both LPS-induced Rab8 activation and localisation in macrophages in 
these CRISPR-KO cell-lines.  
  
Chapter 5: Results 2 
 61 
Results 
Generation of GRAB and Rabin8 CRISPR KO cell-lines 
To begin characterising the functional roles of GRAB and Rabin8 in TLR-activated 
macrophages, I proceeded to generate KO RAW 264.7 macrophage cell lines for each 
of these proteins. Utilising previously published protocols by Ran and colleagues (Ran 
and Hsu et al. 2013), Dr Adam Wall from our laboratory established regimes for using 
the CRISPR-Cas9 system to KO (completely and selectively) Rab8a (Wall and Luo et 
al. 2017) and other proteins such as LRP1 in the RAW 264.7 mouse macrophage cell 
line (Luo and Wall et al. 2018). I therefore set out to make CRISPR KO RAW 264.7 
cell lines for GRAB and Rabin8. 
 
However, despite the previous successes of this CRISPR-process, it was still a 
challenge to perform gene editing in our macrophage cell lines. Some of the 
complicating factors include the difficulty of transfecting macrophages, since these 
cells react very strongly to foreign proteins and genetic material, resulting in immune 
activation followed by programmed cell death (Chow and Deo et al. 2016, Nagata and 
Tanaka 2017) and the variation in CRISPR targeting efficiencies due to 
gene/sequence specific ‘off’ target rates. In all, both GRAB and Rabin8 turned out to 
be much harder to target than the previous gene editing done in the laboratory. Several 
methods were trialled, and alternative approaches were performed over a period of 8 
months, the methodology and the workflow used to ultimately, successfully generate 
the GRAB and Rabin8 KO cell lines is described below. 
 
Construction of CRISPR-Cas9 protein complex and selection plasmids 
Using an online CRISPR guideRNA design tool (originally portrayed on crispr.mit.edu) 
as developed by the Zhang laboratory (Broad Institute, MIT), three different CRISPR 
target sites for each gene were selected (Figure 5.1A). These targeting sequences 
called guideRNAs were designed to recognise regions within the second exon of 
mouse GRAB and third exon of mouse Rabin8 (based on the ‘off’ and ‘on’ target 
scores by the online design tool, Appendix 2). Each of these guideRNAs contain a 20-
nucleotide sequence that is homologous to the target gene, termed ‘spacer’, and a 
protospacer adjacent motif (PAM), which the CRISPR-Cas9 complex uses for binding, 
sequence recognition and cleaving (Figure 5.1A). To maximise the chance of 
generating KO cell lines, three different methods were tried for generating the 
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CRISPR-Cas9 ribonucleoprotein (RNP) functional unit as set out in Figure 5.1B. 
Method 1 uses the cDNA mammalian expression vector px458 (Addgene plasmid 
#48138), a Cas9 expressing plasmid from the Feng Zhang laboratory (McGovern 
Institute, MIT) that endogenously expresses the complex after transfection within the 
cell, while methods 2 and 3 involve generating an exogenous Cas9 RNP complex, 
through mixing the purified Cas9 nuclease from S.pyogenes (IDT) with guide-RNA 
oligos using either a guide-RNA synthesis kit (method 2) or directly made by IDT 
(method 3). By varying the way these RNP complexes were made and introduced to 
the RAW 264.7 cells, we predicted that at least one of these approach es would 
minimise immune cell reactivity, increasing the possibility of attaining successful 
incorporation of a gene KO.  
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Figure 5.1. Design and production of the Cas9-gRNA complex for generating GRAB and Rabin8 KO RAW 
264.7 macrophage cell lines. (A) Schematics denoting the guideRNA target locations on the alleles of GRAB and 
Rabin8 (exons 2 and 3 respectively). These guideRNA sequences are composed of a CRISPR-Cas9 protospacer 
adjacent motif (PAM, in red), and the upstream homologous 20bp ‘spacer’ sequence used for CRISPR-Cas9 
targeting. Each of these guideRNAs were designed and selected using an online CRISPR guideRNA design tool 
(crispr.mit.edu, by the Zhang Lab, Broad institute). (B) Illustration depicting the 3 methods that were used in an 
attempt to minimise macrophage sensitivity to the foreign protein/genetic material. In method 1, Rabin8 and GRAB 
gRNA homologous sequences were cloned into the Cas9-gRNA complex mammalian expression vector px458, 
which was directly transfected and expressed in RAW 264.7 cells. In methods 2 and 3, synthetic gRNA oligos were 
produced either via a synthesis kit (method 2) or ordered from IDT (method 3). The gRNA oligos were later 
complexed with pre-ordered, purified S. pyogenes Cas9 proteins (from IDT), which is later directly transfected into 
RAW 264.7 cells. 
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In conjunction with these RNP complexes, two further methods were utilised to select 
for the KO mutant cell lines after transfection in order to encourage the generation of 
different mutation outcomes: i) nonhomologous end joining (NHEJ) resulting in 
insertions/deletions (indels); ii) homology-directed repair (HDR), whereby a donor 
cDNA sequence (selection cassette) is inserted at the CRISPR cut-site, both of which 
closely follow protocols established by others (Ran and Hsu et al. 2013). In line with 
these methods, 2 resistance plasmids were generated, with guidance from Dr Adam 
Wall in our laboratory, using a neomycin resistance plasmid pFloxNeoFlox to be co-
transfected with the Cas9-guideRNA complex (Figure 5.2).  
 
NHEJ is an endogenous DNA repair mechanism that is prompted after the CRISPR-
Cas9 RNP complex cleaves a double-stranded break in the target gene. This process 
has a high rate of error as it ignores sequence homology and simply ligates the 2 
strands of DNA back together, often resulting in indels (Burma and Chen  et al. 2006). 
This results in a random frameshift mutation, effectively silencing the gene. Co-
transfection of the resistance plasmid (containing GFP) serves as a visual aid for 
comparison of transfection efficiency and for the identification of cells that have been 
successfully transfected with the Cas9-guide RNA complex, that can then be picked 
and screened for mutations. Single colonies of resistant cells were picked and used 
for further screening.  
 
For HDR, after the CRISPR-Cas9 directed cleavage, the co-transfected donor 
resistance plasmid provides a template that contains ~2kb homologous ‘arms’ that 
flank a neomycin resistance cassette (Figure 5.2, right plasmid). During the gene 
repair process, the presence of the template facilitates the insertion of the selection 
cassette into the site of mutation, allowing for the stable expression of resistance in 
addition to disrupting the target gene. A downstream diphtheria toxin A-chain is 
included to negatively select any mutants where a random insertion of the resistance 
cassette has occurred (‘suicide’ sequence). Due to the inherent genomic variation of 
the RAW 264.7 cell line, the relatively long (~2kb) homologous ‘arms’ were cloned 
from RAW 264.7 genomic DNA to maximise the chances of accurate HDR occurring. 
With the integration of the resistance plasmid, the resulting cells will remain in 
selection and be grown as a mixed population of CRISPR-mutated cells. 
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Figure 5.2. Illustration of resistance selection vectors for CRISPR-Cas9 mutant selection. Figure depicts the 
2 different selection plasmids used for generating knockout mutants. The first vector (left) is a simple pFloxNeo 
plasmid meant for transient expression of neomycin resistance to identify positively transfected cells. This was 
used for the positive selection and isolation of single colonies for expansion and generation of clonal gene knockout 
cell-lines. The second vector (right), is the pFloxNeo donor vector containing the homologous sequence ‘arms’ (red 
and green) which flank the target sequence site, along with a diphtheria toxin sequence for negative selection of 
random plasmid insertion. The integration of the resistance cassette into the cleaved gene enables the stable 
expression of neomycin resistance, allowing for the resulting cells to be kept in selection and thus a mixed-cell 
population of mutant cells. 
 
Transfection and selection of GRAB and Rabin8 knockout mutants 
With the components ready, the KO mutants were generated by mixing the different 
Cas9 RNP complexes with the respective resistance plasmid and co-transfecting them 
into RAW 264.7 cells using the LipofectamineTM CRISPRMAXTM (Invitrogen) 
transfection reagent (Figure 5.3A). For the NHEJ transfections, selection (G418, 1 
mg/ml) was applied 24 hr post transfection and removed after 96 hr. The surviving 
single cells were left to recover and expand into colonies for picking. For the HDR 
transfections, neomycin was applied after 72 hr post transfection, to allow time for 
resistance gene integration and expression. This mixed population of transfected cells 
were continuously kept in neomycin selection to maintain the expression of the 
integrated resistance cassette. After the selection process of either method, resulting 
clonal cell lines (NHEJ) and mixed populations (HDR) were first screened for 
successful mutations via a T7 endonuclease cleavage assay (New England Biolabs).  
 
Using screening primers flanking the target CRISPR cut sites (see Figure 5.1A, and 
Table 2.2 in Materials and Methods), I amplified these mutant regions using gDNA 
extracted from each of the mutant cell lines and a wild-type control. The amplified 
sequences were denatured and annealed back together and treated with a T7 
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endonuclease enzyme. Essentially, if a successful mutation has occurred, it would 
result in a mismatch that produces a ‘bulb’ in the annealed DNA sequence which is 
recognised by the nuclease and cleaved, leading to a shortened DNA fragment that 
can be visualised on an agarose gel. In Figure 5.3B, the results of a T7 endonuclease 
assay on gDNA extracted from mixed population cell lines (obtained using the px458 
CRISPR vector with HDR selection, see Figures 5.1B and 5.2) is shown. By comparing 
the band intensities of cleaved product (arrows 2 and 4) between each of the 
guideRNAs, I show that the targeting CRISPR RNAs, GRAB guideRNA 1 and Rabin8 
guideRNA 3, had the highest mutation efficiency. Th is finding demonstrates the 
variability in CRISPR mutation efficiencies (even within the same target exon) and 
importantly, allowed me to focus on one guideRNA for either gene, streamlining 
downstream protocols. 
 
Chapter 5: Results 2 
 67 
 
Figure 5.3. Transfection and screening for generating CRISPR-Cas9 KO RAW 264.7 macrophage cell lines. 
(A) Schematic describing the general workflow used to transfect, select and screen for transfected macrophages 
for creating the knockout cells. First the Cas9 nuclease complex or the px458 CRISPR mammalian expression 
vector is mixed with either the NHEJ or HDR selection plasmids. The selection vectors with the CRISPR -Cas9 are 
mixed with the cationic liposome reagent CRISPR-MAX. Next, the resulting transfection complex is then added to 
the macrophage cell line. Finally, positively transfected cells are then placed in antibiotic selection (G418, 1 mg/ml). 
These selected cells are later screened for CRISPR-mediated mutations via Western blotting. (B) RAW 264.7 cells 
were co-transfected with the CRISPR mammalian expression vector px458 with the various guideRNAs and the 
HDR selection vector. After selection, gDNA was extracted from each mixed population cell line and the T7 
endonuclease assay performed. A representative agarose gel showing the results from the T7 endonuclease 
cleavage screen. Uncut controls of wild-type GRAB and Rabin8 show the original size of the screening primer 
amplicons to be ~700bp for GRAB and 400bp for Rabin8 (arrows 1 and 3 respectively). Positive mutants are 
identified via cleaved PCR fragments (arrows 2 and 4) from T7 endonuclease digestion. 
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Multiple rounds of transfection and selection of both clonal and mixed population cell 
lines were performed. Six ‘mixed population’ cell lines were generated by HDR, these 
represented transfected lines kept under selection but containing a mixture of 
transfected, knockdown and unaffected cells. Some of these populations do show 
reduction or loss of either GRAB or Rabin8 upon Western blotting (see in Figure 5.4, 
GRAB CRISPR cell line Mix 1 and Rabin8 CRISPR cell line Mix 1). In addition, I 
generated various KO and knockdown clonal cell lines (through the NHEJ method) 
which were cloned from the original mutant cell population by single cell selection to 
produce clonal cell lines (see examples in Figure 5.4, with arrows denoting GRAB 
CRISPR clonal cell line 4 and Rabin8 CRISPR clonal cell lines 1 and 4). This one 
GRAB KO and two Rabin8 KO clonal cell lines demonstrated a complete deletion of 
GRAB or Rabin8 protein expression respectively, indicating that these are 
homozygous KO colonies. Sequencing was later used to confirm the mutations. These 
clonal KO cell lines became the primary subjects to investigate the role of GRAB and 
Rabin8, in the regulation of Rab8a activation and function, within an  LPS/TLR-
associated pathway. The initial test was to assess if LPS-induced Rab8 activation is 
affected in the absence of either of these GEFs. 
 
 
Figure 5.4. Screening CRISPR-Cas9 mutant cell lines for protein expression of target gene knockouts. 
Western blot screening of CRISPR transfected cell lines for assessing protein expression levels of either (A) GRAB 
or (B) Rabin8. Blots show the presence of homozygous complete knockout colonies (arrows denoting GRAB colony 
4 and Rabin8 colonies 1 and 4) and knockdown mixed cell populations (GRAB CRISPR mix 1 and Rabin8 CRISPR 
mix 1, left blot third lane). px458 plasmid transfected mixed CRISPR mutant population cell lines are referred to as 
‘Mix’, while ‘Colonies’ refer to lines generated from picked isolated colonies. 
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Both GRAB and Rabin8 contribute to LPS-induced Rab8 activation in mouse 
macrophages 
To assess Rab8a activation, I employed the previously optimised GTPase activation 
assay for GST OCRL-bead capture of GTP-Rab8 (see Figure 4.11). Lysates from LPS 
treated/untreated (100 ng/ml, 15 min) control cells and from GRAB KO and Rabin8 
KO RAW 264.7 cells were applied to the GST-OCRL-RBD probes and the amount of 
GTP-Rab8 captured was compared. GRAB and Rabin8 were both detected in the 
lysates before capture. Results show that the control and KO macrophages have 
variable basal levels of GTP-Rab8 in the capture eluates, but detectable increases 
were found after LPS treatment in all cases signifying LPS-induced Rab8a activation. 
The GRAB KO and Rabin8 KO cells both showed a modest but significant (P<0.05) 
decrease in the amount of GTP-Rab8a captured from LPS activated cells (Figure 5.5). 
While activation of Rab8 was affected, the phosphorylation of the MAP kinase ERK1/2 
remained unchanged between the control and KO cells, suggesting that other 
pathways were unaffected by the deletion of these proteins. These results 
demonstrate that both GRAB and Rabin8 contribute to Rab8 activation in an LPS-
dependent manner in mouse macrophages. Furthermore, they reveal that both GRAB 
and Rabin8 have activities consistent with the role of Rab8 GEFs in activated 
macrophages. At this stage, both proteins are possible GEFs that contribute to one or 
more Rab8-mediated functions triggered by LPS/TLR4.  
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Figure 5.5. Loss of either GRAB or Rabin8 significantly reduces LPS induced Rab8 GTP-loading in 
activated macrophages. Immunoblots showing the levels of active Rab8 pulled-down from the lysate of control 
and (A) GRAB or (B) Rabin8 KO cells +/- LPS (100 ng/ml, 15 min) using GST-OCRL-RBD bound GSH-Sepharose 
beads. Levels of active Rab8 were quantified by using the densitometric ratio between the band intensities of 
captured Rab8 and GAPDH. Significance was measured via two-way analysis of variance (ANOVA) (*P<0.05, 
***P<0.001, n= 3). 
 
Rab8a localisation is unaffected in the absence of either GRAB or Rabin8 
With both GRAB and Rabin8 now shown to be functioning as Rab8 GEFs in LPS 
activated macrophages, I wanted to examine whether the depletion of either GEF 
affected Rab8a membrane localisation in  LPS-treated RAW 264.7 cells. To investigate 
this, I performed confocal live cell imaging on LPS-treated GRAB KO, Rabin8 KO and 
control RAW 264.7 cells transiently expressing GFP-Rab8a to assess the localisation 
of Rab8a in these CRISPR cell lines. GFP-Rab8a was found enriched on ruffles and 
newly formed macropinosomes when it was expressed in control cells or in GRAB KO 
or Rabin8 KO cells (Figure 5.6). Live cell imaging demonstrated that there were no 
striking morphological differences between the control and GRAB KO cells (Figure 
5.6A) and the cells exhibited similar membrane ruffling dynamics and rates of 
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macropinocytosis in response to LPS. In Figure 5.6A, GFP-Rab8a was seen on ruffles, 
internalising macropinosomes and tubules emerging from the macropinosomes and 
the loss of GRAB did not affect this localisation. In Figure 5.6B, GFP-Rab8a was also 
seen on dynamic ruffles, macropinosomes and tubules and its overall distribution 
throughout the cell was similar in the Rabin8 KO and control cells. The loss of Rabin8 
also did not affect LPS-induced ruffling or macropinocytosis, as assessed on movies. 
Thus, despite reducing Rab8a activation, the loss of either GRAB or Rabin8 did not 
affect the ability of Rab8a to be recruited to and enriched on ruffle or macropinosome 
membranes.  
 
Conventionally, GEFs play a key role in stabilising their GTPases on target 
membranes by facilitating activation or GTP-loading, which prevents GDI recognition 
and extraction from the membrane, retaining the Rab on relevant cellular 
compartments for effector interaction (Blümer and Rey et al. 2013, Pfeffer 2013). As 
a further measure of GEF activity I therefore set up an assay to measure GFP-Rab8a 
retention on the macropinosome membranes. Using live cell imaging, I tracked GFP-
Rab8a positive macropinosomes in GRAB KO, Rabin8 KO and respective control 
cells, and measured the time GFP-Rab8a was spent enriched on these membrane 
domains before being lost by tubulation or dissociation during macropinosome 
maturation (Figure 5.6C). The results revealed that the deletion of GRAB did not 
significantly impact the time GFP-Rab8a is spent enriched on macropinosome 
membranes (Figure 5.6D). Similar results were obtained with Rabin8 KO cells, with no 
measurable reduction in macropinosome membrane retention of  GFP-Rab8a (Figure 
5.6D). Thus, these observations indicate that GRAB and Rabin8 do not conform with 
the role of GEFs as stabilisers of Rab membrane association. While this seems to 
indicate that the deletion of either GRAB or Rabin8 does not affect Rab8a localisation 
and membrane retention, it must be noted that these findings were obtained with cells 
overexpressing GFP-Rab8a. While this recombinant fluorescent Rab construct (GFP-
Rab8a) is believed to accurately portray the localisation of its endogenous counterpart, 
more experiments will be needed to thoroughly interrogate the impact of deleting either 
GRAB or Rabin8 on the membrane recruitment of endogenous Rab8 in these 
macrophage cells.  
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Figure 5.6. Absence of either GEF, GRAB or Rabin8 does not affect Rab8a localisation and enrichment on 
macrophage macropinosomes. Live cell confocal spinning disc imaging comparing LPS-treated control with 
either (A) GRAB KO or (B) Rabin8 KO cells transiently overexpressing GFP-Rab8a showing recruitment and 
localisation to macropinosomes and tubules. (C) Illustration accompanied with live cell confocal images of GFP-
Rab8a in LPS-treated RAW 264.7 control cells depicting the dynamics of GFP-Rab8a enrichment observed on 
macropinosomes where GFP-Rab8a becomes enriched on macropinosome membranes (30 sec frame) and is 
later sorted off on tubules that emanate from these endosomes (55-95 sec frames). (D) Graph showing the 
measurement of Rab8a membrane retention times on macropinosomes in LPS-treated control, GRAB KO and 
Rabin8 KO RAW 264.7 cells. Quantifications were performed by observing the total number of timeframes Rab8a 
is spent enriched on each macropinosome, and the macropinosomes from 5 cells of each cell line were used for 
quantification (n=5). Scale bars, 10µm. 
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Discussion 
In the first result chapter, I demonstrated that both known Rab8 GEFs, GRAB and 
Rabin8, have LPS-inducible interactions with Rab8a in LPS-activated mouse 
macrophages. With the identification of both GRAB and Rabin8 as candidate proteins 
of interest, I turned my attention to generating macrophage cell lines depleted of each 
protein and assess this affected TLR-associated Rab8 activation and function. As 
members of the innate immune system, macrophages are well designed to seek, 
identify and eliminate any substance foreign in the microenvironment. As a result, 
genetic and experimental manipulation of these cells becomes challenging due to the 
adverse reactions they have when exposed to various reagents.  
 
A recent study demonstrated that simply adding the transfection reagents 
Lipofectamine 2000 or 3000 (Invitrogen) to either RAW 264.7 cells or BMMs triggered 
type I interferon signalling responses not present in HEK 293T (human embryonic 
kidney cells) or L929 (murine fibroblast) cell lines (Guo and Wang et al. 2019). This 
reactivity often results in a loss of cell viability and transfection efficiency, leading to 
the development of commercial reagents/protocols designed to maximise transfection 
efficiencies specifically for this cell type (Maeß and Wittig et al. 2014, Lai and Xu  et al. 
2018). In anticipation of these difficulties, a multi-pronged approach was organised for 
the creation of stable KO cell lines in macrophages using the CRISPR-Cas9 system. 
This involved generating different versions of the CRISPR-Cas9 RNP complex, along 
with the use of different selection vectors for the isolation of mutant colonies and mixed 
population cell lines. The resultant cell lines obtained from these protocols showed 
that of the CRISPR complexes trialled, method 3 – using ordered synthetic gRNA 
oligos and Cas9 protein from IDT (Figure 5.1B) - proved to have the highest efficiency 
in generating mutant KO lines in RAW 264.7 macrophage cells (positive KO lines in 
Figure 5.4, black arrows highlighting GRAB colony 4 and Rabin8 colonies 1 and 4). 
The other two methods were only successful in producing partial knockdowns of either 
GRAB or Rabin8. While it has not been empirically tested in this study, I predict this 
difference in efficacy is related to a combination of the transfection efficiencies and the 
RNPs being relatively immunologically silent.  
 
Having successfully obtained GRAB KO and Rabin8 KO stable cell lines, these 
became available for functional studies throughout the project. In all cases the loss of 
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either of these proteins had no observable (or measurable) effect on cell growth or 
morphology. The functional studies carried out in this chapter first sought to measure 
LPS-induced Rab8 activation, utilising the activation assay previously established. In 
GRAB KO cells there was still both basal and LPS-induced GTP-Rab8 captured from 
lysates, but less of the LPS-induced GTP-Rab8a was present compared to control 
cells. This provided evidence that GRAB was contributing to, but not wholly 
responsible for, Rab8 activation by LPS or other stimuli (basal activation) in these 
cells. When Rab8 activation was measured in Rabin8 KO cells there was a modest 
reduction in LPS-induced Rab8 suggesting that this GEF also contributes to some of 
the Rab8 activation in stipulated cells. A notable shortcoming of this assay that 
became evident from multiple experiments, was the variable amounts of basal and 
activated GTP-Rab8 obtained in different experiments. This variation remained 
despite many repetitions and attempts to further standardise the assay and significant 
results were obtained by internally controlled quantification within each experiment 
(more information detailed in the Materials and Methods chapter). Nonetheless, it was 
not surprising to find both GRAB and Rabin8 contributing to Rab8 activation. Both 
GEFs are present in the cells and could be contributing to multiple pools of Rab8 
functioning with different effectors in LPS activated cells, or they can act redundantly 
in the same Rab8 function.  
 
In light of this, although Rab8 has multiple roles in trafficking (Peränen 2011), cellular 
processes such as macropinocytosis and ruffling - which require dynamic and rapid 
membrane internalisation and replenishment - did not seem to be affected by loss of 
either GEF (Figure 5.6). With clear membrane trafficking defects observed in other 
cells when either of these GEFs are deleted, seems to imply that in macrophages, 
there is another Rab or GTPase might have a similar membrane trafficking function to 
Rab8. Another possibility could be a single KO of either GRAB or Rabin8 was not 
sufficient to influence Rab8a’s trafficking functions, as while decreased, a detectable 
level of GTP-Rab8 was still present in either KO cell line (Figure 5.5). Both GRAB and 
Rabin8 therefore remain as candidate GEFs for Rab8a in the project moving forward.   
 
A second discriminating factor could be the role of GRAB or Rabin8 in Rab8a 
membrane association and thus I observed and measured GFP-Rab8a localisation in 
live cells after KO of GRAB or Rabin8. In many instances, GEFs are important for both 
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activating and targeting Rabs to relevant membranes for their function. An example 
being the targeted mislocalisation of mutated GEFs Rabex-5 or Rabin8 to 
mitochondrial membranes in Cos-7 cells, which in turn leads to the mistargeting of the 
respective Rabs - Rab5a from endosomes to mitochondria and Rab8a from 
endosomes and plasma membrane to mitochondria (Blümer and Rey et al. 2013). 
Surprisingly, in my experiments, deletion of either GRAB or Rabin8 as Rab8 GEFs, 
did not affect GFP-Rab8a localisation on ruffles, macropinosomes or tubules. Thus, 
the loss of these GEFs in my experiments did not demonstrate a noticeable loss of 
membrane targeting for Rab8a. This suggests that Rab8a remains bound to these 
membranes independently of these GEFs or that GRAB and Rabin8 are not solely 
responsible for recruiting and retaining Rab8a to macropinosome and surface ruffle 
membranes in macrophages. Research has shown that other factors including escort 
proteins, GDIs, post-translational modifications (prenylation and methylation) of 
Rab8a and Rab8b all contribute to targeted membrane binding (Leung and Baron  et 
al. 2007). Additionally, we know that Rab8a is in a complex with the membrane protein 
LRP1 (Luo and Wall et al. 2018) which we believe is important for scaffolding the 
Rab8a-PI3K complex on macropinosomes. Therefore, it is perhaps not surprising that 
the GEFs, in this instance, are not wholly responsible for Rab8 membrane targeting. I 
also measured the retention of GFP-Rab8a on the macropinosome membrane in live 
cells. By this measure also, neither GRAB nor Rabin8 was required to maintain a 
normal level of GFP-Rab8a on the macropinsomes. Thus, membrane retention time 
might also be dictated more by the LRP1 binding than by the GEFs. In future 
experiments, we could use the LRP1 KO cells to examine Rab8a membrane targeting 
and retention.  
 
Given the similarities between GRAB and Rabin8, and the fact that both GEFs appear 
to activate Rab8 in response to LPS, this may indicate potential redundancy between 
these proteins within macrophages. Therefore, to address this, the obvious next step 
is to produce a double GRAB and Rabin8 KO CRISPR cell line to fully interrogate the 
roles these GEFs play in macrophages responding to LPS. 
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6. Results 3 
Introduction 
Macrophages employ pattern recognition receptors of the TLR family to detect 
molecular signals from different classes of pathogens, including bacteria and viruses 
(Akira and Takeda et al. 2001). Upon activation, ligand-bound TLRs, in combination 
with their signalling adaptors, initiate complex signalling pathways that result in 
transcriptional activation for the synthesis and secretion of inflammatory cytokines and 
chemokines. This immune response is a culmination of signal transduction events 
mediated by various kinases such as MAP kinases (MAPKs), Interleukin -1 receptor-
associated kinases (IRAKs) and Akt downstream of TLRs (Gay and Symmons et al. 
2014, Kawasaki and Kawai 2014). As mentioned in the previous chapters, work from 
our laboratory introduced the small GTPase Rab8a as a key player that contributes to 
signalling induced by TLRs (Luo and Wall et al. 2014), and we now know that this 
occurs directly through LRP1 as a crosstalk receptor to TLRs and also to scaffold 
Rab8a. Activated Rab8a then recruits PI3K, which in turn recruits and activates the 
signalling kinase Akt to produce PI(3,4,5)P3 from PI(4,5)P2 (Bellacosa and Chan et al. 
1998). Further to this, we showed that other kinases such as mTOR (Delgoffe and 
Pollizzi et al. 2011), are also activated downstream of Rab8a/PI3K. Under the 
influence of LRP1/Rab8a/PI3K, phospho-Akt and phospho-mTOR are increased 
which go on to drive and modulate transcription of inflammatory cytokines, resulting in 
an anti-inflammatory or M2-like status (Wall and Luo et al. 2017). While several major 
components of this immune signalling complex have been described, the regulatory 
GEF that activates Rab8a for this particular pathway remains unknown. 
 
Two Rab8 specific GEFs, GRAB and Rabin8, were found to have LPS-inducible 
interactions with Rab8a in RAW 264.7 macrophage cells (Figures 4.5B and C). I went 
on to generate CRISPR-Cas9 deletion of these proteins and was able to demonstrate 
that both GRAB and Rabin8 do function as Rab8 GEFs in immune activated 
macrophages (Figure 5.5). Imaging indicated that the absence of either GRAB or 
Rabin8 did not affect Rab8a membrane recruitment or retention  at sites for TLR/Rab8a 
signalling on ruffles and macropinosomes (Figure 5.6). To determine whether GRAB 
and Rabin8 contribute to signalling downstream of Rab8a, I set out to measure LPS-
induced signalling in control cells compared to Rabin8 and GRAB KO cells.  
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To measure and pinpoint the precise location of TLR-driven Akt signalling on 
macropinosomes, I employed an imaging approach to visualise in real-time the spatial-
temporal localisation and distribution of the major signalling kinase Akt in live LPS-
activated macrophage cells. David James and James Birchfield at the University of 
Sydney produced an enhanced fluorescent probe (TagRFP-Akt) to detect Akt in live 
cells, particularly after its activation and recruitment to membranes (Norris and Yang 
et al. 2017). This improved reporter replaces the eGFP with TagRFP, a brighter and 
more stable fluorophore with different structural properties that allows for improved 
recruitment dynamics. This study utilised this probe in murine fibroblast-derived 
adipocytes, demonstrating that despite encoding a human Akt gene, this construct can 
be used equally well in mouse cells as a signalling reporter. This probe was generously 
provided to us to examine Akt in LPS-stimulated macrophages. Live cell imaging was 
performed on RAW 264.7 cells expressing the TagRFP-hAkt1 probe, to visualise the 
real-time localisation of Akt after LPS stimulation and to explore the roles of GRAB 
and Rabin8 on this signalling pathway. The findings reported here reveal that in 
macrophages, GRAB and Rabin8 both contribute to Rab8a activation in response to 
LPS to facilitate downstream TLR signalling and that this signalling is occurring on 
macropinosome membrane domains.  
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Results 
Deletion or overexpression of either GRAB or Rabin8 does not affect Rab8-associated 
TLR-signalling 
In the first result chapter, I described previous work which demonstrated that the 
deletion of either Rab8a and its effector PI3K decreases Akt signalling downstream 
of TLR-activation (Luo and Wall et al. 2014, Wall and Luo et al. 2017) (see Figure 4.2). 
Having identified Rab8 GEFs, GRAB and Rabin8 as activators of Rab8a in LPS-
stimulated macrophages (see Figure 5.5), I next aimed to test if genetic deletion of 
either one of these Rab8 GEFs impacted on PI3K-dependent TLR-signalling function. 
GRAB KO, Rabin8 KO and control RAW 264.7 cells were treated with LPS over a 60 
min time course and their lysates were analysed by Western blotting to compare levels 
of Akt phosphorylation. In control cells, Akt was phosphorylated in response to LPS 
resulting in increased levels of phospho-Akt from 15 to 60 min in control cells (Figure 
6.1A). A side-by-side quantification and comparison with control cells demonstrated 
that GRAB KO and Rabin8 KO cells had similar patterns of Akt 
activation/phosphorylation in response to LPS, with peaks in phospho-Akt at 15 and 
30 min (Figure 6.1A). There was no statistical significance the LPS-mediated Akt 
response across either GRAB KO or Rabin8 KO cells when compared with control 
cells (Figure 6.1A graph). Additionally, deletion of either GRAB or Rabin8 had no effect 
on phospho-ERK1/2 levels induced by LPS which was consistent with previous 
observations in Rab8a KO cells (see Figure 4.1). Therefore, despite a decrease in 
Rab8a activation upon LPS stimulation (see Figure 5.5), knockout of either GRAB or 
Rabin8 did not affect Akt signalling downstream of TLR4.  
 
As an additional test, recombinant GFP-GRAB or GFP-Rabin8 were transiently 
overexpressed in RAW 264.7 macrophages and cells were activated with LPS over 
the same time course. Cells overexpressing GFP-GRAB had similar phospho-Akt and 
phospho-ERK1/2 responses to LPS when compared to the control cells, despite a 
significant overexpression of GFP-GRAB protein (Figure 6.1B). A similar pattern of Akt 
phosphorylation was observed in GFP-Rabin8 overexpressing cells when compared 
to control cells (Figure 6.1C). These results indicate that neither the deletion nor the 
overexpression of either GRAB or Rabin8 is sufficient to affect Rab8a-driven TLR 
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signalling. This result was surprising given that both GEFs contributed to Rab8 
activation in response to LPS.  
 
 
Figure 6.1. Absence or overexpression of either Rabin8 or GRAB does not affect Rab8a-associated TLR 
signalling. (A) Immunoblots showing the comparative levels of Akt (Ser473) phosphorylation, using phospho-
specific antibodies, between the lysates of control, Rabin8 KO and GRAB KO cells treated with LPS over a 60 min 
time course. The immunoblots shown here are representative and levels of Akt phosphorylation were quantified 
using the densitometry ratio between the band intensities of GAPDH and phospho-Akt levels. Significance was 
measured via two-way analysis of variance (ANOVA) (n= 3). (B/C) Levels of Akt phosphorylation was also 
assessed in RAW 264.7 cells transiently overexpressing either (B) GFP-GRAB or (C) GFP-Rabin8 and treated with 
LPS over a 60 min time course. 
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The striking similarities between GRAB and Rabin8 in both localisation and LPS-
dependent Rab8 GEF activity in macrophages suggests that there might be a 
compensatory or redundant relationship between these proteins. This is also 
consistent with reports in literature showing that GRAB and Rabin8 can function in the 
same cellular pathways (Furusawa and Asada et al. 2016, Homma and Fukuda 2016). 
Therefore, as an approach to examine possible complementary roles for GRAB and 
Rabin8, I generated a double KO cell line in which both GRAB and Rabin8 are deleted. 
 
Double knockouts reveal additive functions for GRAB and Rabin8 in LPS-associated 
activation 
To investigate redundancy or overlap in the roles of GRAB and Rabin8, I repeated the 
CRISPR-Cas9 KO protocols described above using constructs to delete Rabin8 in the 
GRAB KO cell line. Clonal cell lines were produced that displayed varying levels of 
Rabin8 protein expression (Figure 6.2A). After rounds of testing, several clonal cell 
lines were observed to have no or greatly decreased Rabin8 protein expression 
compared to the controls (an example shown in Figure 6.2A, colony 1), effectively 
making them a double Rabin8 and GRAB KO cell line (double KO). Initial 
characterisation tests showed that these double KO cells had no growth defects and 
were morphologically similar to control wild-type RAW 264.7 cells (data not shown). 
 
The Rab activation assay was performed on double KO cells alongside the original 
GRAB KO cells and control cells, all of which were subjected to a 60 min LPS time 
course. The assay captured increasing levels of GTP-Rab8 over the LPS time course 
in control cells with a peak at 15-30 min (Figure 6.2B), consistent with earlier results 
(see Figure 4.11D). The GRAB KO cells had a noticeable decrease in LPS-induced 
GTP-Rab8 at the 15- and 30-min marks, whereas in the double KO cells, a greater 
reduction of GTP-Rab8 was observed across the whole time course, surprisingly 
including the untreated cells at time 0 (Figure 6.2B). Phospho-ERK is patently induced 
by LPS across all cell lines with no significant difference in the double KO cells 
compared to control cells. Given the enhanced reduction in the levels of GTP-Rab8 in 
the double KO, this agrees with previous work suggesting that TLR4-induced ERK1/2 
signalling is predominantly independent of Rab8 activity.  
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For ease of quantification, the activation assay was repeated on these cell lines using 
a single time point for LPS treatment (15 min). Notably, the results highlight that not 
only was LPS-induced Rab8 activation significantly impaired in both the GRAB KO 
and double KO cells, but the basal level of GTP-Rab8 in the double KO was also 
significantly decreased when compared to the control. Taken together, these results 
suggest that both GRAB and Rabin8 not only contribute additively to LPS-dependent 
Rab8 activation, but also act to maintain a basal level of constitutively active Rab8 in 
these cells. Thus, I show in terms of Rab8 activation in response to LPS/TLR4, genetic 
deletion of both GRAB and Rabin8 has a measurable effect, over and above that seen 
with KO of GRAB alone. This stands as important new evidence for cooperative GEF 
activity shared by GRAB and Rabin8 for the activation of Rab8.  
 
 
Figure 6.2. Both GRAB and Rabin8 contribute additively to LPS induced Rab8 activation. (A) Western blot 
screen for protein expression levels of both Rabin8 and GRAB in Double KO CRISPR-Cas9 KO colonies 
demonstrating a positive homozygous knockout (denoted by arrow, colony 1). Wild -type control RAW 264.7 lysate 
is referred to as ‘WT’, while a CRISPR empty vector control colony (transfected with the CRISPR RNP but no guide 
RNA) is referred to as ‘Ctrl’. (B) Immunoblots showing the relative amount of Rab8 that was pulled-down using 
GSH-Sepharoase beads bound with GST-OCRL-RBD from the lysate of double KO, GRAB KO and control cells 
treated with LPS over a 60 min time course. Repeat activation assays of untreated and 15 min LPS treatments 
was used for quantification. Levels of active Rab8 were quantified by using the densitometric ratio between the 
band intensities of captured Rab8 and GAPDH. Significance was measured using via two-way analysis of variance 
(ANOVA) (*P<0.05, **P<0.01, n= 3). 
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Analysis of Rab8a membrane localisation and retention in the GRAB and Rabin8 
double knockout cells 
Now, with a cell line depleted of both Rab8 GEFs, I next examine whether Rab8 
localisation and membrane association is impacted in these cells. Confocal live cell 
imaging was performed on LPS-treated double KO and control cells transiently 
transfected with GFP-Rab8a. Initial observations showed no striking morphological 
difference between the double KO and control cells, akin to imaging of the single KO 
cells (see Figure 5.6) where GFP-Rab8a still localises to surface ruffles and is 
enriched on early macropinosomes and resulting tubules. Thus, th e localisation of 
GFP-Rab8a in the double KO cells was similar to control cells (Figure 6.3A). As an 
additional assessment to measure Rab8a membrane retention, I tracked GFP-Rab8a 
positive macropinosomes in both the control and double KO cells and measured the 
time GFP-Rab8a spent enriched on these membranes. Quantification demonstrated 
no significant change in GFP-Rab8a membrane retention and enrichment on 
macropinosomes between the double KO and control cells (Figure 6.3A graph). Even 
after the deletion of both GRAB and Rabin8, GFP-Rab8a localisation, recruitment and 
enrichment on membranes remained unaffected.  
 
As these results were obtained by visualising overexpressed recombinant GFP-
Rab8a, I wanted to assess the membrane association of endogenous Rab8 in these 
double KO cells as an additional confirmation of this result. To do th is, I performed a 
membrane fractionation assay (see Materials and Methods) in which LPS-activated 
cells were mechanically lysed for preparation of post-nuclear supernatants which were 
centrifuged to obtain total membrane and cytosol fractions. Gels and Western blots 
show actin and flotillin as cytosol and membrane markers respectively and reveal that 
Rab8 is found mostly in membrane fractions compared to cytosol, and the relative 
membrane amount is similar across control and double KO cell fractions (Figure 6.3B). 
Therefore, Rab8 membrane recruitment and retention appear to be independent of 
both GRAB and Rabin8.  
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Figure 6.3. Neither Rabin8 nor GRAB controls Rab8 membrane recruitment, localisation or enrichment in 
macrophages. (A) Live cell confocal spinning disc imaging of LPS-treated double KO and control cells 
overexpressing GFP-Rab8a showing recruitment to macropinosomes and tubules. Quantification of Rab8a 
retention on macropinosomes was measured by the number of timeframes Rab8a is spent enriched on each 
macropinosome prior to tubulation or dissociation. 5 cells of each cell line were used for the quantifications (n=5). 
Scale bars, 10µm. (B) Control RAW 264.7 and Double KO cells were treated with LPS (30 min) and a membrane 
fractionation assay was performed. The resulting membrane and cytosolic fractions from both cell -lines were 
analysed by immunoblotting. Immunoblots showing the relative levels of Rab8 in both fractions a long with the 
soluble and membrane markers GAPDH and flotillin respectively with β-actin as a loading control.  
 
GRAB and Rabin8 both contribute to GTP-Rab8a-mediated Akt signalling. 
I next assayed Rab8a mediated LPS/TLR signalling in the double KO cells. Over an 
LPS time course, the double KO cells display reduced levels of phosphorylated Akt 
compared to control cells, and quantification revealed that this is a significant decrease 
at the peak times (15 and 30 min) of Akt activation (Figure 6.4A). I also measured the 
phosphorylation of signalling kinases downstream of Akt, including the proline-rich Akt 
substrate of 40kDa (PRAS40) and the mTOR substrate p70S6 kinase (Figure 6.4B) 
(Luo and Wall et al. 2014). Both kinases showed reduced levels of phosphorylation in 
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double KO cells and these reductions were also significant according to the 
quantification of both proteins over three experiments (Figure 6.4B graph). There was 
no significant change in phospho-ERK by comparison, which supports previous results 
indicating that Rab8 is not a major contributor to TLR-associated ERK1/2 
phosphorylation (Wall and Luo et al. 2017). Thus, the double KO cells indeed show 
clear changes in LPS-induced TLR4 signalling. 
 
 
Figure 6.4. Loss of both GRAB and Rabin8 perturbs Rab8a-associated TLR signalling. Control and Double 
KO cells were treated with LPS over a 60 min time course and the samples were analysed for levels of 
phosphorylation of key signalling substrates. Representative immunoblots of the phosphorylation levels of (A) Akt 
(Ser473) and (B) p70S6K (Thr389) and PRAS40 (Thr246). Quantification of immunoblots was performed using the 
densitometric ratio between the band intensities of phosphorylated proteins and GAPDH. The gels are 
representative, and significance was measured via two-way analysis of variance (ANOVA), (*P<0.05, **P<0.01, 
****P<0.0001, n= 3 each). 
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To ensure these signalling changes are specifically due to the loss of GRAB and 
Rabin8 function, I reintroduced GFP-tagged versions of both proteins into the double 
KO cells by transient co-transfection and the expression of GFP-GRAB and GFP-
Rabin8 in these rescue cells was confirmed by Western blot (Figure 6.5). The double 
KO cells were transfected with GFP alone as a negative control (Figure 6.5). Akt 
signalling was measured after LPS activation (15 min) and i t demonstrates increased 
phosphorylation of Akt in the rescue cells compared to the controls. This confirms that 
reduced TLR4 signalling in the double KO cells is specifically due to the loss of 
GRAB/Rabin8. We can now conclude that Rab8a function in this TLR signalling 
pathway requires both GRAB and Rabin8 as GEFs, for optimal Rab8a activation and 
signalling.  
 
 
Figure 6.5. Reintroduction of both Rabin8 and GRAB recovers LPS-induced Akt phosphorylation in double 
KO macrophages. (A) Double KO cells were transiently transfected with either an empty GFP construct (Control) 
or co-transfected with GFP-Rabin8 and GFP-GRAB and treated with LPS (15 min). Immunoblots comparing the 
levels of phosphorylated Akt and ERK1/2, along with Rabin8, GRAB, GFP and GAPDH between control and rescue 
double KO cells. 
Visualising signalling through Akt enrichment on macropinosome membranes 
In order to pinpoint the location of Rab8a-PI3K-mediated signalling and to further test 
the involvement of GRAB and Rabin8, I introduced an image-based method to 
visualise Akt membrane recruitment in response to receptor activation. The 
recombinant TagRFP-hAkt1 reporter (Norris and Yang et al. 2017) introduced 
previously can be used to pinpoint sites of Akt enrichment in response to receptor 
signalling (Figure 6.6A). I transfected cells with TagRFP-hAkt1 to perform live-cell 
spinning-disc imaging. Based on initial experiments, I co-transfected cells with soluble 
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GFP as a marker of the cytosol, to discriminate between soluble and membrane-bound 
TagRFP-hAkt1. The representative images of live-cell microscopy on LPS-treated 
macrophages depicts overlapping pools of cytoplasmic TagRFP-hAkt and soluble 
GFP (Figure 6.6B). In addition, TagRFP-hAkt is enriched around macropinosomes at 
the leading edge of the cell (inset). By simultaneous capture of both RFP and GFP 
channels, a ratiometric heat map of the TagRFP-hAkt labelling relative to the GFP 
background was produced, highlighting the most intense staining due to specific 
enrichment of the Akt probe on the macropinosome membranes, compared to other 
sites in the cell. This provides new evidence to support earlier findings from our group 
indicating that macropinosomes are signalling centres in activated macrophages (Wall 
and Condon et al. 2018).  
 
 
Figure 6.6. Optimisation of imaging protocols for demonstrating live cell Akt enrichment on 
macropinosome membrane domains. (A) Schematic of TagRFP-hAkt1 probe used to visualise Akt enrichment 
on signalling membranes. (B) Image from confocal live cell imaging of an LPS-treated RAW 264.7 cell co-
expressing TagRFP-Akt1 and soluble GFP. Using GFP as a soluble protein marker, a ratio metric ‘heat-map’ was 
generated by dividing the RFP signal over GFP, which allows for a clearer visualisation of Akt membrane 
enrichment on macropinosomes (inserts) as an analysis tool. 
 
Rab8 GEFs are involved in Akt signalling on macropinosomes 
The TagRFP-hAkt1 reporter was then used to bridge Akt signalling to GTP-Rab8a-
mediated complexes downstream of TLRs. Live cell imaging was performed on the 
double KO and control cells after transient co-expression of GFP and the TagRFP-
hAkt1 reporter. Cells were imaged untreated and then activated with LPS to continue 
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live cell imaging of the same cells with simultaneous capture of both RFP and GFP 
channels. In the absence of LPS, small flashes of TagRFP-hAkt1 appeared randomly 
and continuously over the plasma membrane indicating basal cell signalling activity. 
Both control and double KO cells performed constitutive macropinocytosis which was 
captured in the imaging with some enrichment of TagRFP-hAkt1 to the 
macropinosomes (not shown).  
 
Upon LPS activation, macropinocytosis was upregulated in both control and KO cells. 
The LPS treated control cell demonstrated enrichment of TagRFP-hAkt1 (at 105s) 
upon closure of the macropinosomes (Figure 6.7, left panels). Following 
macropinosome closure, the Akt signal is lost indicating the inherent dynamism and 
duration of the signalling period. In double KO cells, the macropinosomes still form 
(over a 120s interval, Figure 6.7, right panels); however, a significantly reduced 
proportion of macropinosomes show enrichment of TagRFP-hAkt1 (Figure 6.7, graph). 
Notably, the flashes of Akt are still present in the cells as confirmation of the reporter 
activity. This result shows that the control and double KO cells have similar levels of 
basal Akt reporter activity. Counting macropinosomes under these conditions in both 
cell types confirmed that there is a significant loss of TLR-mediated Akt enrichment on 
macropinosomes in the double KO cells. This finding agrees with previous biochemical 
analysis that demonstrated a reduction in Akt phosphorylation in the double KO cells 
in response to LPS (Figure 6.4A). Here I confirm through live-cell microscopy that 
Rab8a-controlled Akt signalling is occurring on macrophage macropinosomes, 
denoting these cellular compartments as important sites for TLR and Rab8a-mediated 
signalling.  
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Figure 6.7. The Rab8 GEFs GRAB and Rabin8 jointly controls TLR-associated Akt immune signalling on 
macrophage macropinosome membranes. Control and Double KO cells were transiently co-transfected with 
C1-GFP and TagRFP-T-Akt1 and live cell spinning disc confocal microscopy was performed. A ratiometric ‘heat 
map’ of Akt intensity was generated by using the ratio of TagRFP-Akt1 signal intensity to the soluble GFP to identify 
regions of Akt membrane enrichment. The cells were imaged with and without LPS. Macropinosomes with Akt 
enrichment were counted as number of events per cell, expanded panels show examples of macropinosomes 
observed with and without Akt enrichment in the control and Double KO cells respectively. Movies were taken over 
15 min with 5 sec intervals and quantification was performed by counting the number of Akt enriched 
macropinosomes observed per cell over a sample of 5 cells for each cell line. Significance wa s measured via 
Student’s t-test. (*P<0.05, **P<0.01 and n= 5 cells). Scale bars, 10µm. 
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Discussion 
In this chapter, the roles of two Rab8 GEFs, GRAB and Rabin8, were examined for 
their possible involvement in Rab8a-mediated signalling downstream of TLR4/LRP1. 
Previous work in our group revealed that this pathway activates Rab8a to recruit the 
effector PI3K, which in turn modulates membrane lipids for the recruitment and 
enhanced activity of signalling kinases, Akt and mTOR (Luo and Wall et al. 2014). 
Ultimately, this signalling is important for driving a biased cytokine response to 
downregulate inflammation.  
 
The experiments here first tested the loss of individual GEFs, GRAB or Rabin8 in 
CRISPR KO cell lines. However, LPS-induced signalling assayed in these KO cell 
lines showed no differences compared to control macrophages. This was surprising, 
given that previous results revealed a decrease in LPS-induced Rab8a activation in 
both KO cell lines (Figure 5.3). Thus, by this measure, both GRAB and Rabin8 have 
GEF activity towards Rab8 in macrophages, but this might be for Rab8 functions 
unrelated to TLR signalling. The next approach then involved making a CRISPR 
double KO line, using the GRAB KO as a background for additional deletion of Rabin8. 
This was successful and double KO lines were produced which show no detectable 
expression of either GEF (Figure 6.2).  
 
When the double KO line was assayed, there was, pleasingly, a step wise reduction 
in Rab8 activation from the single to the double loss of GEF expression. The GRAB 
and Rabin8 double KO had significantly less activation of Rab8 and also reduced basal 
activation in unstimulated cells. The signalling results also showed, now, a clear 
change in the phosphorylation of Akt, PRAS40, p70S6K in response to LPS (Figure 
6.4). These changes implicate GRAB and Rabin8 as drivers of Rab8 activity upstream 
of TLR-associated Akt and mTOR signalling. In the past we have shown that Rab8 
and PI3K influence the LPS induced phosphorylation of Akt and of mTOR (Luo and 
Wall et al. 2014, Wall and Luo et al. 2017). Previous studies have shown that Rab8a-
recruited PI3K goes on to bias the synthesis and secretion of pro- and anti-
inflammatory cytokines through Akt/mTOR. Although cytokine responses remain to be 
measured directly, we predict that the double KO of GRAB and Rabin8 would similarly 
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alter the cytokine output from LPS-induced macrophages by driving pro-inflammatory 
cytokine production resulting in a hyper inflammatory status.  
 
The reintroduction of both GFP-GRAB and GFP-Rabin8 in the double KO cells 
rescued the phosphorylation of Akt in response to LPS, confirming that this phenotype 
is specifically due to the loss of these proteins (Figure 6.5). These results demonstrate 
that GRAB and Rabin8 are indeed GEFs for Rab8a in the TLR signalling pathway. 
GRAB and Rabin8 may additionally have roles in other Rab8-mediated cellular 
functions which may contribute to the basal levels of Rab8a activation seen in these 
cells.  
 
A notable factor in these experiments is that only the double KO of both GEFs 
produced a measurable change in Rab8 mediated TLR signalling, while the loss of 
either GEF alone did not impair Akt signalling. In other cell types, studies have mostly 
assayed trafficking roles of Rab8 where knockdown or knockout of a single GEF had 
a measurable effect. More specifically, knockdown or mutagenesis of Rabin8 had a 
considerable impact in ciliogenesis or neurite outgrowth (Chiba and Amagai et al. 
2013, Homma and Fukuda 2016). Furthermore, another study demonstrated that 
knockdown of GRAB reduced axon outgrowth in mouse neuron cells (Furusawa and 
Asada et al. 2016). A possible explanation for this difference could be in the relative 
amount of Rab8 activation required for trafficking versus signalling functions. Vesicle 
trafficking may be readily perturbed by loss of a single GEF because it requires a near 
maximal level of active Rab to recruit effectors for large scale vesicle deployment or 
movement. Our live imaging highlights that TLR-mediated Akt signalling occurs in very 
short local bursts upon PI3K recruitment, and this may require only small local levels 
of active Rab8a. Consequently, knockout of both GEFs was necessary to perturb 
active Rab8 below activation threshold. This is also consistent with the stepwise levels 
of GTP-Rab8 recovered after single and double GEF KO (Figure 6.2B). The effects of 
GRAB and Rabin8 are most likely to be additive, rather than compensatory since there 
was no change in the protein levels of either GRAB or Rabin8 in response to the 
opposite knockdown (Figure 6.1). This observation hints to a functional overlap 
between GRAB and Rabin8, jointly regulating Rab8a TLR-signalling in macrophages.  
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Following Rab8a activation is signalling through the Akt/mTOR pathway for cytokine 
modulation through the effector PI3K. The serine/threonine kinase Akt promotes cell 
survival and proliferation, and it has long been studied for its association with various 
diseases such as cancer and diabetes (Manning and Cantley 2007). In our studies, 
Akt emerges as an important signalling kinase during TLR-activation in macrophages 
(Luo and Wall et al. 2014); where it is recruited and signals from upon TLR activation 
is poorly understood. In macrophages, Akt signalling is difficult to detect since it occurs 
at low levels and is very dynamic. Whereas in Cos-7 cells for example, endogenous 
Akt can be readily immunostained all over the plasma membrane in response to EGF 
receptor activation (Wang and Wu et al. 2006). Similarly in adipocytes, insulin 
stimulation induces marked recruitment of Akt to the plasma membrane where it can 
be detected by membrane fractionation (Carvalho and Eliasson  et al. 2000). David 
James and James Birchfield at the University of Sydney designed an Akt reporter that 
allows detection of Akt in live cells, which they used to demonstrate dramatic and 
dynamic oscillations of insulin-induced Akt recruitment to the plasma membrane in 
3T3-L1 adipocytes (Norris and Yang et al. 2017). By utilising this fluorescent Akt1 
reporter, I was able to detect and localise TLR-driven Akt recruitment in live 
macrophages for the first time (Figure 6.6B). Unlike the sustained Akt responses to 
EGF and insulin (Norris and Yang et al. 2017), our live imaging showed very small 
focal flashes of Akt on macrophage plasma membranes and forming 
macropinosomes. The live imaging showed that macropinosomes internalising from 
the cell surface are a key site for TLR-induced Akt and this was further confirmed by 
loss of Akt labelling in double GEF KO cells. Moreover, this data corroborates earlier 
findings from our group using a Rab8a FRET biosensor to show that Rab8a is indeed 
activated on macropinosome membranes (Wall and Condon  et al. 2018). Together 
these findings place a firm focus on the early macropinosome as a key site for 
GRAB/Rabin8/Rab8a-mediated Akt signalling in response to TLR4 activation in 
macrophages.  
 
Here, I define a newly found joint function of GRAB and Rabin8 in regulating 
macrophage TLR-associated Akt signalling on macropinosome membranes through 
controlling Rab8 activation. I describe an expansion of the Rab8a complex that 
participates in TLR signalling in macrophages by identifying the GEFs, GRAB and 
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Rabin8, as modulators for activating Rab8a in this context (Figure 6.8). These findings 
highlight the mechanistic importance of Rab regulation in modulating macrophage 
responses in infection and inflammation.  
 
 
Figure 6.8. TLR4-associated Rab8a activation and signalling is jointly regulated by the GEFs GRAB and 
Rabin8. The new proposed TLR4-LRP1-Rab8a signalling pathway. This introduces the Rab8 regulatory GEFs, 
GRAB and Rabin8, as activators of Rab8a for the recruitment of PI3Kγ, and can now be regarded as new 
components of the LRP1-Rab8a complex. Based on findings in this project, I propose that upon GEF-driven 
activation of Rab8a, PI3K phosphorylates and converts PI(4,5)P2 to PI(3,4,5)P3 on macropinosome membranes 
for the recruitment and phosphorylation of Akt, facilitating a biasing of downstream immune signalling and cytokine 
secretion towards an anti-inflammatory state. 
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7. Results 4 
Introduction 
Rab8 is a ubiquitous and multifunctional GTPase that is able to interact with numerous 
effectors (Peränen 2011). Therefore, regulatory mechanisms are needed to 
discriminate between these effectors to ensure the appropriate Rab-effector 
interaction takes place to elicit a desired function. A key part of this regulatory 
machinery controls the recruitment and activation of the Rab GEF on relevant 
membrane domains, which in turn, dictate the spatio-temporal activation of the Rab 
for location and context specific effector recruitment (Müller and Goody 2018). In the 
previous chapters, I identified two Rab8 GEFs, GRAB and Rabin8, which jointly 
contribute to modulating Rab8 activation and its downstream effector, PI3K, for TLR4-
associated signalling on macropinosome membranes. Identifying the proteins involved 
in the recruitment and activation of these Rab8 GEFs, would further expand the 
regulatory network controlling TLR4-Rab8a-PI3K signalling in macrophages. 
Through recent collaborations with the Guo Laboratory (University of Pennsylvania), 
we have access to Rabin8 constructs and studies from the Guo group provide insights 
into Rabin8 activation that might be relevant in our context (Wang and Ren et al. 2015). 
Therefore, the experiments in th is chapter have a refined focus on Rabin8 and on 
identifying potential regulatory partners for this particular Rab8 GEF in LPS activated 
mouse macrophages.  
 
One known mechanism for regulating GEF activity and specificity is through kinase 
driven phosphorylation of serine and/or tyrosine residues near the GEF domains of 
these proteins, which can either promote or inhibit their interactions with their cognate 
GTPase (Cherfils and Zeghouf 2013, Patel and Karginov 2014, Kulasekaran and 
Nossova et al. 2015). Wei Guo and colleagues demonstrated that Rabin8 exists in an 
auto-inhibited state, which can be relieved via the phosphorylation of four serine 
residues (16, 19, 247 and 250) adjacent to its functional GEF domain. Phosphorylating 
these residues causes Rabin8 to enter an ‘open’ state allowing Rab8 to interact with 
its GEF domain (Wang and Ren et al. 2015). Furthermore, ERK1/2 was identified as 
the kinase responsible for phosphorylating these residues to activate Rabin8 during 
EGF signalling and functionally ERK1/2 phosphorylation was found to influence Rab8-
associated transferrin recycling in retinal pigment epithelial cells (Wang and Ren et al. 
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2015). Given that ERK1/2 is also markedly activated in LPS-treated macrophages 
(see Figure 4.2), I set out to examine if ERK1/2 could be likewise responsible for 
activating Rabin8 GEF activity to facilitate TLR4-Rab8a signalling. Therefore, 
preliminary studies described here used an ERK1/2 inhibitor and our GEF KO cells in 
signalling experiments.  
 
Another important regulatory mechanism for modulating GEF function is through the 
specific and targeted recruitment of these proteins to the appropriate membrane 
domains for Rab activation. While GEFs can be targeted individually to membranes, 
an emerging concept is that of Rab cascades, whereby the GEF of on e Rab is 
recruited as an effector of another upstream Rab (Mizuno-Yamasaki and Rivera-
Molina et al. 2012). Having such cascades involved in trafficking and signalling on 
macrophage membranes is an attractive but yet unproven concept, since sequences 
of multiple Rabs are known to be recruited for the formation of macropinosomes and 
phagosomes (Egami and Taguchi et al. 2014, Yeo and Wall et al. 2016). The 
intervening GEFs could quite nicely coordinate these GTPase arrays. For instance, 
Rab13, is largely recruited and localised to macrophage surface ruffles and is 
responsible for the formation of large LPS-induced macropinosomes (Condon and 
Heddleston et al. 2018). Rabs 8 and 13 are related as members of the Rab8 subfamily 
and they share some regulatory proteins. The studies shown in this chapter explore 
the relationship between Rabs 8 and 13 on macropinosome membranes. 
Furthermore, a new unbiased screen for novel Rabin8 binding partners was conducted 
and one of the binding partner candidates emerging from this work raises the spectre 
of having an unconventional linker that coordinates the activities of Rabin8, Rab8 and 
Rab13.  
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Results 
Investigating kinase mediated activation of Rabin8 in macrophages  
Using a mitogen-activated protein kinase 1 (MEK1) inhibitor, U0126, which prevents 
the phosphorylation and activity of the downstream serine/threonine kinase ERK1/2, 
Wang and colleagues demonstrated reduced Rabin8 GEF activity after EGF 
stimulation of HeLa cells (Wang and Ren et al. 2015). In order to examine and optimise 
the inhibition of ERK1/2 phosphorylation in macrophages, a dose response test of 
U0126 was performed on LPS-treated RAW 264.7 cells. RAW 264.7 cells were pre-
treated for 1 hr with the appropriate concentration of U0126 or DMSO and stimulated 
with LPS (30 min). The cells were lysed, and extracts were examined by Western blot 
analysis using a phospho-specific ERK1/2 antibody. The results show potent and 
complete inhibition by U0126 and at 10µM, U0126 completely abolishes ERK1/2 
activation even in the presence of LPS (Figure 7.1A), which matches the working 
concentration utilised in other studies (Hotokezaka and Sakai et al. 2002, Wang and 
Ren et al. 2015). Given the importance of ERK1/2 in multiple essential cell survival 
pathways, the cytotoxicity of U0126 on RAW 264.7 was tested to see if acute treatment 
would affect macrophage survivability and metabolism using an MTT cell viability 
assay. Dose dependent treatments were performed on RAW 264.7 cells for over 4hrs 
and the results showed that treatment with any of the U0126 doses tested did not 
appear to affect cell viability (Figure 7.1B). With the working concentration of U0126 
now established at 10µM, I next wanted to assess the effects of ERK1/2 inhibition on 
LPS-associated Rabin8 GEF function. 
 
A Rab8 activation assay was performed over a 60 min LPS time course with RAW 
264.7 macrophages treated with either DMSO (control) or U0126 (10µM). As 
expected, U0126 abolished ERK1/2 phosphorylation in both the untreated (time 0 min) 
and LPS-induced samples (Figure 7.1C). Despite this, U0126 had little or no effect on 
Rab8 activation across the time course (Figure 7.1C), particularly at the peak time 
point, where earlier results showed that Rabin8 KO did reduce Rab8 activation (see 
Figure 5.5A). This preliminary result suggested that ERK1/2 may not be involved in  
activating Rabin8 for its GEF activity in response to LPS. Independently, we decided 
to assess whether ERK1/2 is required for Rab8-mediated signalling in the LPS treated 
macrophages.  
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I next tested U0126 treatment on LPS/TLR4-induced signalling in RAW cells. In 
addition, I made use of the GEF KO cell lines produced and used for signalling assays 
in Chapters 4 and 6. Based on the earlier finding that Akt signalling was reduced in 
the double KO cells (see Figure 6.5), here, I coupled the GRAB KO cells with the 
U0126 inhibitor to see if this produces an effective ‘double KO’ result. Control and 
GRAB KO cells +/- LPS (15 min) were treated with either DMSO or U0126 (10µM) and 
Western blots were used on the cells lysates to observe changes in Akt 
phosphorylation as a read out of Rab8-PI3K signalling. Repeated experiments 
produced quantitative data showing that LPS-induced Akt phosphorylation was 
unaffected by loss of GRAB alone (as expected) or by ERK1/2 inhibition, alone or in 
combination with GRAB KO (Figure 7.1D). From these results, it appears that the 
MAPK, ERK1/2, while important for regulating Rabin8 GEF activity in other cell types, 
is not involved in activating Rabin8 for Rab activation nor for regulating Akt signalling 
in response to LPS in macrophages.  
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Figure 7.1. The MAP kinase ERK1/2 does not regulate Rabin8-Rab8a associated TLR-signalling. (A) RAW 
264.7 cells were treated with either vehicle (DMSO) or varying concentrations of U0126, ranging from 1µM to 20µM, 
before being incubated with LPS (100ng, 30min). Immunoblotting was performed on the resulting cell extracts and 
analysed for ERK1/2 phosphorylation and total AKT levels. (B) Graph showing the results of an MTT cell viability 
assay performed to test the effects of varying concentrations of the ERK1/2 inhibitor U0126 on the RAW264.7 
macrophage cells. Relative cell survival was quantified using the untreated cell samples as the baseline. (C) 
RAW264.7 cells treated for 1hr with either vehicle (DMSO) or 10µM U0126 before being subjected to a 60-minute 
time course of LPS and the cell extracts were analysed for Rab8 activation, as well as, ERK1 /2 (Thr202/Tyr204) 
phosphorylation  and GAPDH. Graph quantifying the relative band intensity of GTP-bound active Rab8 recovered 
from the Rab8 activation pull-down via ratiometric analysis between the levels of Rab8 in the pulldown sample 
against total Rab8 from the input. Result is representative of one experiment. (D) Control and GRAB KO cells were 
treated with LPS and the samples were analysed for levels of phosphorylation Akt. Quantification of immunoblots 
was performed using the densitometric ratio between the band intensities of phosphorylated Akt and GAPDH (n=3). 
The gels are representative, and significance was measured via two-way analysis of variance (ANOVA). 
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Due to both these early negative results for ERK1/2 and time constraints for the 
project, the ERK1/2 studies were not pursued further. However, we propose that an 
alternative kinase is responsible for phosphorylating Rabin8 in macrophages, since 
relieving the auto-inhibition of Rabin8 is likely to be a ubiquitous requirement for its 
GEF activity. I attempted to examine the serine phosphorylation of Rabin8 in LPS 
treated cells using immunoprecipitation and a pan phospho-serine antibody. 
Unfortunately, this antibody was of no use in this context and future studies will need 
to measure Rabin8 serine phosphorylation using alternative approaches.  
 
Identification of a new Rabin8 binding partner in mouse macrophages  
The Guo group provided us with their GST-tagged Rabin8 constructs in the pGEX-
6P1 bacterial expression plasmid. These included a phospho-mimic mutant (S to D, 
serine to aspartic acid) and a phospho-deficient mutant (S to A, serine to alanine) to 
represent and mimic the active ‘open’ and inactive ‘closed’ states respectively, along 
with a wild-type construct (Wang and Ren et al. 2015). The availability of these 
reagents suggested another approach for examining Rabin8 activation, namely, use 
of pull-downs with the phospho-mimetic Rabin8 to identify activating or recruiting 
binding partners.  
 
Using the phospho-mimic Rabin8 construct as bait, I performed a pull-down 
experiment using the lysate of LPS-treated (30 min) iBMMs. As with the previous 
experiments identifying GRAB as a Rab8a binding partner (see Figure 4.4), the use of 
iBMMs for this pull-down as opposed to primary BMMs was to satisfy the need for the 
large number of cells required. Briefly, LPS-treated (30min) iBMM whole cell extracts 
were applied to Sepharose beads bound with either GST alone or the GST-Rabin8 
mutant construct (phospho-mimic). The bound samples were eluted via GST cleavage 
using a PreScission Protease protocol as described in previous chapters (GE 
Healthcare Life Sciences). Mass spectrometry analysis was then performed on the 
resulting eluant to identify both known and novel binding partners and the resulting 
peptides aligned with a number of known Rabin8 interacting partners including Rab8a 
and Rab8b, along with Rab11 (Vetter et al. 2015), indicating that the pull-down was 
indeed successful (Figure 7.2C). Interestingly, in addition to these known binding 
partners of Rabin8, the results revealed that the inositol polyphosphate 5-
phosphatase, OCRL is also a potential binding partner for the phospho-mimic Rabin8 
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in these macrophages (Figure 7.2). While OCRL is well known to interact with Rab8 
as an effector, (Hagemann and Hou  et al. 2012, Pirruccello and De Camilli 2012), an 
interaction between Rabin8 and OCRL has not previously been reported. 
 
 
Figure 7.2. The Rab effector OCRL is a novel Rabin8 binding protein. RAW 264.7 macrophage lysate was 
used for protein pull-down experiments with GST-tagged Rabin8 (phospho-mimic mutant) and analysed with mass 
spectrometry. (A) The elutes were separated on a 7-15% SDS-PAGE gradient gel, a faint band at 100 kDa 
indicating the presence of a novel Rabin8 binding partner, the multi -Rab effector OCRL which is absent in the GST 
control sample. Table shows the identified peptide sequences of OCRL identified during the analysis with a 5.65 
score, with 3 different peptide chains identified with >95% confidence by the analysis. (B) Schematic of identified 
peptides (in green) over entire OCRL sequence. (C) Example list of identified known Rabin8 interacting proteins 
from the mass-spectrometry analysis. The mass spectrometry score is a measurement of peptide confidence from 
the ProteinPilot scoring algorithm: Score = -log(1-(PercentConfidence/100)). For example, a score of 2 = 99% 
confidence, whereas a score of 4 = 99.99% confidence. %Cov (coverage) refers to the percentage of all identified 
peptide(s) relative to total amino acid sequence, whereas %Cov (50%) and %Cov (95%) refer to peptide coverage 
with 50% and 95% confidence respectively. 
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OCRL localisation in LPS-activated macrophages 
As part of characterising OCRL as a potential binding partner, its localisation in 
macrophages was determined. Live-cell confocal imaging of LPS-treated RAW 264.7 
cells transiently expressing mCherry-OCRL demonstrated that OCRL localising on 
membrane ruffles and macropinosomes (Figure 7.3A). This was further supported by 
a publication from our laboratory, demonstrating that OCRL is indeed located on 
macrophage macropinosomes (Wall and Condon  et al. 2018). 
 
RAW 264.7 cells were then co-transfected with mCherry-OCRL and GFP-Rab8a, and 
the imaging showed strong co-localisation of OCRL with Rab8a on the same 
macropinosomes, indicating that OCRL is spatially and temporally in the right place 
for taking part in a Rab8a-mediated TLR signalling pathway (Figure 7.3B). Co-
transfection of Rabin8 and OCRL was not successful in initial attempts due to the 
difficulty of expressing either or both of these proteins. 
 
Figure 7.3. OCRL is recruited to Rab8a positive macropinosomes. Images taken from live cell confocal imaging 
of an LPS-treated RAW 264.7 cell expressing either (A) mCherry-OCRL or co-expressing (B) mCherry-OCRL and 
GFP-Rab8a. (A) Upon LPS activation, RAW 264.7 macrophage cells have enhanced macropinocytic activity and 
OCRL is found to be enriched on a subset of these macropinosomes (arrows). (B) Simultaneous imaging of both 
OCRL and Rab8a demonstrate that both proteins are present on the same macropinosome membranes related to 
TLR-signalling. Scale bars, 10μm 
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OCRL interacts directly with Rabin8 independently of Rab8 
I next wanted to verify the interaction of the OCRL with Rabin8 in these RAW 264.7 
macrophages. Here GST pull-downs were performed from LPS-treated iBMM extracts 
with phospho-mimic Rabin8 and phospho-deficient Rabin8 mutants and the wild type 
Rabin8 construct. The pull-downs were then blotted for OCRL, which was detected in 
all three pull-downs, but it was dramatically increased in the phospho-mimic Rabin8 
pull-down (Figure 7.4A). The phospho-mimic Rabin8 is essentially an active form that 
binds to the Rab8 GTPase. Therefore, there is a likelihood of having both Rabin8 and 
Rab8 in tertiary complexes, and either could recruit OCRL.  
 
To investigate this further, a pull-down experiment was performed using purified, 
bacterially expressed versions of Rabin8 and OCRL. While using a full-length OCRL 
construct would be optimal for use in this experiment, the size and complexity of OCRL 
made it challenging for bacteria expression. Indeed, many studies expressing full-
length OCRL have utilised insect cells (Sf9 cells) instead of bacteria expression 
systems (Erdmann and Mao et al. 2007, Mao and Balkin  et al. 2009). Therefore, a 
bacterially expressible and codon-optimised OCRL-RBD (OCRL539-901) used in 
Chapter 5 for my activation assays was made with a His-Tag using a different bacteria 
expression vector pOpine (Figure 7.4B and C). This His-OCRL RBD was then applied 
to resin bound GST-Rabin8. Western blot analysis was performed with anti-His 
antibodies, and this served to confirm the presence and binding of His-OCRL to GST-
Rabin8 (Figure 7.4E). This result demonstrates a novel genuine, direct interaction 
between purified proteins, the Rab8 GEF Rabin8 and the multi-Rab effector OCRL, 
that is independent of the GTPase, Rab8.  
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Figure 7.4. OCRL has an enhanced interaction with constitutively active Rabin8. (A) Immunoblot analysis 
was performed on mass spectrometry samples using OCRL-specific antibodies to confirm presence of the protein. 
(B) Illustration of the pOpine (6X)His-MBP-OCRL bacterial expression plasmid. (C) Schematics of the bacterially 
expressed GST-Rabin8 and His-OCRL-RBD constructs. (D) and a commassie stained SDS-PAGE gels showing 
the results of protein expression and purification using TALON® metal affinity resin. (E) Bacteria expressed 
(6X)His-Maltose binding protein-tagged OCRL was loaded onto GST-tagged Rabin8 beads and analysed via 
immunoblotting using OCRL-specific antibodies, demonstrating direct interaction between Rabin8 and OCRL. 
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This finding is intriguing, potentially setting up a scenario where the GEF is in a 
complex with the GTPase and its effector, with all three proteins interacting at some 
point (discussed below). While uncommon, Rab effector-GEF interactions have been 
previously reported, exemplified by an interaction between the Rab5 effector, Rabatin-
5 and the Rab5 GEF, Rabex-5, which form a complex that stabilises active Rab5 on 
endosomes to facilitate fusion (Horiuchi and Lippé et al. 1997). A second consideration 
is that OCRL is a promiscuous effector, known to be recruited by Rab8 and also by 
Rab13. Therefore, a second model might be that an upstream Rab13-OCRL complex 
recruits Rabin8 as a GEF for Rab8 as part of a Rab cascade.  
 
We thus set out to examine the relationship between Rabs 13 and 8 on ruffle and 
macropinosome membranes using live cell imaging on co-transfected cells. LPS-
treated RAW 264.7 cells transiently co-expressing td-Tomato-Rab8a with either GFP-
Rab13 or GFP-Rab5a were imaged (Figure 7.5A). In the movie segment shown in 
Figure 7.5B, GFP-Rab13 is consistently and stably associated with ruffle membranes 
and with macropinosomes forming from them, while tdTomato-Rab8a is gradually 
enriched on the newly forming macropinosome. Therefore, Rab13 is present and 
enriched on the membranes prior to the enrichment of Rab8a and they both overlap 
and co-localise transiently on the new macropinosome. This visually confirms that 
Rab13 would be positioned to recruit proteins prior to Rab8a activation.  
 
Imaging with GFP-Rab5a and tdTomato-Rab8a demonstrated that upon Rab8a 
enrichment on macropinosomes, Rab5a is subsequently recruited to these 
membranes where it replaces Rab8a on maturing macropinosomes (Figure 7.5C). 
Notably, Rab5 is recruited from the cytoplasm, since it is not found on the ruffles. 
Taken together, these results place two GTPases in quick succession before and after 
Rab8a on early stage macropinosomes where my results (see Figures 6.6B and 6.7), 
along with our previous studies indicate that PI3K/Akt signalling occurs in TLR 
pathways (Wall and Condon  et al. 2018). Thus, these Rabs are poised to act in a 
cascade and interestingly all three Rabs have the ability to bind OCRL (Fukuda and 
Kanno et al. 2008).  
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Figure 7.5. Rabs 13, 8a and 5 are sequentially recruited during macropinocytosis in mouse macrophages. 
(A) Schematic of the fluorescent constructs used to visualise the recruitment and localisation of Rab13 and Rab5a 
with Rab8a. (B/C) Representative time lapse images shown here were from live cell confocal images of LPS-
treated RAW 264.7 macrophages co-expressing either (B) GFP Rab13 or (C) GFP-Rab5 with td-Tomato Rab8a. 
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Further studies are now required to further examine the interactions and conjoint 
functions of Rabin8 as part of dynamic and likely multi-functional Rab complexes. 
Other students will now take up projects stemming from the base established by my 
findings.  
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Discussion 
This chapter describes preliminary investigations into the regulators of the Rab8 GEF, 
Rabin8 in mouse macrophage TLR signalling pathways. Two main aspects of Rabin8 
regulation were examined by experiments here, firstly looking at ERK1/2 as potential 
kinases for activating Rabin8 in LPS-activated macrophages. The results discount 
ERK1/2 as Rabin8 activators in this context but set up future studies that can explore 
Rabin8 phosphorylation and seek other kinases responsible for GEF activation. The 
second level of Rabin8 regulation I examined, used an unbiased screen to identify the 
effector and inositol polyphosphate 5-phosphatase, OCRL as a part of a possible 
recruiting mechanism for Rabin8. Excitingly, OCRL could act through a novel effector-
GEF interaction and/or as part of a multi-Rab cascade for recruiting Rabin8. Rab13 
and Rab5 were shown to flank Rab8 on macropinosomes and they could be part of 
such a cascade. While time constraints did not allow me to pursue these studies 
further, my results have established fruitful and interesting findings that will be the 
basis for future studies to elucidate how GEFs contribute to Rab-mediated TLR 
signalling and macropinocytosis.  
 
While the function and regulation of the Rab GTPase family of proteins is important 
and has been well established, the proteins involved in regulating Rabs such as GEFs 
and GAPs are still poorly understood. One fundamental question is how GEF activity 
is regulated to ensure that inappropriate Rab activation does not occur. It has been 
suggested that one common method for hindering or promoting GEF activity is through 
altering the efficiencies for binding to the target Rab, via occluding/exposing its GEF 
binding domain. Indeed, several GEFs including TIM (RhoA GEF) (Yohe and 
Rossman et al. 2007), Rabin8 (Wang and Ren et al. 2015) and intersectin (Cdc42 
GEF) (Kintscher and Wuertenberger et al. 2010) have been reported to exist in 
‘folded’, auto-inhibited states that block GTPase binding. Therefore, interaction with 
various regulators is required for relieving this inhibited state and promoting GEF 
function. For Rabin8, kinase driven activation by ERK1/2 was found to be responsible 
for activating this Rab8 GEF in response to EGF signalling in HeLa cells, producing 
dramatic effects on Rab8 activation (Wang and Ren et al. 2015). Interestingly, while it 
is not known if GRAB naturally exists in an auto-inhibited state like Rabin8, other 
kinases have also been reported to alter its GEF activity (Furusawa and Asada et al. 
2016). Therefore, establishing the kinase(s) responsible for controlling the TLR-
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associated interactions between Rab8 and the GEFs GRAB and Rabin8 would further 
expand our understanding of the regulatory pathways that govern Rab8 macrophage 
immune functions. As a preliminary kinase of interest, I found that inhibition of ERK1/2 
phosphorylation did not affect LPS-induced Rab8 activation or downstream Rab8a 
associated signalling functions (see Figure 7.1). While not empirically tested here, 
other studies have showed that U0126 specifically inhibits ERK1/2 phosphorylation 
and not other kinases such as JNK and p38 phosphorylation (Cohen and Lawrence et 
al. 2010). Future work could systematically test the inhibitors of other kinases known 
to regulate GRAB and Rabin8 GEF functions (see Figure 1.6) and identify those 
involved in TLR associated GEF and Rab8a activation in macrophages. 
 
In addition to modulating Rab nucleotide binding and effector recruitment, GEFs often, 
but not always, help to anchor the GTPase on target membrane domains, thereby 
promoting location-specific function (Grosshans and Ortiz et al. 2006). The precise 
enlistment of the GEFs themselves to the proper cellular compartments plays an 
important role in driving selective Rab-effector functions. With GRAB and Rabin8 now 
confirmed as Rab8 GEFs that function downstream of TLR4, investigating how these 
GEFs are being recruited and activated on macropinosome membranes will  be 
essential to understanding the regulator machinery that controls Rab8 activity in 
macrophages. As mentioned in the introduction chapter, Rab11 is the most well 
characterised recruitment partner for Rabin8 in Rab8 pathways (Knödler and Feng et 
al. 2010, Horgan and Hanscom et al. 2013). However, given its primary association 
with recycling and exocytic complexes (Welz and Wellbourne-Wood et al. 2014), it is 
unlikely that Rab11 is playing a similar role during this particular Rab8a immune 
signalling pathway. Protein pull-down assays with mass spectrometry analysis using 
GST-Rabin8 constructs has identified a novel Rabin8 interacting protein, the multi-
Rab effector OCRL. Further experiments with bacterially expressed proteins have 
proven that this interaction is direct and independent of Rab8. This surprising pairing 
raises two interesting scenarios (Figure 7.6). The first (Rabin8 recruiting OCRL as a 
Rab8a effector), implies that there will be two competing Rab8a effectors present on 
these LPS-induced macropinosomes, PI3K and potentially OCRL. Both effectors 
preferentially act on the same substrate, the phospholipid PI(4,5)P2. PI3K 
phosphorylates it to become PI(3,4,5)P3, while OCRL dephosphorylates it to produce 
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PI(4)P1 (Zhang and Jefferson  et al. 1995, Vanhaesebroeck and Waterfield 1999). 
These phosphoinositides are essential for controlling the signalling and maturation of 
macropinosomes and other endocytic pathways (Bohdanowicz and Balkin et al. 2012, 
Bohdanowicz and Grinstein 2013) and for recruiting signalling kinases such as Akt. If 
validated, this might suggest a dual role for Rab8a in controlling the phosphoinositide 
environment on these signalling membranes, mediating Akt signalling and potentially 
influencing the maturation of the macropinosome, and Rabin8 recruitment of OCRL 
might be an effector recruitment factor that modulates this process.  
 
For the second scenario, our previous studies have iden tified multiple Rabs 
associated with macrophage ruffles and macropinosome membranes, including Rabs 
13, 31 and 5, along with Rab8 (Yeo and Wall et al. 2016, Wall and Luo et al. 2017, 
Condon and Heddleston  et al. 2018). Most notably, Rab13 is implicated in the 
formation of LPS-induced ruffles and the formation of large macropinosomes, 
indicating that this Rab is likely upstream of Rab8 TLR-signalling functions. Live cell 
imaging confirmed this arrangement with Rab13 shown to be localised and enriched 
on macrophage membrane ruffles prior to macropinosome formation and Rab8a 
enrichment (see Figure 7.5B). Being a multi-Rab effector, OCRL is also known to 
interact with Rab13 (Fukuda and Kanno et al. 2008). Therefore, a possible model is 
that OCRL is recruited as an upstream effector of Rab13 where it is poised to 
subsequently recruit Rabin8 to newly formed macropinosomes to facilitate Rab8 
activation (as depicted in Figure 7.6). This scenario establishes a potential Rab 
cascade that links the regulators of macropinocytosis and TLR-signalling pathways. 
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Figure 7.6. Proposed models for a Rabin8-OCRL interaction in macrophages. Proposed models for an OCRL-
Rabin8 interaction in Rab8a-TLR signalling pathways. In the first scenario (left pathway), Rabin8 functions as a 
novel recruiter of the Rab8 effector OCRL to macrophage macropinosome membranes. Upon activation of Rab8a 
by Rabin8, this Rabin8-OCRL interaction is proposed to place OCRL in close proximity to the newly active Rab8a 
for Rab-effector function. In the second scenario (right pathway), with Rab13 known to function upstream of Rab8a 
on macrophage ruffles, OCRL is initially recruited as a Rab13-effector and recruits Rabin8 to macropinosome 
membrane to facilitate Rab8 activation. 
A final piece of the recruitment picture is the relationship of the GEFs and Rab8a with 
the TLR crosstalk receptor LRP1. We know from our earlier studies that LRP1 binds 
to both GDP and GTP-bound Rab8a and LRP1 is needed for LPS-induced Rab8a 
activation (Luo and Wall et al. 2018). This implies that the GEFs may also be recruited 
to a complex scaffolded by LRP1 and unpublished evidence from Lin Luo in the group 
shows that Rabin8 appears in LRP1 pull-downs in macrophages (not shown). Future 
studies will address the full context for the recruitment and activation of both GEFs, 
Rabin8 and GRAB to dynamic and likely complex arrays of proteins that regulate Rab8 
and its effectors for TLR signalling.  
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8. Final Discussion and Future Directions 
Significance and overview 
With inflammation now recognised as a component of an increasing number of chronic 
and acute diseases, it has never been more important to understand the mechanisms 
that control inflammatory cytokines and other mediators. TLR-activated macrophages 
are major contributors to inflammation in many settings including infection and chronic 
disease; TLR pathways are therefore targets for developing new therapeutic strategies 
to modulate inflammation in different diseases and tissues (Zhu and Yang et al. 2014, 
Ullah and Sweet et al. 2016). Alzheimer’s disease and metabolic diseases, such as 
diabetes (melitis, Type I , II) are now known to have major inflammatory components 
that will require new drugs and therapies (Lien and Zipris 2009, Bieghs and Trautwein 
2013, Zolezzi and Inestrosa 2017). TLR pathways are also critical for infection control, 
immune surveillance and pathogen destruction (Kawai and Akira 2005). In this area 
too, new therapies are necessary to counteract antibiotic resistance and new viral and 
bacterial outbreaks. Finally, there are also roles for TLRs in ageing (Lavelle and 
Murphy et al. 2010, Panda and Qian  et al. 2010). TLR signalling pathways contain 
potential drug targets in the form of signalling kinases, GTPases, lipid kinases and 
phosphatases and signalling adaptors.  
 
A major underlying goal for my project was to develop a deeper understanding of the 
TLR signalling machinery. Specifically, this project was focused on the Rab GTPase, 
Rab8a, which had earlier been implicated in signalling and cytokine regulation 
downstream of TLRs by work from our laboratory. The TLR-induced, LRP1-Rab8a-
PI3K-Akt signalling axis emerged from this work, as a key driver of anti-inflammatory, 
M2-like phenotypes in macrophages (Luo and Wall et al. 2014, Wall and Luo et al. 
2017). While my experiments have focussed on mouse macrophages, PI3Kγ has a 
similar effect downstream of TLRs in both mice and humans (Kaneda and Messer et 
al. 2016). Indeed, druggable proteins in this pathway already include PI3K which is 
inactivated by the  specific inhibitor, IPI-549, currently in clinical trials for several 
cancer types (Tolcher and Hong et al. 2016, Sullivan and Hong et al. 2018). Its use 
therein is predicated on in vitro and animal studies which show that loss or inhibition 
of PI3K enhances proinflammatory responses and maintains macrophages in a 
cancer killing, M1 state (Kaneda and Cappello et al. 2016). Early results from these 
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clinical trials confirm enhanced proinflammatory responses resulting from use of the 
inhibitor in human subjects (De Henau and Rausch  et al. 2016). This is reflected in 
other studies using mouse models (Kaneda and Messer et al. 2016) and in 
humans (Takeda and Maher et al. 2019) where PI3K is inactivated through genetic 
ablation or mutation. The application of PI3K inhibitors in cancer for manipulating 
TLR-mediated signalling affirms the importance of these pathways and as potential 
targets in inflammatory disease. This also highlights the significance of my project in 
studying Rab8a as a key recruiter of PI3K in macrophages. The ability to use drugs 
or biologicals to manipulate Rab8a activation will be an interesting prospect for the 
future and one that depends on a deeper understanding of Rab8a activation and its 
GEF activators.  
  
At the outset of my project, the molecules that activate Rab8a in TLR pathways had 
not been identified. Nevertheless, based on other known evolutionarily conserved Rab 
regulatory pathways, there was a likely possibility that one or more GEFs would be 
required for this purpose. The specific goal of my project was thus primarily to finding 
the GEF regulator(s) for Rab8a in TLR pathways. Several approaches were employed 
for this research, including protein pull-downs and mass spectrometry screens, 
CRISPR knockout of proteins, novel Rab activation assays, biochemical analysis of 
cell signalling and the use of fluorescent reporters to visualise real-time signalling 
events in cells. The main outcome of this project was the identification of GRAB and 
Rabin8 as GEFs for Rab8a in TLR signalling. These are two new molecules that I have 
added to the TLR pathway that influence inflammation, thus extending the repertoire 
of potential molecular targets available for future biomedical and pharmacological 
studies. We would expect that specifically targeting GRAB and Rabin8 with inhibitors 
or activators would modulate Akt/mTOR signalling and inflammatory programs. 
Moreover, other studies performed in conjunction with my project explored other 
molecules in this pathway, such as OCRL, that if validated would also be novel 
additions to this signalling axis and provide further opportunities for manipulating 
disease-associated processes. The following sections further discuss the overall 
findings and insights that emerged from my studies along with possible future 
directions. 
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Rab8 activation  
As master regulators of many cellular pathways, mounting evidence has linked the 
aberrant activation of small GTPase family members to the pathogenesis of various 
diseases (Cook and Rossman et al. 2014, Simanshu and Nissley et al. 2017, Banworth 
and Li 2018). As molecular switches, all GTPases cycle between a GTP-bound ‘active’ 
and GDP-bound ‘inactive’ state and alternating between these configurations is critical 
for regulating their function. The ability to reliably detect and quantify the activation of 
specific GTPases in cellular systems is critical for elucidating the identity and role of 
GTPase regulators. Experimental activation assays have been traditionally used to 
assess the GTP-bound status of many subfamilies of endogenous GTPases. One 
approach for such assays is the use of effector binding domains as probes that define 
GTP-bound states of GTPases. For instance, using an assay based on the Ral-binding 
domain of the effector Ral binding protein 1, Chen and colleagues were able to identify 
a Ral GAP complex that regulates RalA activity for insulin-associated Glut4 
translocation to the plasma membrane (Chen and Leto et al. 2011). In another study, 
Koo and colleagues used the CRIB domain of Pak1, a Rac1 effector, to demonstrate 
that Arf6 is recruiting the Rac GEF, kalirin, to facilitate Rac activation on the plasma 
membrane for actin remodelling to generate membrane ruff les and protrusions for cell 
migration (Koo and Eipper et al. 2007). In TLR-Src-associated pathways, a role for 
RhoA was established using the RBD of the RhoA effector rhothekin to show induction 
of RhoA GTP loading (Manukyan and Nalbant et al. 2009). A final example is the use 
of a bead-based system bound with the GTPase effector binding domains of Pak1 
(Rac1 effector), rhotekin (Rho effector), RalGDS (Rap1 effector) and RILP (Rab7 
effector) was to demonstrate GTPases involved in a new multi-GTPase cascade for 
Hantavirus infection in HeLa cells (Buranda and BasuRay et al. 2013). Taken together, 
these examples demonstrate the broad applications of these assays as biological tools 
for investigating the molecular mechanisms that modulate the activation and 
inactivation of GTPases. 
 
As mentioned in chapter 4, there is currently no commercially available Rab8 
activation probe or assay available. Thus, to identify and validate the regulatory Rab8 
GEFs in the macrophage TLR4 signalling complex, I generated three different Rab 
activation probes using the RBDs of known Rab8 effectors: OCRL, MICAL-L2 and 
PI3K. Using an optimised protocol of the OCRL-RBD probe in combination with my 
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CRISPR GEF KO cell lines, I was able to demonstrate a step-wise decrease in Rab8 
activation with the subsequent deletions of GRAB and Rabin8 in macrophages (see 
Figure 6.2B). This assay proved invaluable in validating both Rab8 GEFs GRAB and 
Rabin8 as joint activators of Rab8a during TLR4-signalling in macrophages (Tong and 
Wall et al. 2019). Other uses for this assay have been implemented by our group. For 
instance, we measured Rab8a activation downstream of multiple TLRs in 
macrophages, implicating Rab8a in innate immune responses to a wide range of 
pathogens (Wall and Luo et al. 2017). Future studies could expand the use of the 
assay to examine Rab8a activation in macrophages, or indeed in other cells types, 
under varying infectious or metabolic conditions. We have not tested the efficacy of 
the assay for measuring Rab8a activation in other cell processes where it functions, 
such as vesicle traffic to and from recycling endosomes or apical cell surfaces 
(Peränen 2011) but potentially such applications would also be possible.  
 
In the context of this project, all three probes were only screened and tested for their 
ability to detect Rab8 activation; however, work by Fukuda and colleagues have shown 
that the Rab effectors OCRL and MICAL-L2 can interact with a broader array of 
different Rabs (Fukuda and Kanno et al. 2008). Thus, the assays I set up using probes 
from these proteins could be optimised for examining the activation of additional Rabs 
by blotting the protein pull-down samples with other Rab antibodies. Ultimately, if 
successful these three probes are predicted to have the combined ability to detect the 
activation of Rabs 1, 3, 5, 6, 8, 10, 13, 15, 22, 35 and 36 (Fukuda and Kanno et al. 
2008), along with Ras – effectively establishing a multi-Rab/GTPase activation assay 
for systems analysis. This would allow users to perform screens in parallel for the 
activation of these GTPases in cells responding to specific stimuli.  
 
GEFs in TLR signalling 
TLR signal transduction is comprised of highly complex networks of trafficking and 
signalling pathways which require the precise, sequential recruitment of signalling 
complexes and adaptors to direct and propagate downstream events to elicit tailored 
immune responses (Kawasaki and Kawai 2014). Therefore, it is unsurprising that as 
master regulators of cellular trafficking and signalling pathways, small GTPases and 
their associated GEFs have been implicated in various immune signalling processes. 
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For instance, the RhoA GEF, GEF-H1 has been shown to be activated downstream of 
TLR4 in LPS-treated endothelial cells, and through RhoA, promotes the activation of 
the transcription factor NFB for driving IL-8 expression and secretion (Guo and Tang 
et al. 2012). Another RhoA GEF, protein kinase A anchoring protein 13 (AKAP13), is 
also demonstrated to facilitate NFB function downstream of TLR2 in HEK293 cells, 
resulting in increased IL-8 and monocyte chemoattractant protein-1 (MCP-1) 
expression (Shibolet and Giallourakis et al. 2007). Similarly, in LPS-activated RAW 
264.7 macrophages, TLR4-associated actin-cytoskeleton reorganisation results in the 
activation of Rac1 by its GEF, Cdc42, which enhances phagocytosis (Kong and Ge 
2008). The TLR-induced activation of RhoA by different GEFs suggests this as a 
mechanism for selectively managing a variety of receptor-driven, RhoA-dependent, 
actin-mediated responses such as phagocytosis, macropinocytosis or cell migration.  
 
Previous work by our laboratory identified the small Rab GTPase Rab8a as an 
essential component of a TLR-signalling complex, which ultimately biases cytokine 
output through the signalling kinase PI3K (Luo and Wall et al. 2014, Wall and Luo et 
al. 2017). My findings reported here, identified the Rab8 GEFs GRAB and Rabin8 as 
joint activators of Rab8a that facilitate PI3K effector-mediated TLR-signalling. From 
our previous findings, is it also likely that Rabin8 and GRAB regulate Rab8a/PI3K 
signalling from not only TLR4, but other additional TLRs as well (Wall and Luo et al. 
2017). While neither GRAB nor Rabin8 were observed to influence Rab8a recruitment 
and enrichment on cell membranes in macrophages, these results highlight both 
GRAB and Rabin8 as new members of this regulatory TLR-signalling machinery and 
uncovers a redundant relationship between these GEFs as activators of Rab8a to 
drive specific PI3K-associated TLR-signalling outputs.  
 
For both GRAB and Rabin8, directly influencing Rab8a in a signalling role is unique, 
as previous studies on these GEFs have been more focused on the regulation of 
various Rab8-associated trafficking functions in processes such as ciliogenesis (Feng 
and Knödler et al. 2012), growth of axons in neuronal cells (Furusawa and Asada et 
al. 2016, Homma and Fukuda 2016) and the polarised transport of cellular 
components/vesicles (Hattula and Furuhjelm et al. 2002). Furthermore, at other times 
when Rab8 has been shown to influence receptor signalling, it was through controlling 
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the trafficking and localisation of the receptor itself rather than downstream signalling 
kinases (Nagabhushana and Chalasani et al. 2010, Esseltine and Ribeiro et al. 2012, 
Finetti and Patrussi et al. 2015). In saying this, during the course of my PhD, another 
surprising Rab8 GEF was identified associated with TLR trafficking (Sellier and 
Campanari et al. 2016), namely, a trimeric protein complex containing chromosome 9 
open-reading frame 72 - Smith–Magenis syndrome chromosome region candidate 8 - 
WD repeat domain 41 (C9ORF72-SMCR8-WDR41).  
 
First identified from genetic abnormalities observed in patients with amyotrophic lateral 
sclerosis (ALS) and fronto-temporal dementia (FTD), this C9ORF72-SMCR8-WDR41 
complex has been mostly tied to endosomal trafficking pathways, particularly during 
the stages involving lysosome fusion and function (Sullivan and Zhou  et al. 2016). 
Structural studies of the components in this complex have discovered that two of the 
proteins, C9ORF72 and SMCR8, contain Rab GEF DENN domains (Zhang and Iyer 
et al. 2012, Levine and Daniels et al. 2013). A preliminary in vitro nucleotide exchange 
assay using purified recombinant proteins demonstrated that Rab8a GTP-release was 
enhanced by the addition of C9ORF72 alone or in complexes with  SMCR8 and WDR4 
(Sellier and Campanari et al. 2016). Taken together, these studies highlight a rather 
uncommon phenomenon where a structurally unrelated DENN domain GEF is able to 
facilitate nucleotide exchange in Rab8a, instead of a typical Sec2 GEF such as GRAB 
or Rabin8 (Ishida and Oguchi et al. 2016). This opens up potential possibilities for 
novel GEF-Rab interactions, suggesting that different subfamilies of GEFs are able to 
cross-activate previously unrelated Rab GTPase subfamilies. To validate this, protein 
crystallisation and structural studies will be required to further investigate how Rab8a 
interacts with this new GEF complex for facilitating nucleotide exchange. 
 
Of particular relevance to this project, the C9ORF72-SMCR8-WDR4 complex was 
also linked to TLR-signalling, by evidence demonstrating that inactivation of one or 
more of these proteins resulted in increased endosomal TLR-signalling and excessive 
inflammatory cytokine output (McAlpine and Sun  et al. 2018). The authors attribute 
this finding to activation of Rab8 for TLR receptor trafficking (reduced degradation) 
suggesting that multiple GEFs could activate Rab8a for different roles in TLR 
trafficking and signalling. It is worth noting that none of the components of this 
C9ORF72-SMCR8-WDR41 complex were identified in GST-Rab8a pull-downs and 
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mass spectrometry in LPS-treated BMM cell lysates (performed in Chapter 4). 
Furthermore, TLR-PI3K-associated Akt signalling observed in our double KO (GRAB 
and Rabin8) cells mimicked the levels of signalling previously seen in the Rab8a KO 
cells (see Figures 6.4A and 4.2A). Thus, it is unlikely another Rab8a GEF, other than 
GRAB and Rabin8, is influencing Rab8a-PI3K signalling in this context. The TLR-
induced deployment of multiple GEFs for Rab8, Rabin8, GRAB versus C9ORF72-
SMCR8-WDR41, is analogous to the recruitment of multiple RhoA GEFs discussed 
above and it illustrates how small GTPases are used in various roles for carefully 
controlled responses elicited in these innate immune pathways.  
 
Rab8 and its GEFs and membrane recruitment in macrophages  
Controlling the precise recruitment of Rabs to the appropriate membrane domains is 
fundamental for driving specific Rab effector mediated functions (Grosshans and Ortiz 
et al. 2006). As mentioned previously, this targeted membrane recruitment of the Rab 
can be orchestrated by a host of different binding partners such as GEFs, GDIs, GAPs, 
as well as escort proteins and prenylation enzymes (Müller and Goody 2018). Of these 
interacting partners, the Rab GEFs have been shown to influence both the recruitment 
and retention of Rabs onto their respective cellular compartments for effector binding 
and function (Cherfils and Zeghouf 2013). This was exemplified by an innovative 
strategy employed by Blumer and colleagues which used recombinant GEFs with  
mitochondrial membrane tags, Rabex-5, DrrA and Rabin8, to mistarget their 
respective Rabs (Rab5, Rab1A and Rab8 respectively) onto mitochondrial 
membranes in order to uncouple the Rabs functionally from their endogenous settings 
(Blümer and Rey et al. 2013). This strategy relied on GEFs with joint responsibilities 
for membrane targeting and activation of the specific Rabs.  
 
In my studies, despite a significant reduction in Rab8 activation observed in the double 
GRAB and Rabin8 KO macrophages (see Figure 6.2B), imaging and biochemical 
approaches showed that Rab8a macropinosome membrane recruitment, enrichment 
and retention remained unaffected by its activation state or by the loss of the GEFs 
(see Figure 6.3). This indicated that in macrophages, Rab8a membrane recruitment 
and retention is independent of both GRAB and Rabin8. Another example in the 
literature demonstrates a similar scenario for the closely related Rab8 family member, 
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Rab13 whose membrane recruitment to vesicles is also independent of its GEF and 
prenylation. This study by Ioannou and colleagues demonstrated that constitutively 
inactive Rab13 or nonprenylated Rab13 mutants were still recruited to endocytic 
vesicle membranes, in keeping with the location of active or wild type Rab13 (Ioannou 
and Girard et al. 2016). This was presumed to occur through overriding protein-protein 
interactions that anchored Rab13 irrespective of its activation state or prenylation. 
Curiously, the relevant Rab13 GEF, DENND2B, was shown  in previous work to be 
required for Rab13 recruitment to the plasma membrane (Ioannou and Bell et al. 
2015). This highlights two different contexts with only one requiring the GEF for Rab13 
membrane recruitment. Thus, my work concurs with such findings in illustrating that 
Rab8 membrane attachment is uncoupled from GEF function and location, at least in 
the context of macrophage ruffles/macropinosomes. Indeed it would be interesting to 
explore Rab13 and DENND2B in macrophage ruffles where its recruitment precedes 
Rab8a (Condon and Heddleston  et al. 2018). 
 
It is thus likely that protein-protein interactions control Rab8 membrane recruitment in 
our macrophage system, with the most obvious candidate being the TLR crosstalk 
receptor LRP1. As mentioned previously, our group has reported that Rab8a is able 
to directly interact with this receptor in a LPS-dependent manner to perform its PI3K-
signalling function (Luo and Wall et al. 2018). Additionally, protein pull-down 
experiments from this study also showed that this Rab8a-LRP1 interaction is 
independent of the activation state of Rab8a, agreeing with observations in the 
Rabin8/GRAB double KO cells (activation independent Rab8 membrane enrichment, 
see Figure 6.3A). Hence, this LRP1-mediated recruitment of Rab8a could could be 
the GRAB and Rabin8 independent recruitment mechanism for Rab8a enrichment on 
macropinosomes observed in LPS-treated double KO macrophages. Future 
experiments can assess possible changes to Rab8a membrane enrichment and 
recruitment in the absence of LRP1 using LRP1 KO RAW 264.7 cells previously 
generated in our laboratory by Dr Adam Wall. Aside from LRP1, other studies have 
demonstrated that Rab8a can also be recruited to other receptor complexes to perform 
functions through trafficking effectors. For instance, Rab8a is recruited to T-cell 
receptors and to cilia sensory receptors (Wang and Morita et al. 2012, Finetti and 
Patrussi et al. 2015) helping to determine the trafficking for those receptor complexes. 
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Live cell imaging on the double KO cells also showed the presence of Rab8a on 
constitutive macropinosomes irrespective of LPS stimulation, indicating that there is 
also at least one other protein-protein interaction that positions Rab8a on 
macropinosome membranes besides through LRP1. Finding additional novel binding 
partners for Rab8a on macropinosomes could be approached in the future by 
performing pull-downs with GST-Rab8a and mass spectrometry analysis on BMM 
lysates (not treated with LPS in this case), as done previously by the group (Luo and 
Wall et al. 2014). Based on the hypothesis that Rab8a is part of a Rab cascade, other 
binding partners could also include upstream Rab effectors or accessory proteins.  
 
The macropinosome is a hub for immune receptor signalling 
As vital components of the innate immune system, macrophages are part of the first 
line of defence against pathogens, distinguished by their ability to rapidly detect foreign 
molecules and elicit robust inflammatory responses. Mediated by immune receptors 
such as TLRs, this surveillance system is dependent on receptor-ligand recognition 
and rapid downstream signalling pathways. While the individual components of TLR-
signalling pathways have been characterised (Kagan and Su  et al. 2008, Kawasaki 
and Kawai 2014), the exact signalling compartments and membrane domains that are 
involved in TLR signalling have yet been fully elucidated (Barton and Kagan 2009). 
Activated TLRs are recruited to and cluster in specific l ipid microdomains that go on 
to form signalling platforms to facilitate receptor signal transduction (Varshney and 
Yadav et al. 2016). Membrane cholesterol levels, and cholesterol-depleting statins, 
can thus influence pro-inflammatory signalling downstream of TLRs (Chansrichavala 
and Chantharaksri et al. 2010). The endosomal compartments housing TLR signalling 
are still not fully defined. 
 
A distinct characteristic of macrophages as immune sentinels is their prodigious 
macropinocytic capacity, which facilitates the indiscriminate uptake and rapid 
sampling of the extracellular environment (Kerr and Teasdale 2009). As large portals 
of entry into the cell, macropinosomes are in a prime position for TLR-ligand 
recognition, activation and signalling. Accordingly, I demonstrated that the TLR 
adapter TRAM as part of TLR complexes, is localised on macropinosome membranes 
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upon macrophage activation (see Figure 4.1C). Additionally, I demonstrated using a 
fluorescent reporter that upon stimulation with LPS, the signalling kinase Akt is 
enriched on macropinosomes and this enrichment is affected by the absence of the 
Rab8 GEFs GRAB and Rabin8 (see Figure 6.7), pinpointing the macropinosome as a 
site of Rab8a controlled TLR4-PI3K signalling. Through these experiments, I 
established the early macropinosome as the cellular compartment where this TLR4-
Rab8a-PI3K signalling complex is functioning. However, studies from our group have 
implicated this same Rab8a-PI3K signalling complex with other TLRs, including the 
endosomal TLRs, TLR9 and TLR3 (Wall and Luo et al. 2017). This raises an important 
question: do these endosomal TLRs signal from the same macropinosome 
compartment as the extracellular receptor TLR4? Future work is necessary to repeat 
the live cell imaging using the fluorescent Akt reporter with control and double GRAB 
and Rabin8 KO cells treated with the TLR9 ligand CpG or the TLR3 ligand Poly (I:C) 
to address this question. If validated, these results highlight macrophage 
macropinosomes as a central signalling site for multiple TLRs, and perhaps other 
immune receptors.  
 
Identification of a novel Rab effector-GEF interaction between OCRL and Rabin8 
The focus of this project was to identify the upstream regulatory GEFs that activate 
Rab8a and drives its TLR signalling function in macrophages. In understanding that 
both GEFs GRAB and Rabin8 jointly contribute to Rab8 activity in this TLR signalling 
complex, we ventured further upstream to investigate the regulatory partners that 
recruit and activate these Rab8 GEFs. Mass-spectrometry analysis and subsequent 
bacterially expressed recombinant protein pull-down experiments validated the multi-
Rab effector OCRL as a genuine Rabin8 binding partner (see Figures 7.2 and 7.4). 
Live cell imaging with fluorescent Rab8a and OCRL constructs have shown that both 
these proteins are actively recruited to and enriched on macrophage macropinosomes 
at similar times in response to LPS (see Figure 7.3B). As mentioned in chapter 7, this 
led to the hypothesis that two different scenarios exist for the potential involvement of 
OCRL. Either 1) Rabin8 helps to recruit OCRL as a Rab8 effector, or 2) OCRL recruits 
Rabin8 to macropinosomes to act as the Rab8a GEF (see Figure 7.6).  
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If Rabin8 is recruiting OCRL as an alternative effector for Rab8a on macropinosomes, 
this places Rab8a in an interesting situation where, through both its effectors PI3K 
and OCRL, it would be acting to alter the phosphoinositide environment on the 
macropinosome membrane. This would allow Rab8a to potentially direct the 
maturation, trafficking and signalling outcomes of the macropinosome (Di Paolo and 
De Camilli 2006) as well as controlling signalling. To test this, future work will include 
performing live cell imaging in Rabin8 KO cells where I would predict seeing loss of 
OCRL on macropinosome membranes. However, as both OCRL (phosphatase) and 
PI3K (kinase) compete for the same substrate [PI(4,5)P2] with opposite outcomes, 
this puts into question whether OCRL is also able to interact with GRAB in 
macrophages. A study by Bohdanowicz and colleagues demonstrated that inhibition 
of Rab5 associated recruitment of OCRL to late phagosomes enhanced Akt signalling 
due to the increase in conversion of PI(4,5)P2 to PI(3,4,5)P3 by phospholipid kinases, 
skewing cell signalling outputs and endosome maturation processes (Bohdanowicz 
and Balkin et al. 2012). My findings showed that in both single GRAB or Rabin8 KO 
cells, PI3K associated Akt signalling remained unchanged, suggesting there was no 
competition by OCRL in the absence of either GEF, possibly indicating the balance 
between PI3K and OCRL function remained relatively intact. If this OCRL-GEF 
interaction is exclusive only to Rabin8, an increase in PI3K-associated Akt signalling 
due to the lack of OCRL competition would have been expected. I was not able to 
assess if GRAB is likewise able to bind to OCRL in macrophages; however, now with 
a bacterially expressed GST-OCRL construct, another potential future experiment will 
be to use this OCRL construct in a pull-down experiment to assess if GRAB is also 
likewise able to interact with OCRL. Additionally, live cell imaging of fluorescent OCRL 
can be performed in the double KO cells to see if OCRL recruitment to 
macropinosomes is affected in the absence of both GEFs. 
 
For the second scenario, live cell imaging with recombinant Rab13 and Rab8a 
constructs have shown that Rab13 is indeed spatially and temporally upstream of 
Rab8a macropinosome enrichment in macrophages (see Figure 7.5B). As a multi -Rab 
effector, OCRL has the ability to bind to multiple Rabs including Rab13 and Rab8a. 
Therefore, in this context, OCRL could be first recruited to the macropinosome as a 
Rab13 effector which then acts to recruit Rabin8 to these macropinosomes for 
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downstream Rab8a activation. If this proves accurate, it would describe a novel Rab 
cascade that ties in Rab13-associated macropinocytosis (Condon and Heddleston  et 
al. 2018), and Rab8a TLR-signalling function (Luo and Wall et al. 2014). To test this, 
future work will involve Rab8 activation assays performed in CRISPR Rab13 KO 
macrophages will determine if Rab13 is functionally upstream of Rab8a in this TLR-
signalling pathway. Additionally, live cell imaging with fluorescent Rabin8 in Rab13 KO 
cells can be used to investigate if the absence of Rab13 affects Rabin8 recruitment to 
macropinosomes. Thus, the early studies carried out in this project presage interesting 
scenarios for OCRL involvement in TLR signalling and macrophage innate immune 
responses.  
 
Conclusions 
In this study, I describe an expansion of the TLR4-LRP1-Rab8a-PI3K complex that 
contributes to inflammatory signalling in macrophages by identifying two GEFs 
responsible for activating Rab8a in this context. I demonstrated that the Rab8 GEFs, 
GRAB and Rabin8, interact with Rab8a in macrophages in an LPS/TLR4 inducible 
fashion but gene deletion in vitro showed that neither GEF is required for Rab8a 
membrane localisation on macropinosome membranes. The absence of either GRAB 
or Rabin8 affects LPS induced Rab8 GTP-loading, and deletion of both GEFs together 
impairs the phosphorylation of key kinases and signalling molecules in the LPS-
induced Akt/mTOR pathway. Using a fluorescent Akt probe, I visually confirmed that 
Akt enrichment occurs on macropinosomes in response to LPS and this recruitment 
of Akt is diminished in the absence of both GEFs, defining the macropinosome as the 
exact site of activation for this TLR-signalling complex. Furthermore, using 
biochemical techniques, I identified a novel Rab8 GEF-effector interaction between 
Rabin8 and OCRL, introducing an exciting new regulatory protein for Rab8 function in 
macrophages. 
 
Through the TLR4-LRP1-Rab8a-PI3K complex, GRAB and Rabin8 are predicted to 
control inflammatory cytokines, since the other members of the complex both 
individually and as a cohort, constrain pro-inflammatory cytokine output and enhance 
anti-inflammatory cytokines (Fukao and Koyasu 2003, Stark and Sriskantharajah  et 
al. 2015, Luo and Wall et al. 2018). In this context, the complex controls macrophage 
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polarization towards the M2, inflammation-resolving phenotype. Thus, GRAB and 
Rabin8 are anticipated to also be inflammation constraining regulators and further 
cytokine assays on the KO cell lines or future KO mice will be able to confirm this. 
These Rab GEFs add to a complex mixture of other Rab GEFs and small GTPases 
that influence TLR trafficking and signalling. Their respective distributions and possible 
association with macropinosomes will be interesting and important to resolve through 
future imaging studies.  
 
In conclusion, this thesis defines a previously unknown function for GRAB and Rabin8 
in regulating macrophage TLR signalling for the control of inflammatory responses, 
further developing our understanding of the regulatory machinery that controls 
inflammatory signalling in macrophages. 
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Appendix 1. University of Queensland Animal Ethics Letter 
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Appendix 2. CRISPR guide RNA on and off target scores 
 
Table 10.1. Off and on target scores for CRISPR guideRNAs (IDT gRNA analysis) 
CRISPR gRNA Sequence (5 - 3) On-target Off-target 
Rabin8 CRISPR I ATGGGCTTCGTAAACGCGACAGG 33 98 
Rabin8 CRISPR II TTTACGAAGCCCATCTGTTCTGG 56 75 
Rabin8 CRISPR III TAGAGAGAAGGGCTACGAAAGG 34 56 
GRAB CRISPR I CGCAGGCGTGACACATCCAGTGG 25 71 
GRAB CRISPR II TCTCCATGGAGGAACTGCGCAGG 58 71 
GRAB CRISPR III CTTCTCTCGGATCTCCATGGAGG 61 24 
 
 
  
Chapter 10: Appendixes 
 151 
Appendix 3. Uncropped blots for Figures 4.5B and C 
 
Figure 10.1. Uncropped immunoprecipitation blots of Figures 4.5B and C. 
